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ABSTRACT 
 
Recognition of host target cells by invasive bacteria is an essential step to infection, but the 
impact of the host cell cycle on the invasion of bacterial pathogens is still largely unknown. 
During these studies it was found that mitotic cells were more efficiently targeted for invasion by 
Salmonella enterica Typhimurium (S. Typhimurium) than cells in other phases of their cell cycle. 
This targeting was dependent on the SPI-1 (Salmonella pathogenicity island-1) T3SS (type 3 
secretion system) translocase SipB, which binds to cholesterol at the surface of host cells. 
Using the cholesterol binding dye filipin and a fluorescent ester of polyethylene glycol-
cholesterol, which cannot flip through the plasma membrane, the levels of plasma membrane 
and cell surface cholesterol along the cell cycle were measured and both found to be maximal 
during mitosis. This increase was due to a transient loss in cholesterol asymmetry at the plasma 
membrane during mitosis. It was found that cholesterol changed from a ~20:80 outer:inner 
leaflet repartition during interphase to ~50:50 during mitosis. This explains the increase in 
surface levels that make mitotic cells more susceptible to S. Typhimurium invasion and perhaps 
to other viruses and bacteria that enter cells in a cholesterol-dependent manner. Additionally, it 
was found that the change in cholesterol partitioning favours the recruitment of 
phosphatidylinositol 4,5‑bisphosphate (Pi(4,5)P2) and activated ERM (Ezrin, Radixin, Moesin) 
proteins to the plasma membrane. This recruitment was shown here to support cell rounding 
during mitosis, as Pi(4,5)P2 and activated ERM are responsible for cross linking the plasma 
membrane to the actin cytoskeleton during mitosis.  
Some bacterial pathogens and viruses are known to interfere with the host cell cycle. Although 
several reports have shown significant correlation between chronic infections and cancer 
formation caused by Salmonella enterica Typhi, the impact of Salmonella on dividing cells was 
unclear before this study. During this investigation it was found that intracellular S. Typhimurium 
causes cytokinesis defects, which lead to binucleation of host cells. Intracellular replication of S. 
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Typhimurium is modulated by the action of bacterial effectors translocated across the 
Salmonella-containing vacuole (SCV) by the SPI-2 T3SS. In this study it was determined that 
the cytokinesis failure induced by S. Typhimurium occurs during abscission and is caused by 
the presence of a cluster of SCVs (microcolony) inside the dividing cell. Translocation of the 
effectors SseF and SseG is important to induce cytokinesis failure, in a process that seems to 
depend on the activity of the kinase Aurora B, known to regulate abscission. Importantly, 
binucleation was also observed in infected cells in the intestinal epithelium of mice previously 
inoculated with S. Typhimurium. Similarly to other enteric pathogens known to block the cell 
cycle of the host, perhaps cytokinesis failure caused by S. Typhimurium delays the epithelial 
cell turnover of the intestine, facilitating its colonization by the bacteria 
 
 
 
 
 
 
 
 
 
 
 
 
4 
 
ACKNOWLEDGEMENTS 
 
First and most importantly, I would like to thank my supervisor David Holden. Thanks for the 
teaching, the inspiration, encouragement and the scientific input. I really feel privileged that I had the 
chance to work directly with such a scientist. The lessons I’ve learned during my PhD are invaluable 
and what I’ve grown as a scientist in these last years are mainly thanks to you! Working in your lab 
was really an inspiration. The stimulating environment and the constant scientific discussions made 
this experience unforgettable. Therefore, huge thanks to everyone that shared the lab with me 
during my stay! From those, I would like to thank a few that were especially important for me:  
Francisco and Kieran, thanks a lot for all your help and support. I learned a lot from you. Discussing 
science with you guys was a real pleasure and your constant feedback really helped my project to 
come along. I hope I can find such amazing colleagues like you in the future! Rita, thanks for your 
patience, your support and your great advises. I know you are a true friend. I will never forget how 
much you helped and I will definitely miss our conversations. Nathalie, thanks for being such a nice 
person. Always willing to help, I really couldn’t ask for a better person to work with! Sophie, thanks a 
lot for everything really. Your true friendship will stay with me. Your kind words and constant support 
really cheered me up, especially during my down periods. Gigi and Alan, a big thanks to you guys for 
being such great friends and for supporting me in the good and bad times. You guys provided my 
best times in London and you are great fun to work with.        
I would also like to express here my gratitude to Emmanuel Boucrot, who co-supervised my PhD. 
Emmanuel, this project wouldn’t have been the same without your input. Thanks for all the guidance 
and for allowing me to learn so much from a bright mind like you. I think that you and I make a great 
team. It’s a pity if I never join your lab like we planned. You are a great scientist and a great person. I 
will never forget your support throughout these years.  
Also, I would like to express my full gratitude to Joana Moscoso, for being such an incredible friend 
that I will keep forever, and to António Ferreira, for being responsible for most of the fun and good 
times I had in London. Also, big thanks to all my dear friends from GABBA. This journey started with 
you guys and you are all just amazing! 
Finally, I dedicate this thesis to my family for all their love and support!  
This work was supported by a fellowship from the Fundação para a Ciência e a Tecnologia (FCT), 
Portugal. 
 
5 
 
CONTENTS 
 
TITLE PAGE 1
ABSTRACT 2
ACKNOWLEDGMENTS 4
CONTENTS 5
FIGURES AND TABLES 11
CHAPTER 1 - INTRODUCTION 14
   1. Salmonella pathogenesis 14
      1.1. Taxonomy and evolution of the Salmonella genus 14
      1.2. Host adaptation and disease caused by Salmonella 16
         1.2.1. Disease in humans 17
            1.2.1.1. Gastroenteritis 18
 1.2.1.2. Invasive bacteraemia 18
 1.2.1.3. Typhoid fever 19
      1.3. Animal models of infection 22
         1.3.1. The gastroenteritis model 22
         1.3.2. The typhoid fever model 23
         1.3.3. In vitro models 25
      1.4. Virulence determinants of Salmonella 25
         1.4.1. Salmonella pathogenicity islands (SPIs) 25
         1.4.2. The spv operon 26
         1.4.3. Two-component systems 27
         1.4.4. Fimbriae 28
         1.4.5. Flagella 29
         1.4.6. Type 3 secretion systems (T3SS) 29
6 
 
      1.5. T3SS-1 31
         1.5.1. Adhesion and “intimate attachment” to host cells 31
         1.5.2. Invasion: remodelling the host actin cytoskeleton  32
         1.5.3. Early biogenesis of the SCV 35
         1.5.4. Inflammation 37
      1.6. T3SS-2 38
         1.6.1. SCV maturation and activation of the T3SS-2 38
         1.6.2. Positioning of the SCV 39
         1.6.3. SCV membrane dynamics 40
         1.6.4. Interactions with the host cytoskeleton 44
         1.6.5. Modulation of the ubiquitin system 45
   2. The mammalian mitotic cell cycle 47
      2.1. Overview 47
      2.2. Mitosis 48
         2.2.1. Cytokinesis 50
            2.2.1.1. Formation of the contractile ring 51
            2.2.1.2. Abscission 51
      2.3. Cell cycle control 53
         2.3.1. CDKs and cyclins 53
         2.3.2. Quality control: the checkpoints 54
3. Bacterial interactions with the host cell cycle 57
      3.1. Cyclomodulins 57
      3.2. Bacteria and cancer development 61
4. Aims of this project 63
      4.1. Strategy regarding in vitro cell cultures 64
CHAPTER 2 - MATERIALS AND METHODS 65
      2.1. Materials 65
7 
 
         2.1.1. Bacterial strains 65
         2.1.2. Plasmids 68
         2.1.3. Bacterial growth conditions 70
         2.1.4. Electrocompetent bacterial cells 71
         2.1.5. Construction of deletion mutants of sipB and sipD 71
         2.1.6. Eukaryotic cell culture 72
         2.1.7. Antibodies and dyes 73
      2.2. Methods 75
         2.2.1. Bacterial infections of HeLa and RPE1 cells 75
         2.2.2. Manipulation of the cholesterol levels 76
         2.2.3. Transfection of RPE1 cells 76
         2.2.4. Immunofluorescence microscopy 76
            2.2.4.1. Sample preparation for microscopy analysis of fixed cells 76
               2.2.4.1.1. Image acquisition and processing  77
               2.2.4.1.2. Phosphatidylinositol-4,5-bis-phosphate (Pi(4,5)P2) extraction with 1-
butanol  77
         2.2.5. Flow cytometry  78
         2.2.6. Cell surface cholesterol and asymmetry measurements 78
            2.2.6.1. Filipin staining of live cells 78
            2.2.6.2. Cell surface cholesterol measurement (with fPEG-cholesterol) 79
            2.2.6.3. Cell surface phophatidylserine (PS) staining (with Annexin V-FITC) 79
            2.2.6.4. Staurosporine treatment of cells 79
            2.2.6.5. Cholesterol asymmetry measurements 79
         2.2.7. Immunoblot 80
         2.2.8. In vivo studies 81
            2.2.8.1. Mice infections 81
               2.2.8.1.1. Histology 81
8 
 
               2.2.8.1.2. Small intestine disaggregation for flow cytometry analysis 82
         2.2.9. Statistical analysis 82
CHAPTER 3 - SALMONELLA PREFERENTIALLY INVADES MITOTIC EPITHELIAL 
CELLS IN A T3SS-1 DEPENDENT MANNER 83
      3.1. Introduction 83
      3.2. Results 85
         3.2.1. Salmonella does not invade 100% of epithelial cells in culture even at very 
high MOIs 85
         3.2.2. Salmonella invasion in relation to the host cell cycle 86
         3.2.3. Salmonella invades mitotic cells preferentially 87
         3.2.4. Flow cytometry analysis of mitotic cell preference by Salmonella 91
         3.2.5. Infection rates of S. Typhimurium for each stage of the host cell cycle 94
         3.2.6. Salmonella targets mitotic cells independently of their size or shape 96
         3.2.7. Targeting of mitotic cells by Salmonella is dependent on the T3SS-1 98
         3.2.8. Yersinia invasin-mediated invasion of epithelial cells by S. Typhimurium did 
not show preference towards mitotic cells 101
         3.2.9. Generation of Salmonella sipB and sipD mutant strains 105
         3.2.10. Preferential targeting of S. Typhimurium to mitotic cells is dependent on 
the translocon proteins SipB and SipD 107
CHAPTER 4 - PREFERENTIAL INVASION OF MITOTIC CELLS BY SALMONELLA 
REVEALS A CHANGE IN PLASMA MEMBRANE CHOLESTEROL DURING CELL 
DIVISION 110
      4.1. Introduction 110
      4.2. Results 111
         4.2.1. The levels of cholesterol in the plasma membrane mediate the preferential 
targeting of mitotic cells by Salmonella 111
         4.2.2. Cell surface cholesterol increases during mitosis 114
9 
 
         4.2.3. Determination of cell surface cholesterol by a membrane-impermeable 
probe 118
         4.2.4. Plasma membrane cholesterol asymmetry ceases during mitosis 121
         4.2.5. Enrichment with cholesterol leads to a volume increase in mitotic cells 122
         4.2.6. Enrichment with cholesterol does not affect the levels of RhoA, Cdc42 or 
Rac1 in the plasma membrane during mitosis 124
         4.2.7. Transient loss in plasma membrane cholesterol asymmetry supports pERM 
recruitment 127
CHAPTER 5 - INTRACELLULAR SALMONELLA INDUCES CYTOKINESIS FAILURE 
IN HOST CELLS 133
      5.1. Introduction 133
      5.2. Results 135
         5.2.1. Intracellular Salmonella induces an accumulation of cells with 4n DNA 135
         5.2.2. Salmonella induces binucleation in host cells 137
         5.2.3. Host cell binucleation induced by Salmonella begins at later stages of 
infection 139
         5.2.4. Binucleation of host cells induced by Salmonella is T3SS-2 dependent 139
         5.2.5. Identification of effectors responsible for binucleation of host cells induced 
by Salmonella 141
         5.2.6. The T3SS-2 effectors SseF, SseG and SifA are required to induce 
binucleation in host cells 144
         5.2.7. Intracellular Salmonella does not affect centrosomal migration or arrest 
cells in mitosis  146
         5.2.8. Binucleation of host cells is dependent on the formation of a microcolony 149
         5.2.9. SseG and SseF localize Salmonella to the intercellular bridge during 
cytokinesis   152
         5.2.10. Intracellular Salmonella arrests cells in cytokinesis by affecting the NoCut 
10 
 
pathway  153
         5.2.11. Intracellular Salmonella induces binucleation in vivo 155
CHAPTER 6 - DISCUSSION 160
      6.1. Salmonella preferential invasion of mitotic cells is mediated by SipB  160
      6.2. Salmonella preference to invade mitotic cells might contribute to their tumour-
targeting 161
      6.3. Salmonella preference to invade mitotic cells might facilitate the localization of 
the bacteria to the intestinal crypts  163
      6.4. Cell surface cholesterol is maximal during metaphase due to a loss in its 
asymmetry at the plasma membrane during mitosis 166
      6.5. A cholesterol transporter within the plasma membrane is probably responsible 
for the loss of its asymmetry during mitosis 167
      6.6. Cholesterol asymmetry supports mitotic cell rounding 168
      6.7. Intracellular Salmonella microcolonies induce failure during cytokinesis leading 
to binucleated host cells 170
      6.8. Possible roles of the effectors SifA, SseF and SseG in cytokinesis failure of 
host cells 171
      6.9. Cytokinesis failure induced by Salmonella probably occurs during abscission 
and seems to depend on the activity of Aurora B  173
      6.10. Implications of cytokinesis failure of host cells during Salmonella infection 175
DECLARATION REGARDING AUTHORSHIP 178
PUBLICATIONS 178
BIBLIOGRAPHY 179
 
 
 
11 
 
FIGURES AND TABLES 
 
CHAPTER 1 - INTRODUCTION  
   Figure 1.1. Evolution of the Salmonella genus 16
   Figure 1.2. Progression of S. Typhi in humans 21
   Figure 1.3. Salmonella T3SS-1 apparatus 33
   Figure 1.4. Invasion process of non-phagocytic cells by Salmonella 36
   Figure 1.5. Intracellular life of Salmonella 42
   Figure 1.6. The major steps of cytokinesis 52
   Figure 1.7. Bacterial cyclomodulins and their interference with the host cell cycle 60
CHAPTER 2 - MATERIALS AND METHODS 
   Table 2.1 – Bacterial strains used in this study 65
   Table 2.2 – Plasmids used in this study 68
   Table 2.3 – Antibodies and dyes used in this study 73
CHAPTER 3 - SALMONELLA PREFERENTIALLY INVADES MITOTIC EPITHELIAL 
CELLS IN A T3SS-1 DEPENDENT MANNER 
   Figure 3.1. Infection rates of epithelial cells using different MOIs of S. Typhimurium 86
   Figure 3.2. Histograms of DNA content in epithelial cells incubated with S. 
Typhimurium strains 88
   Figure 3.3. S. Typhimurium preferentially invades mitotic cells 90
   Figure 3.4. Mitotic cell markers confirm S. Typhimurium preferential targeting of 
mitotic cells 92
   Figure 3.5. Infection rates of S. Typhimurium in each stage of the cell cycle of 
epithelial cells 95
   Figure 3.6. S. Typhimurium targets mitotic cells independently of their size or shape 97
   Figure 3.7. Model of Salmonella invasion into epithelial cells and the strategy used to 
12 
 
investigate the mechanism of its preferential targeting of mitotic cells 100
   Figure 3.8. S. Typhimurium targeting of mitotic cells is dependent on the SPI-1 T3SS 102
   Figure 3.9. Yersinia invasin-mediated internalization into epithelial cells by S. 
Typhimurium 104
   Figure 3.10. Generation of S. Typhimurium sipB and sipD mutant strains using the λ 
red recombinase system 106
   Figure 3.11. S. Typhimurium targeting of mitotic cells is dependent on the translocon 
proteins SipB and SipD 108
CHAPTER 4 - PREFERENTIAL INVASION OF MITOTIC CELLS BY SALMONELLA 
REVEALS A CHANGE IN PLASMA MEMBRANE CHOLESTEROL DURING CELL 
DIVISION 
   Figure 4.1. Cell surface cholesterol mediates the targeting of S. Typhimurium to 
mitotic cells 113
   Figure 4.2. Cell surface cholesterol is maximal during mitosis 116
   Figure 4.3. Cell surface cholesterol determination by fPEG-cholesterol 120
   Figure 4.4. Cholesterol asymmetry ceases during mitosis 123
   Figure 4.5. Metaphase cells enriched with cholesterol are bigger 125
   Figure 4.6. Cholesterol enrichment does not affect the levels of RhoA, Cdc42 or Rac1 
in the plasma membrane 128
   Figure 4.7. Loss in cholesterol asymmetry during mitosis supports recruitment of ERM 
proteins and Pi(4,5)P2 to the plasma membrane 131
CHAPTER 5 - INTRACELLULAR SALMONELLA INDUCES CYTOKINESIS FAILURE 
IN HOST CELLS 
   Figure 5.1. Intracellular Salmonella induces an increase of 4n cells 136
   Figure 5.2. RPE1 Infected cells with S. Typhimurium strains 12023, SL1344 and LT2 
for 14 h show an increased population of binucleated cells 138
   Figure 5.3. Time-course of the fold increase in 4n cells infected with EGFP-
13 
 
Salmonella 140
   Figure 5.4. SseF, SseG and SifA contribute to the increase in 4n cells induced by 
intracellular Salmonella 142
   Figure 5.5. Immunofluorescence microscopy analysis of RPE1 cells infected for 14 h 
with wild-type Salmonella, mutant strains and complemented mutant strains 145
   Figure 5.6. At 9 h of infection intracellular Salmonella does not have an effect on the 
number or migration of centrosomes and does not arrest mitosis 148
   Figure 5.7. Binucleation of host cells induced by Salmonella is dependent on the 
formation of a microcolony 151
   Figure 5.8. Localization of Salmonella and epitope-tagged effectors to the intercellular 
bridge during cytokinesis 154
   Figure 5.9. Intracellular Salmonella arrests cells in abscission by preventing Aurora B 
degradation 156
   Figure 5.10. Intracellular Salmonella induces binucleation of host cells in vivo 158
CHAPTER 6 - DISCUSSION 
   Figure 6.1. Salmonella localization to the intestinal crypts 165
   Figure 6.2. Intracellular Salmonella microcolonies prevent abscission via Aurora B 174
 
 
 
 
 
 
 
 
14 
 
CHAPTER 1 
INTRODUCTION 
   
1. Salmonella pathogenesis 
 
1.1. Taxonomy and evolution of the Salmonella genus 
Salmonella species are Gram-negative, rod-shaped, motile facultative anaerobes that belong to 
the Enterobacteriaceae family. Salmonella was first identified by Salmon and Smith in 1885, as 
these scientists attempted to isolate the causative agent of the common hog cholera. Although 
later research showed that Salmonella rarely causes enteric symptoms in pigs, and was not the 
agent they were seeking, Salmonella has since been isolated from a broad spectrum of hosts, 
including mammals, birds and reptiles, in which the resulting diseases range from 
gastroenteritis to systemic infections (Lan et al., 2009). 
The first attempt to generate a consensual nomenclature for the Salmonella genus was based 
on a serological classification. Kauffmann and White proposed to distinguish 
Salmonella serovars by two highly variable surface antigens, the O antigen, reflecting variation 
of lipopolysaccharide, and the H antigen, reflecting variation in flagellin, the major component of 
flagella (Lan et al., 2009). The Salmonella genus was initially composed of a single species but 
was later divided into 3 different species: S. enterica, S. bongori and, more recently, S. 
subterranean. This new classification arose from the utilization of two molecular techniques: 
multi-locus enzyme electrophoresis (MLEE) and DNA hybridisation (Crosa et al., 1973; Reeves 
et al., 1989).  
Phylogenetic analysis of the distribution of Salmonella genes has revealed that Salmonella 
diverged from the Escherichia genus approximately 120-160 million years ago and that 
15 
 
virulence evolved in several steps through the acquisition of multiple virulence genes. These 
encode factors that mediate adherence to the epithelium of the intestine, such as type I fimbriae 
and long polar fimbriae, encoded by the fim and lpf operons, respectively, and importantly, a 
Type 3 Secretion System (T3SS), which enables invasion of non-phagocytic cells, such as the 
epithelial cells from the gut (Baumler, 1997; Baumler et al., 1998). This T3SS is encoded by the 
Salmonella pathogenicity island-1 (SPI-1), which delivers bacterial proteins into the host cell to 
stimulate bacterial uptake (Galan and Curtiss, 1989a). As a consequence, Salmonella could 
explore a new niche within the epithelial and subepithelial layers of the intestine without 
competing for nutrients with commensal bacteria.  
The divergence of S. enterica and S. bongori was mainly mediated by the acquisition of a 
second T3SS, encoded by the Salmonella pathogenicity island-1 (SPI-2), by S. enterica. SPI-2 
enables bacterial replication inside host cells. This permitted S. enterica to disseminate to 
systemic sites, whilst S. bongori remained an exclusive gastrointestinal pathogen (Ochman et 
al., 1996; Baumler, 1997; Grant et al., 2012).     
Further diversification of the S. enterica species gave rise to host expansion and led to the 
division of this group into seven different subspecies: enterica (I), salamae (II), arizonae (IIIa), 
diarizonae (IIIb), houtenae (IV), indica (VI) and another yet to me named (VII). Subspecies I, 
encompassing more than 2400 serovars based on the Kauffman-White serological 
classification, evolved to colonise warm-blooded vertebrates. The other subspecies of S. 
enterica and S. bongori mainly infect reptiles (Brenner et al., 2000). The evolution of the 
Salmonella genus is depicted in figure 1.1. 
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Figure 1.1. Evolution of the Salmonella genus. Salmonella acquired adhesion and invasion virulence 
genes (SPI-1) to evolve from an intestinal commensal into a pathogen. Subsequent acquisition of SPI‐2 
enabled S. enterica to replicate inside host cells and cause systemic disease. Loss or acquisition of 
further virulence factors led to the divergence of Salmonella into several subspecies with distinct host 
specificities. 
 
1.2. Host adaptation and disease caused by Salmonella  
Serovars of S. enterica subsp. enterica (henceforth referred to as Salmonella or S. enterica) 
present a broad spectrum of host specificity and can cause disease, ranging from severe 
gastroenteritis to acute systemic infections. The type of disease caused by Salmonella is 
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dependent on the infecting serovar as well as on the species and immunological status of the 
infected host.  
Some serovars are host-restricted, such as S. Typhi and S. Paratyphi, which cause typhoid 
fever in humans and other primates, and S. Gallinarum, which causes systemic disease solely 
in poultry (Kingsley and Baumler, 2000; Lan et al., 2009). Other serovars are host-adapted, but 
are able to colonise and cause disease in different animal species; S. Dublin, S. Cholaraesuis 
and S. Enteritidis are commonly associated with cattle, pigs and poultry, respectively, but are 
also able to colonise mammals, including humans (Uzzau et al., 2000). On the other hand, S. 
Typhimurium can colonise a wide range of host species, such as rodents, pigs, cattle and 
humans, without a particular colonisation preference between the host species. In humans, S. 
Typhimurium normally causes a self-limiting gastroenteritis, but in some cases the infection can 
result in invasive bacteraemia (Santos et al., 2001).  
 
1.2.1. Disease in humans 
Diseases caused by Salmonella species are designated salmonelloses. In humans, there are 
three different salmonelloses, distinguished by their different clinical manifestations: typhoid 
fever, gastroenteritis and invasive bacteraemia. Typhoid fever is a life-threatening condition 
caused by S. Typhi and S. Paratyphi that is common in developing countries, especially in Asia 
and North Africa, mostly due to poor hygienic conditions. Typhoid fever is estimated to affect 
approximately 22 million people and more than 200,000 deaths per year (Ohl and Miller, 2001; 
Crump et al., 2004). Infections with Non-Typhoidal Salmonella (NTS) cause gastroenteritis in 
healthy individuals or an invasive bacteraemia in the immunocompromised. Gastroenteritis is 
normally self-limiting and patients recover after a short period of time (between 3-7 days) 
without medical treatment. Nevertheless, Salmonella-mediated gastroenteritis is the most 
frequent bacterial food-borne disease in the US, with more than one million cases estimated per 
year (Zhang et al., 2003; Scallan et al., 2011). The increasing number of cases of invasive 
18 
 
bacteraemia caused by NTS is now a major health concern, especially in the sub-Saharan 
regions of Africa. The disease is strongly associated with HIV-infected adults and 
immunocompromised children (Graham et al., 2000b; Gordon et al., 2002; Kingsley et al., 
2009).  
 
1.2.1.1. Gastroenteritis 
The NTS serovars S. Enteritidis and S. Typhimurium are the most common causative agents of 
gastroenteritis in humans. This salmonellosis is a self-limiting illness that is characterized by 
abdominal pain, diarrhoea, nausea, vomiting and fever. The bacteria invade and colonise the 
ileum, Peyer’s patches and mesenteric lymph nodes. The symptoms result from mucosal 
oedema and acute inflammation of the intestine, with recruitment of polymorphonuclear 
leukocytes (PMN). Although this recruitment is normally sufficient to contain the infection in 
the intestinal mucosa (Santos et al., 2001), there is a risk of dehydration, derived from the 
diarrhoea, which can lead to increased morbidity of otherwise healthy patients. The symptoms 
occur between 6 and 72 h after consumption of contaminated water or food, such as chicken, 
eggs or lettuce, and resolves spontaneously within a week. Treatment includes rehydration with 
water and electrolytes (Zhang et al., 2003). 
 
1.2.1.2. Invasive bacteraemia 
S. Enteritidis and S. Typhimurium are a common cause of NTS bacteraemia in children and 
HIV-positive adults in Sub-Saharan Africa. Cases of bacteraemia are reported to be fatal for 20-
25% of children, and if the infection disseminates to the meninges the fatality rate increases to 
approximately 50% (Graham et al., 2000a; Brent et al., 2006). In HIV-infected individuals, NTS 
bacteraemia has a mortality rate of 20-25% (Gordon et al., 2002). This bacteraemia occurs 
when bacteria cross the intestinal epithelium and reach the blood stream. In healthy individuals, 
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bacteria in the bloodstream are cleared through complement and antibody-mediated killing. In 
immunocompromised individuals, deregulation of the adaptive immune response leads to 
recruitment of high antibody loads against bacterial lipopolysaccharide (LPS). This in turn 
obstructs and prevents the anti-bacteriocidal antibody-mediated recruitment of complement to 
the bacterial surface and hence prevents their killing (MacLennan et al., 2008; Gondwe et al., 
2010; MacLennan et al., 2010). 
 
1.2.1.3. Typhoid fever 
Salmonella enterica serovars S. Typhi and S. Paratyphi are the causative agents of typhoid 
fever, a systemic disease characterized by high fever, abdominal pain, sometimes perforation of 
the intestine and subsequent haemorrhage, and swelling of the mesenteric lymph nodes 
(MLNs), spleen and liver (Parry et al., 2002). Humans are considered to be the major reservoir 
of S. Typhi and transmission is mediated by ingestion of food or water contaminated with faeces 
of an infected person. The symptoms develop over 8 to 14 days. The pathogenesis of typhoid 
fever differs very much from that of gastroenteritis, since it results only in a mild inflammation of 
the intestine, mainly localized in the Peyer’s patches. After reaching the small intestine, 
Salmonella must cross the intestinal mucus layer before encountering and adhering to cells of 
the intestinal epithelium. Invasion of host cells occurs mainly at the terminal ileum, through 
specialized entry into microfold (M) cells that overlay the Peyer’s patches. Bacterial-mediated 
invasion of M cells is believed to represent the main route for Salmonella to cross the intestinal 
wall. Bacteria are engulfed by macrophages and dendritic cells in the sub mucosa and can then 
replicate within these host cells. Next, S. Typhi is thought to induce macrophage cell death and 
escape to the extracellular environment. As a free pathogen or still residing in phagocytic cells, 
S. Typhi eventually reaches the blood stream directly or by passing through lymphatic vessels 
and the MLNs. From the blood stream or lymph, the bacteria reach and colonise the liver, 
spleen and bone-marrow. Within these organs, the bacteria are engulfed by macrophages and 
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undergo a second round of intracellular replication, followed by spreading to neighbouring cells 
(de Jong et al., 2012). S. Typhi can also reach and colonise the gallbladder. In there, it is 
thought to replicate inside epithelial cells and extracellularly, forming biofilms in gallstones 
(Crawford et al., 2010; Gonzalez-Escobedo and Gunn, 2013). The colonisation of the 
gallbladder is critical for the progression of the disease, as it works as the main reservoir for 
chronic infections: it allows the bacteria to extensively replicate and from there re-seed the gut, 
via bile excretion (Gonzalez-Escobedo et al., 2011). Secondary colonisation of the intestine 
frequently leads to haemorrhagic necrosis of the epithelium. As a consequence, peritonitis 
develops and the gut wall may be perforated, which is the main cause of death associated with 
typhoid fever (Everest et al., 2001) (figure 1.2).  
From 3 to 5% of individuals infected with S. Typhi develop a chronic infection in the gallbladder, 
which can persist for decades without clinical manifestations. When the bacteria re-seed the 
gut, approximately 75% of the patients experience clinical manifestations of typhoid fever again. 
The other 25% never experience any symptoms during the acute phase of the disease, 
although they are contagious. Because S. Typhi is restricted to high primates, mostly humans, 
the chronic carriers are considered to be a crucial reservoir for the spreading of disease through 
bacterial shedding in urine and faeces (Bhan et al., 2005) (Gonzalez-Escobedo et al., 2011). 
Importantly, chronic carriers of S. Typhi have an approximately eight-fold excess risk of 
developing carcinoma of the gallbladder compared to non-carriers (Caygill et al., 1995; Shukla 
et al., 2000). 
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Figure 1.2. Progression of S. Typhi in humans. Following oral ingestion, S. Typhi colonises the 
epithelium of the small intestine, in particular the Peyer’s patches. By invasion of M cells and enterocytes, 
some bacteria cross the intestinal mucosa and are taken up by macrophages and dendritic cells, reaching 
the mesenteric lymph nodes. Via the blood stream, the bacteria spread systemically and reach the 
spleen, bone marrow and liver. After replication in these sites, some bacteria re-enter the intestine via the 
gallbladder, leading to further damage of the intestinal mucosa.   
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1.3. Animal models of infection 
Animal models are used to understand the complex mechanisms that lead to salmonelloses in 
humans. These models proved to be of great value in understanding the process and outcome 
of different salmonelloses, by helping to define bacterial virulence factors and host responses.    
 
1.3.1. The gastroenteritis model 
Infection of calves and of cow ileal loops with S. Typhimurium can induce a gastroenteritis, 
whose clinical manifestations closely resemble those experienced by humans, such as 
diarrhoea, fever and dehydration (Zhang et al., 2003). However, the use of these animals is 
surely not easy, since they are large and therefore expensive, and between animals there is 
significant genomic variability, as they are outbred (Valdez et al., 2009). 
Susceptible mice infected with S. Typhimurium develop a systemic disease similar to typhoid 
fever (see below), with minimal intestinal colonisation. Nevertheless, treating mice with 
antibiotics, followed by infection with S. Typhimurium, results in a disease that resembles 
human gastroenteritis, and so this method has been used to model it. Antibiotic treatment 
allows bacteria to colonise the intestine efficiently, presumably by eliminating most of the gut 
microflora. Therefore, shortly after oral inoculation with the bacteria, the infected mice develop 
an inflammation of the caecum and colon, accompanied by infiltration of neutrophils (Barthel et 
al., 2003). Since it is a very cost-effective model that provides reproducibility, mice pre-treated 
with streptomycin have been widely used to study colitis pathogenesis induced by Salmonella 
(Hapfelmeier et al., 2004; Coburn et al., 2005).  
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1.3.2. The typhoid fever model 
Because S. Typhi is restricted to primates, to have a suitable animal model of typhoid fever is a 
challenge. Nevertheless, infection of susceptible mice with S. Typhimurium, a natural pathogen 
of rodents, has proved to be a useful way of studying the pathogenesis of this disease.  
The systemic disease associated with infection of mice with S. Typhimurium resembles that of 
typhoid fever in humans and shares some of its described pathology. Mice can be infected with 
S. Typhimurium by oral, intraperitoneal or intravenous inoculation. If oral inoculation is 
administrated, which is the most physiological route of infection, some bacteria survive the low 
pH of the stomach and colonise the intestine (Carter and Collins, 1974). After crossing the 
intestinal epithelium, the bacteria migrate via the reticuloendothelial system (RES) to colonise 
the liver and spleen, where they proliferate (Carter and Collins, 1974; Fields et al., 1986). 
Common features between this murine model and typhoid fever in humans include: enlarged 
Peyer’s patches, thickening of the ileal mucosa, diffuse enteritis (without intestinal epithelial 
destruction), replication in macrophages and dissemination and multiplication of bacteria in the 
liver, spleen and gallbladder (Carter and Collins, 1974; Valdez et al., 2009). Therefore, for 
several decades now, the murine model of typhoid fever has been of invaluable use to 
investigate the mechanisms of Salmonella virulence as well as the host immune responses. But 
different mouse strains may vary in their susceptibility to Salmonella infections, and that 
variation has been used to study different aspects of the disease. For instance, the outcome of 
infecting mice with S. Typhimurium is determined by the Nramp-1 gene (gene for natural 
resistance-associated macrophage protein-1). This gene encodes a divalent metal transporter 
present in the membrane of phagosomes of macrophages and neutrophils (Forbes and Gros, 
2001). In Salmonella infections, Nramp-1 was shown to limit iron availability inside the cell, 
leading to a great inhibitory effect on the intracellular replication of Salmonella (Nairz et al., 
2009). There are two mice lineages that lack functional Nramp-1: BALB/c and C57BL/6. Both 
these lineages of mice are susceptible to Salmonella and are widely used to model the acute 
phase of typhoid fever. 
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Alternatively, mice that are Nramp-1 positive, such as the lineage 129sv, are used as a model to 
study the chronic side of the disease. These mice are known to be naturally resistant to 
Salmonella since they are able to contain bacterial proliferation at systemic sites, never 
developing acute typhoid disease. Nevertheless, S. Typhimurium reaches the spleen, liver and 
gallbladder of these animals and is able to remain in the infected host for long periods of time, 
mimicking persistent carriage of S. Typhi in humans (Monack et al., 2004). 
Although the murine model has been of extreme importance in the study of typhoid fever, 
differences exist between the pathology of S. Typhi in humans and of S. Typhimurium in mice. 
One clear limitation of the murine model is that, although S. Typhimurium is detected in the 
mouse gallbladder, and in there is able to replicate inside epithelial cells and cause extensive 
inflammation, there is no evidence showing that these bacteria can re-seed the intestine of 
mice, contrary to what is known about S. Typhi in humans (Menendez et al., 2009). Additionally, 
there are important differences in the virulence determinants of S. Typhimurium and S. Typhi. 
For example, the Vi capsular antigen is present in S. Typhi, but not in S. Typhimurium, and is 
thought to allow immune evasion, by down-regulating TLR-mediated responses and by 
increasing resistance to complement-mediated killing (Raffatellu et al., 2006). On the other 
hand, another important virulence factor, the spv operon, is essential for the pathogenesis of S. 
Typhimurium in mice, but it is absent in S. Typhi. 
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1.3.3. In vitro models 
Several studies have shown that the intracellular lifestyle of Salmonella is essential in its ability 
to cause disease (Ibarra and Steele-Mortimer, 2009). Therefore, one way to investigate the 
molecular mechanisms of Salmonella pathogenesis is by infecting cells grown in vitro. 
Salmonella survives and replicates inside a variety of host cell types, such as epithelial cells 
and macrophages. Studying the interaction of these bacteria and the host cell in vitro has been 
invaluable in unravelling mechanisms that are crucial for the establishment of disease, such as 
the invasion of non-phagocytic cells (Patel and Galan, 2006), survival and intracellular 
replication in macrophages (Helaine et al., 2010), maturation of the Salmonella containing-
vacuole (SCV) (Meresse et al., 1999; Steele-Mortimer et al., 1999), and Salmonella-mediated 
cytotoxicity (Chen et al., 1996; Hersh et al., 1999; Rytkonen et al., 2007). 
A variety of cell lines is commonly used in the Salmonella pathogenesis field, most from human 
or mouse origin. The carcinoma derived macrophage-like cell lines, like RAW 264.7 or J774, as 
well as primary cells, such as bone marrow-derived macrophages (BMM), are commonly used 
to study killing and replication of Salmonella inside macrophages (Helaine et al., 2010; 
Hoffmann et al., 2010). Epithelial cells derived from carcinomas, such as HeLa or Caco-2, have 
been used extensively to investigate the invasion process (Hayward and Koronakis, 1999) and 
the complex interactions that Salmonella establishes with the host vesicular trafficking pathways 
(McGourty et al., 2012). 
 
1.4. Virulence determinants of Salmonella 
1.4.1. Salmonella pathogenicity islands (SPIs) 
S. enterica carries many genes implicated in virulence that are also present in non-pathogenic 
strains. To survive and colonise the gut, S. enterica antagonizes host microbicidal products or 
synthesises nutrients that are available in insufficient amounts. They share these abilities with 
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commensal bacteria, as they face the same challenges from the host environment. In addition, 
S. enterica acquired many virulence determinants that make these bacteria specialized 
pathogens. Most of the virulence factors were acquired by horizontal gene transfer, and are 
located in a variety of genetic elements, such as prophages, plasmids or pathogenicity islands 
(PAIs) (Groisman and Ochman, 1997). 
PAIs are clusters of genes integrated in the chromosome, characteristically with low G+C 
content compared to other areas of the genome. The virulence of Salmonella is dependent on 
the PAIs. In the case of Salmonella, these are specifically designated Salmonella pathogenicity 
islands (SPIs). There are 21 different SPIs identified so far within the Salmonella genus, which 
frequently correlate with host specificity (Marcus et al., 2000; Hansen-Wester and Hensel, 2001; 
Hensel, 2004). S. Typhimurium and S. Typhi share 11 SPIs, although their structure differs 
between the two serovars (Sabbagh et al., 2010). The genes present within the SPIs are 
responsible for several virulence properties characteristic of Salmonella. Two particular SPIs, 
both encoding for type 3 secretion systems (T3SS), have been widely characterized throughout 
the last three decades. In addition to other activities, the SPI-1 T3SS is required for bacterial 
invasion of non-phagocytic cells (Zhou and Galan, 2001) and the SPI-2 T3SS is necessary for 
replication inside epithelial cells and macrophages (discussed in further detail in sections 1.5. 
and 1.6) (Helaine et al., 2010).    
 
1.4.2. The spv operon 
Various serovars of Salmonella carry the highly conserved spv (Salmonella plasmid virulence) 
operon, although it is absent in S. Typhi. This operon is predominantly located within a virulence 
plasmid, but can also be found occasionally on the chromosome (Boyd and Hartl, 1998). The 
spv operon has a key role in the growth of S. Typhimurium in mice, being essential in the 
establishment of systemic disease (Gulig et al., 1993). The operon is constituted by the genes 
spvA, spvB, spvC, spvD preceded by spvR, which regulates the expression of the operon. The 
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virulence associated with this operon has been shown mostly to rely on the actions of SpvB and 
SpvC, which are delivered into the host cell cytosol by the SPI-2 T3SS. SpvB functions as an 
actin-ribosyltransferase to prevent the formation of actin filaments. This destabilizes the host 
cell cytoskeleton and therefore contributes to cytotoxicity. On the other hand, SpvC is a 
phosphothreonine lyase, with a possible role in modulating the host immune responses, since 
its overexpression results in downregulation of pro-inflammatory cytokine release. Interestingly, 
SpvC has been recently shown also to be delivered by the SPI-1 T3SS (Libby et al., 2000; 
Lesnick et al., 2001; Matsui et al., 2001; Mazurkiewicz et al., 2008; Haneda et al., 2012).   
 
1.4.3. Two-component systems 
Two-component regulatory systems are widely used by bacteria to respond to environmental 
stimuli, such as pH, temperature, nutrient concentration or harmful compounds. These systems 
are composed of an inner membrane-located histidine-kinase, that senses a specific external 
signal, and a cognate cytoplasmic response regulator that mediates the cellular response by 
acting as a transcription regulator, controlling the differential expression of target genes 
(Mascher et al., 2006).  
PhoP/PhoQ is a major two-component regulatory system that coordinates the expression of 
more than 40 genes. This system is essential for the pathogenesis of many Gram-negative 
bacteria, including Salmonella. The expression of most of its target genes has been associated 
with virulence phenotypes, and a Salmonella mutant strain lacking either PhoP or PhoQ is 
highly attenuated in virulence in mice (Galan and Curtiss, 1989b; Miller et al., 1989). PhoP is 
the histidine-kinase, found in the inner membrane. It senses low pH, [Mg2+] and antimicrobial 
peptides (Miller et al., 1989; Alpuche Aranda et al., 1992; Garcia Vescovi et al., 1996; Bader et 
al., 2005; Monsieurs et al., 2005). It responds to these signals by phosphorylating its cognate 
response regulator PhoQ, which is then able to bind DNA and regulate the expression of 
several genes. Inside host cells, Salmonella exists within a vacuole whose lumen is 
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characterized by an acidic pH and low Mg2+. These conditions are thought to be sensed by the 
PhoP/Q system, whose response enables bacterial survival (Sciara et al., 2008). Genes 
positively regulated by the PhoP/Q system, designated pags, include those encoding for 
proteins involved in the transport of Mg2+, in the resistance to anti-microbial peptides (AMPs) 
and in the modification of LPS (Soncini et al., 1996; Ernst et al., 2001). The target genes 
repressed by this system are named prgs, and include regulators of the SPI-1 T3SS and flagella 
(Bijlsma and Groisman, 2005). 
Another two-component regulatory system important for the virulence of Salmonella is the 
OmpR/EnvZ system. This system senses and responds to environmental changes in osmolarity 
and pH (Bang et al., 2000). It was shown to influence the expression of SPI-2 genes, as it 
regulates transcription of the SPI-2-encoded SsrA/B two-component system (Garmendia et al., 
2003). Salmonella mutant strains lacking a functional OmpR/EnvZ system are greatly 
attenuated in virulence in mice (Dorman et al., 1989).  
 
1.4.4. Fimbriae 
Before invading epithelial cells, Salmonella attaches to the mucosal surfaces of the intestine. 
This is thought to be mediated by fimbriae - hair-like structures present at the surface of 
bacteria that establish the initial contact with the targeted cell. Salmonella serovars carry in their 
genomes several fimbriae-encoding genes. S. Typhimurium has 12 predicted fimbrial operons, 
including fim (type I fimbriae), pef (plasmid-encoded fimbriae) and lpf (long polar fimbriae) 
(Sabbagh et al., 2010). Fimbriae play a major role in the colonisation of the intestinal epithelium 
by conferring adhesion to the mucosal surfaces and subsequent invasion of epithelial cells 
(Baumler et al., 1996b). Furthermore, infections of mice with S. Typhimurium showed that 
fimbrial adhesions confer tropism towards Peyer’s patches of the small intestine, mostly due to 
the action of lpf and pef operons (Baumler et al., 1996a; Baumler et al., 1996c). Additionally, it 
has been shown that FimH, a fimbrial adhesin present in Salmonella, binds to glycoprotein 2, 
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which is highly expressed in ‘M’ cells of Peyer’s patches in the intestine. This binding was 
shown to be critical for bacterial invasion of M cells in vivo (Hase et al., 2009) and this is thought 
to be the main route for Salmonella to cross the epithelium of the small intestine. Additional 
studies have shown that fimbrial adhesions can target Salmonella for direct uptake by dendritic 
cells (DC) (Guo et al., 2007). Direct uptake of Salmonella by DCs, from the gut lumen through 
the intestinal epithelium, is thought to be an alternative route by which the intestinal barrier can 
be crossed (Niess and Reinecker, 2005; Chieppa et al., 2006).        
 
1.4.5. Flagella 
Bacterial flagella confer mobility of the organism within its environment, allowing bacteria to 
move towards nutrients and away from repellents (Blair, 1995). S. Typhimurium has 
approximately 6 to 10 flagella per bacterial cell that are arranged peritrichously around its 
surface. The filament, which acts as a propeller, is approximately 10 μm in length and is 
composed of flagellin protein, either FliC or FljB (Silverman, 1980). It is still unclear if the 
flagellum of Salmonella has a role in cell invasion. It has been proposed that it contributes to 
invasion of epithelial cells in the intestine, but mutants lacking the flagella apparatus or that are 
incapable of producing flagellin maintain full virulence in the mouse model (Schmitt et al., 2001). 
On the other hand, flagellin is detected by TLR-5, which leads to inflammation in the gut 
epithelium (Gewirtz et al., 2001). Additionally, it has been demonstrated that flagellin is 
translocated into host macrophages by the SPI-1 T3SS. This is thought to induce caspase-1-
mediated cell death via activation of the inflammasome (Miao et al., 2006; Sun et al., 2007). 
 
1.4.6. Type 3 secretion systems (T3SSs) 
Type 3 secretion systems (T3SSs) are specialized organelles with a needle-like configuration, 
sometimes referred to as “injectisomes”. They span the inner and outer membranes of Gram-
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negative bacterial pathogens and their central function is to deliver bacterial virulence proteins, 
or effectors, into eukaryotic cells (Cornelis, 2010). T3SSs are composed of more than 20 
proteins, many of which share common ancestry with the flagella secretion system. These 
systems are tightly regulated, both at the level of transcription and post-transcription, since it is 
essential that the proteins delivered exert their function in a manner that is temporal and 
spatially coordinated (Lucas and Lee, 2000). The structure of the T3SS is composed of the 
needle complex, the basal body, and the inner rod, which connects the basal body to the 
needle. The basal body is structurally very similar to the flagellar base and the needle complex 
is analogous to the flagellar hook, a structure that connects the base to the flagellar filament 
(Aizawa, 2001).  
After the assembly of the secretion system and the needle, a group of proteins known as 
“translocases” are secreted through the needle and likely form a pore in the host cell 
membrane. This pore enables the passage of effector proteins directly from the bacterial cytosol 
into the host cell cytoplasm. The recruitment and unfolding of the T3SS substrates is promoted 
by an ATPase located at the base. This unfolding is essential for successful secretion of 
substrates, due to the limited diameter of the secretion channel (Galan and Wolf-Watz, 2006; 
Cornelis, 2010).  
Salmonella enterica carries two T3SSs that are encoded by two distinct pathogenicity islands, 
SPI-1 and SPI-2. The injection of bacterial effectors by the SPI-1 T3SS (T3SS-1) promotes 
invasion of epithelial cells. Bacterial effectors stimulate the formation of actin-rich membrane 
ruffles that drive bacterial internalization (Galan and Curtiss, 1989a). Following internalisation 
into the host cell, bacteria replicate in a membrane-bound compartment. Bacterial replication 
inside host cells is largely enabled by the translocation of effectors by the second T3SS, 
encoded by 
SPI-2 (T3SS-2), which delivers approximately 30 effectors across the vacuolar membrane 
(Ochman et al., 1996; Hensel et al., 1998; Figueira and Holden, 2012). Until recently, it was 
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thought that these two systems functioned independently, however, a much closer relationship 
between the T3SS-1 and the T3SS-2 is becoming apparent: some effectors involved in invasion 
also have a role in the intracellular phase of infection (Humphreys et al., 2009; Srikanth et al., 
2010; Rodriguez-Escudero et al., 2011). 
 
1.5. T3SS-1 
1.5.1. Adhesion and “intimate attachment” to host cells 
Invasion of epithelial cells is dependent on the T3SS-1, although T3SS-1-independent invasion 
of non-phagocytic cells has been shown in vitro (Aiastui et al., 2010).  
The initial contact between bacteria and host cells is mediated by fimbriae, and is essential for 
invasion of non-phagocytic cells (Baumler et al., 1997). Following that initial contact, which is 
reversible, the needle apparatus is assembled and secretion of translocon proteins occurs. 
These form a pore in the host cell membrane that is essential for stable binding between the 
bacteria and the host cell, the so-called “intimate attachment” (Misselwitz et al., 2011b). In the 
case of T3SS-1, the proteins that assemble the pore, also called translocases, are SipD, SipB 
and SipC (Collazo and Galan, 1997; Lara-Tejero and Galan, 2009). The translocase SipD is 
present at the tip of the needle complex prior to contact with the host cell, and is thought to 
operate as a sensor of host cell membranes (Lara-Tejero and Galan, 2009). In the absence of 
SipD, the other two translocases, SipB and SipC, are not secreted and the translocon pore is no 
longer formed. Thus, both the initial contact of Salmonella to the host cell and the subsequent 
association established by SipD, are required for full activation of the T3SS-1 (Lara-Tejero and 
Galan, 2009) (figure 1.3).  
Strains lacking SipD, SipB or SipC are unable to associate intimately with host cells (Lara-
Tejero and Galan, 2009). The mode of action of SipD is still to be determined, but the binding 
targets of SipB and SipC in the host cell membrane are known. SipB binds to cholesterol 
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present at the surface of host cells. Depletion of cholesterol leads to reduced attachment of 
Salmonella to host membranes and was shown to impair translocation of effectors (Hayward et 
al., 2005). SipC binds Exo70, a component of the exocyst complex that mediates the fusion of 
vesicles to the plasma membrane. It has been proposed that Exo70 is recruited to the 
attachment sites of S. Typhimurium and binds to SipC (Nichols and Casanova, 2010). The 
intimate attachment of S. Typhimurium with host cells is likely to result from the concerted 
binding activity of the translocases SipB, and SipC, to their respective targets at the host 
plasma membrane. Evidence gathered so far suggests that only SipB and SipC insert into and 
associate within the plasma membrane to form the pore, probably due to their hydrophobic 
properties, and that this process is somehow guided by SipD. In addition, it is believed that the 
binding of SipB to cholesterol initiates the assembly of the translocon pore, and that this binding 
is crucial to attach the bacterium irreversibly to the host cell membrane (Hayward et al., 2000; 
McGhie et al., 2002; Picking et al., 2005). 
 
1.5.2. Invasion: remodelling the host actin cytoskeleton  
After activation of the T3SS-1, 11 effector proteins are known to be translocated directly into the 
host cell cytosol (Haraga et al., 2008). To invade non-phagocytic cells efficiently, Salmonella 
relies on the combined activity of at least five T3SS-1 effectors: SipA, SipC, SopB, SopE and 
SopE2. These effectors target the actin cytoskeleton in different ways to cause localized 
membrane ruffling and bacterial uptake (figure 1.3). 
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Figure 1.3. Salmonella T3SS-1 apparatus. The needle complex is assembled from about 25 proteins 
which span the inner and the outer membrane of the bacterial cell wall (red). The translocon proteins, 
SipB and SipC, bind to the host cell membrane (yellow) likely to form a pore, through which the effectors 
(green) are secreted.   
 
SopE and SopE2 mimic the functions of eukaryotic guanine exchange factors (GEFs). They 
activate proteins of the Rho-family GTPases. Rho-family GTPases are key regulators of the 
host cell architecture and their mechanisms of action have been characterized in great detail. 
There are slight substrate specificity differences between SopE and SopE2. It has been shown 
that SopE mainly activates Rac1 and Cdc42, whereas SopE2 seems to be specific for Cdc42 
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activation. The activation of Rac1 by SopE is required for Salmonella invasion. On the other 
hand, although Cdc42 is targeted by both SopE and SopE2, its activation is dispensable for 
Salmonella invasion. Additional data suggest that the activation of Cdc42 by Salmonella is 
important to stimulate pro-inflammatory responses (Patel and Galan, 2006). Another T3SS-1 
effector involved in Salmonella invasion is SopB, which is an inositol phosphatase. SopB is able 
to activate the exchange factor RhoG. Although its mechanism of action is not yet fully 
understood, it is believed that this activation occurs indirectly, through the host SH3-containing 
guanine nucleotide exchange factor (SGEF), which is able to activate RhoG and possibly other 
Rho-GTPases (Norris et al., 1998; Patel and Galan, 2006). The cooperative actions of SopE, 
SopE2 and SopB, through activation of host Rho-GTPases, triggers a complex signalling 
pathway that ultimately leads to recruitment and activation of the Arp2/3 complex (Criss and 
Casanova, 2003). The Arp2/3 complex, by interacting with members of the Wiskott-Aldrich 
syndrome protein (WASP) family, such as N-WASP (activated by Cdc42) and WAVE2 
(activated by Rac1), promotes actin nucleation and bundling (Stradal et al., 2004; Unsworth et 
al., 2004; Shi et al., 2005). There is a degree of redundancy in the function of SopE, SopE2 and 
SopB, since single mutant strains lacking individual proteins are still invasive, but a strain 
lacking all three effectors is defective in invading non-phagocytic cells (Zhou et al., 2001).  
Contrary to SopE, SopE2 and SopB, the other two proteins secreted by the T3SS-1 that are 
involved in invasion, SipA and SipC, bind actin directly to mediate its polymerization and 
bundling. The carboxy-terminal domain of SipA binds to actin filaments, increasing their stability 
and reducing de-polymerization by host cell proteins, such as ADF, cofilin or gelsolin (McGhie et 
al., 2001; Lilic et al., 2003; McGhie et al., 2004). SipA also stabilizes actin filaments by 
enhancing the localised actin-bundling activity of T-plastin (Zhou et al., 1999a). Besides its 
function as a translocase, SipC has also been shown to nucleate actin through direct binding at 
its C-terminal region (Hayward and Koronakis, 1999). The actin nucleation and bundling 
promoted by SipC was shown to contribute directly to the cytoskeletal rearrangements during 
bacterial invasion in vivo (Chang et al., 2005). SipA and SipC are thought to work together to 
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nucleate actin, facilitate the formation of actin filaments and prevent their disassembly (McGhie 
et al., 2001). Both these proteins can produce small F-actin foci at sites of bacteria-host contact, 
however they cannot induce ruffling and invasion by themselves (Zhou et al., 1999b; Jepson et 
al., 2001; Higashide et al., 2002; Schlumberger et al., 2005; Cain et al., 2008). 
After bacterial internalization, the host cell cytoskeleton returns to its resting state through the 
activity of SptP, another T3SS-1 effector. SptP mimics eukaryotic GAPs, deactivating Rac1 and 
Cdc42 and reverting the actin rearrangements induced by SopE, SopE2 and SopB (Fu and 
Galan, 1999; Murli et al., 2001; Humphreys et al., 2009). 
The major steps of the invasion process of non-phagocytic cells by Salmonella are depicted in 
figure 1.4. 
 
1.5.3. Early biogenesis of the SCV 
Once bacterial internalization is completed, the T3SS-1 still has an important role in the 
intracellular fate of Salmonella, by contributing to the biogenesis of the Salmonella-containing 
vacuole (SCV).  
Besides its role in the rearrangement of actin after invasion, SptP is also thought to contribute to 
the SCV biogenesis. SptP can function as a tyrosine phosphatase and was shown to 
dephosphorylate the AAA+ ATPase VCP, controlling the recruitment of proteins to the SCV 
(Humphreys et al., 2009). 
A key effector involved in SCV biogenesis and maturation is SopB. As an inositol phosphatase, 
SopB was shown to dephosphorylate a range of phosphoinositide phosphate and inositol 
phosphate substrates in vitro (Patel and Galan, 2005). During bacterial internalization, the 
hydrolysis of PI(4,5)P2 induced by SopB, at the ruffling membrane, increases the fusion of 
plasma membrane invaginations to rapidly enclose the bacteria within a sealed phagosome (the 
SCV) (Terebiznik et al., 2002). In addition, SopB recruits the GTPase Rab5, an early-
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endosomal/lysosomal marker, to the SCV, along with its interacting partner Vps34. This results 
in the generation of PI(3)P, which is thought to lead to the recruitment of EEA1, LAMP1 and the 
host SNARE protein Vamp8 to the membrane of the SCV (Patel and Galan, 2005; Dai et al., 
2007; Steele-Mortimer, 2008). Interestingly, another T3SS-1 effector, SopD, is believed to act 
cooperatively with SopB in most of these processes (Bakowski et al., 2007). Furthermore, a 
report suggested that the activity of SopB as an inositol phosphatase controls the charge of the 
membrane surface of nascent SCVs, by reducing levels of negatively charged lipids. The 
authors propose that this SopB activity results in the dissociation of a number of host-cell 
endocytic trafficking proteins from the vacuole, which is thought to inhibit the fusion of 
lysosomes to the SCV and subsequent bacterial killing (Bakowski et al., 2010). 
 
 
Figure 1.4. Invasion process of non-phagocytic cells by Salmonella. During the binding step, the 
bacteria adhere reversibly to cells via fimbriae (blue). Irreversible binding or “intimate attachment” is 
mediated by the translocon proteins of the T3SS-1 (red). Following injection of effectors (purple), host 
membrane ruffling is induced. Subsequent closure of the host membrane encloses the bacterium inside, 
producing the early SCV.     
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1.5.4. Inflammation 
A well established feature of S. Typhimurium infections is an acute inflammation of the gut 
mucosa. This is mainly triggered by the detection of bacterial PAMPs (pathogen-associated 
molecular patterns) by PRRs (pattern recognition receptors) within the mucosa, in response to 
Salmonella penetrating the intestinal epithelium and surviving in macrophages (Broz et al., 
2012). This response is characterized by the secretion of key cytokines such as IL-18 and IL-23. 
The release of these cytokines ultimately leads to an amplified inflammatory response by 
paracrine signalling mechanisms, inducing massive secretion of IFNγ, IL-22 and IL-17 by 
resident T-cells of the intestinal mucosa (Broz et al., 2012).  
Intestinal inflammation is also triggered by T3SS-1 effectors, resulting in distinctive 
gastroenteritis induced by Salmonella infections. SopE, SopE2 and SopB activate MAPK 
(mitogen-activated protein kinase) pathways that lead to the production of pro-inflammatory 
cytokines, such as IL-8 and the recruitment of PMNs (Bruno et al., 2009). Additionally, SipA and 
SopA are two other T3SS-1 effectors shown to induce chemokine release and to cause 
neutrophil migration to the infection sites (Lee et al., 2000; Zhang et al., 2006). On the other 
hand, SopB has been shown to contribute directly to diarrhoea as it induces secretion of 
chloride and fluids (Galyov et al., 1997). Importantly, this acute inflammatory response is greatly 
exacerbated by two important T3SS-1 effects: disruption of the tight junctions of the intestinal 
epithelium by SopB, SopE, SopE2 and SipA (Boyle et al., 2006) and death of macrophages and 
dendritic cells induced by SipB, in a process thought to be mostly dependent of caspase-1. This 
cell death is termed pyroptosis and involves the activation of the pro-inflammatory cytokines IL-
1β and IL-18 (Fink and Cookson, 2007). 
Interestingly, Salmonella has evolved a number of mechanisms to decrease the acute 
inflammation its infection induces. SptP was shown to downregulate MAPK-mediated signalling 
and production of IL-8 (Haraga and Miller, 2003; Lin et al., 2003) and the acetyltransferase 
activity of AvrA inhibits apoptosis by blocking the activation of MAPK (Jones et al., 2008; Du 
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and Galan, 2009). These mechanisms to dampen the inflammatory responses might contribute 
to the establishment of persistent colonisation of the gut intestine.      
 
1.6. T3SS-2 
1.6.1. SCV maturation and activation of the T3SS-2 
Following invasion of epithelial cells or uptake by phagocytic cells, the SCV gradually matures 
into a specialized compartment through a succession of complex interactions with the host cell 
endocytic pathway. The SCV acquires features that are similar to late endosomes, such as an 
acidified lumen and the presence of late endosomal markers in the SCV membrane, such as 
vATPase and the lysosomal glycoproteins (lgp) LAMP1 and LAMP2. The acquisition of different 
lgps is thought to be dependent on the activity of Rab7 (Garcia-del Portillo and Finlay, 1995; 
Meresse et al., 1999). In epithelial cells, the SCVs mature as they migrate along the 
microtubules towards the microtubule-organizing centre (MTOC), a perinuclear location close to 
the Golgi network (Salcedo and Holden, 2003; Abrahams et al., 2006). SCV movement is 
dependent on the recruitment of dynein to the vacuolar membrane via a Rab7-RILP interaction 
(Guignot et al., 2004).  Dynein is a motor protein that moves toward the minus-end side of 
microtubules in a centripetal manner, in a process known as retrograde movement (Vale, 2003). 
This process of migration has been shown to also depend on Rab7 and Rab11.  
Upon arrival at the Golgi region of epithelial cells, Salmonella undergoes several rounds of 
replication, forming a cluster of bacteria, commonly termed “microcolony”, a process that is 
dependent on a functional T3SS-2. The T3SS-2 is believed to be formed approximately 4 h after 
bacterial entry into the host cell (Cirillo et al., 1998; Knodler and Steele-Mortimer, 2003; Smith et 
al., 2005a; Figueira and Holden, 2012) in response to low pH, nutrient deprivation, reduced 
[Mg2+] and presence of anti-microbial peptides in the lumen of the SCV (Deiwick et al., 1999). 
Approximately 30 different effectors are translocated across the vacuolar membrane by the 
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T3SS-2 (Figueira and Holden, 2012). Similarly to T3SS-1, translocation of effectors by T3SS-2 
requires the formation of a translocon, which in this case is composed of SseB, SseC and SseD 
(Nikolaus et al., 2001). After the translocon pore is formed in the membrane of the SCV, the 
neutral pH from the host cell cytosol is sensed by an unknown mechanism, and only then 
translocation of effectors take place (Yu et al., 2010). 
 
1.6.2. Positioning of the SCV 
The juxtanuclear positioning of the SCV is dependent on at least three T3SS-2 effectors: SifA 
(Boucrot et al., 2005), SseG (Salcedo and Holden, 2003) and SseF (Deiwick et al., 2006). 
Salmonella mutant strains lacking either SseF or SseG localize initially to the MTOC/Golgi 
region, but then scatter throughout the cell, which indicates that these effectors are essential to 
maintain the juxtanuclear positioning of the SCV, but not to its migration (Deiwick et al., 2006; 
Ramsden et al., 2007b). In addition, vacuolated sifA mutants have been shown to display 
centrifugal scattering (Boucrot et al., 2005). Importantly, mutant strains lacking SseF, SseG or 
SifA have been shown to possess replication defects inside the host cell, which suggests that 
the positioning of the microcolony close to the Golgi apparatus might be important for bacterial 
replication (Hensel et al., 1998; Beuzon et al., 2002). In the eukaryotic cell, the Golgi is a point 
of convergence in the traffic of vesicles. It is believed that the juxtaposed positioning of the 
Salmonella microcolony to the Golgi network could provide increased nutrient and membrane 
acquisition, by fusion of Golgi and/or endosomal vesicles with the SCV (Salcedo and Holden, 
2003; Ramsden et al., 2007a; Mota et al., 2009).  
SseF and SseG are integrated in the vacuolar membrane, co-localize to the microtubule 
network and are involved in the formation of tubular membranous structures known as 
Salmonella-induced filaments (Sifs) (Kuhle and Hensel, 2002; Kuhle et al., 2004) (discussed in 
1.6.3.). Single ∆sseF or ∆sseG mutants have very similar growth defects in macrophages and 
are equally attenuated in virulence in mice (Hensel et al., 1998; Kuhle and Hensel, 2002). 
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Furthermore, there is no cumulative effect on virulence attenuation in a double mutant strain 
lacking both SseF and SseG compared to the single mutants. Not surprisingly, SseF and SseG 
have been shown to interact with each other and thus thought to share the same function in 
host cells (Deiwick et al., 2006). 
It is still not known how SseF and SseG control the positioning of the microcolony in the Golgi 
region. One possibility is that they form a complex in the SCV membrane that interacts with 
Golgi-associated molecules. This way, the SCV might remain tethered to the Golgi. This Golgi-
tethering model has gained strength from live imaging observations of infected cells, and most 
importantly by the fact that treatment of cells with Brefeldin A, which disassembles the Golgi 
complex, mimics the positioning of the SCVs in cells infected with ∆sseF or ∆sseG mutant 
strains (Ramsden et al., 2007a).   
 
1.6.3. SCV membrane dynamics 
One distinctive feature of intracellular Salmonella is its ability to form tubular membranous 
structures known as Sifs. Those are dramatic centrifugal extensions of the vacuolar membranes 
along host cell microtubules (Garcia-del Portillo et al., 1993). Some researchers believe that, by 
offering additional contact surface, Sifs function as a means to increase the probability of 
vesicular fusion to the SCV, providing more acquisition of nutrients and membranes for the 
bacteria, although further evidence is required to support this hypothesis. SifA is essential for 
the formation of Sifs (Stein et al., 1996). Mutant strains of Salmonella lacking SifA do not 
produce Sifs and gradually lose the vacuolar membrane several hours after bacterial entry 
(Beuzon et al., 2000). This results in the release of ∆sifA mutant bacteria into the cytosol of host 
cells. In macrophages, the mutant is killed after SCV breakdown, probably due to the presence 
of anti-microbial peptides (AMPs) in the macrophage cytosol (Hiemstra et al., 1999; Beuzon et 
al., 2002). Therefore, sifA mutant strains are severely attenuated in virulence in mice (Beuzon et 
al., 2000). Interestingly, in non-phagocytic cells, the intracellular fate of the ∆sifA mutant seems 
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to depend on the cell line used: this mutant replicates faster than the wild-type in HeLa cells 
(Beuzon et al., 2002; Brumell et al., 2002), but not in other epithelial cell lines tested in our 
laboratory. Before the disruption of the SCV, ∆sifA mutant bacteria accumulate kinesin-1 at the 
vacuolar membrane. Kinesin-1 is a molecular motor that transports cargo towards the plus-end 
side of microtubules, normally towards the cell periphery, in a process known as anterograde 
movement. (Vale, 2003; Boucrot et al., 2005). Since SifA has been shown to interact with SKIP, 
a eukaryotic protein that binds kinesin-1, it is thought that the SifA-SKIP complex prevents the 
accumulation of kinesin-1 around the vacuoles (Boucrot et al., 2005). This leads to increased 
anterograde transport in the cell and promotes vesicular budding from the SCV (Dumont et al., 
2010). Depletion of SKIP in cells infected with wild-type Salmonella, leads to loss of the 
vacuolar membrane, similarly to what is observed in cells infected with a ∆sifA mutant strain 
(Boucrot et al., 2005). Although still unclear, it is now thought that Sifs result from the vesicular 
budding events originated by the activity of SifA-SKIP complex at the SCV.  
The recruitment of kinesin-1 to the SCV is due to the activity of PipB2, another T3SS-2 effector 
(Henry et al., 2006). There is a functional link between PipB2 and SifA activities, since the 
inhibition of kinesin activity prevents the rupture of the vacuolar membrane of ∆sifA mutants 
(Guignot et al., 2004). However, a Salmonella strain carrying mutations in both sifA and pipB2 
still loses the vacuolar membrane, even without recruitment of kinesin-1 (Henry et al., 2006). In 
fact, ∆pipB2 mutant strains preserve SCV integrity. Nevertheless, it is evident that PipB2 is 
involved in kinesin-driven SCV dynamics and in the formation of Sifs (Knodler and Steele-
Mortimer, 2005), but the mechanism underlying SCV rupture is still subject of research. 
Importantly, it has been shown that PipB2 contributes to Salmonella virulence in the mouse 
model (Knodler et al., 2003). 
 
 
 
42 
 
 
Figure 1.5. Intracellular life of Salmonella. Following invasion of epithelial cells, the SCV gradually 
matures into a specialized compartment through a succession of complex interactions with the host cell 
endocytic pathway. Upon arrival at the MTOC/Golgi region, Salmonella undergoes several rounds of 
replication, forming a cluster of bacteria, the microcolony. Intracellular replication is fully dependent on the 
T3SS-2 and the maintenance of the juxtanuclear positioning of the SCVs depends on the actions of the 
effectors SifA, SseG and SseF.  
 
SopD2 is another T3SS-2 effector involved in SCV stability. A recent study showed that deletion 
of sopD2 reduces the loss of membrane around ∆sifA mutant vacuoles, which indicates that 
SopD2 is somehow involved in the dynamics of the SCV membrane (Schroeder et al., 2010). 
SopD2 localizes to the SCV membrane, Sifs, late endosomes and lysosomes and it has been 
shown to be involved in Sif formation (Jiang et al., 2004). Similarly to SopD2, SseJ is another 
effector shown to influence the SCV dynamics, since the combined deletion of sseJ and sifA 
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leads to reduced loss of vacuolar membrane around the bacteria (Ruiz-Albert et al., 2002). 
Interestingly, another study showed that ∆sseJ mutant bacteria form more Sifs than the wild-
type (Ohlson et al., 2005). The influence of SseJ in vacuolar integrity and Sif formation indicates 
that SseJ antagonizes the activities of SifA. Interestingly, both sseJ and sopD2 are 
pseudogenes in S. Typhi, but both are important for virulence of S. Typhimurium in mice (Jiang 
et al., 2004; Ohlson et al., 2005). This suggests that S. Typhimurium and S. Typhi use different 
mechanisms to maintain the integrity of their vacuoles.   
One characteristic phenotype associated with SseJ is that cells infected with wild-type 
Salmonella contain significantly more lipid droplets than cells infected with a ∆sseJ mutant. It is 
known that lipid droplets are enriched in esterified cholesterol, and SseJ has been shown to 
possess both glycerophospholopid:cholesterol acyltransferase (GCAT) and phospholipase A 
activities (Lossi et al., 2008; Nawabi et al., 2008). Both activities of SseJ allow it to remove 
esterified cholesterol from SCVs into lipid droplets, by acting on the phospholipids present at the 
SCV membrane and transferring acyl chains to cholesterol (Lossi et al., 2008; Nawabi et al., 
2008). This activity might be important for the anchoring of proteins to the SCV membrane. 
Interestingly, it is well established that the rigidity of membranes is affected by cholesterol 
composition (Petrache et al., 2006), so by removing cholesterol from the SCV, SseJ would 
increase its rigidity, which might explain the role of SseJ in the rupture of vacuoles surrounding 
∆sifA mutant bacteria (Lossi et al., 2008). 
Since SCVs share many characteristics with lysosomes, the question of how Salmonella is 
apparently able to escape fusion with lysosomes and subsequent killing has remained a 
paradox for a long time. It was known that the retrograde traffic of hydrolytic enzymes, from 
endosomes to the Trans-Golgi network (TGN), requires Rab9 (Raposo et al., 2007). A recent 
report from our laboratory shows that SKIP interacts with Rab9 to negatively regulate retrograde 
transport of lysosomal enzymes, and that binding of SifA to SKIP enhances this. Thus, SifA-
SKIP complexes act as a “sink” for Rab9, inhibiting lysosomal function (McGourty et al., 2012). 
This provides an explanation for how intracellular Salmonella interacts with lysosomes without 
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being degraded. It also accounts for the finding that SCVs are relatively devoid of lysosomal 
enzymes delivered by the mannose-6-phosphate receptor (Garcia-del Portillo and Finlay, 1995; 
Rathman et al., 1997). 
 
1.6.4. Interactions with the host cytoskeleton 
One interesting aspect about the intracellular state of Salmonella is the accumulation of a dense 
F-actin meshwork around the microcolony (Meresse et al., 2001; Unsworth et al., 2004). This 
was shown in our laboratory to be due to the serine/threonine kinase activity of another T3SS-2 
effector, SteC (Poh et al., 2008). Subsequent work, also from our group, showed that SteC 
phosphorylates MEK1 and activates ERK and MEK pathways. This leads to the activation of 
myosin-II, an actin motor protein that facilitates F-actin bundling. As a result, F-actin fibres form 
within and around the microcolony. Surprisingly, this process seems to downregulate bacterial 
replication inside the host cell, as mutants lacking SteC display increased replication inside host 
cells compared to the wild-type bacteria. Accordingly, ∆steC mutant Salmonella are 
hypervirulent in mice (Odendall et al., 2012). 
Two other T3SS-2 effectors that localize to the SCV-associated F-actin meshwork are SspH2 
and SrfH, although neither seems to contribute to its formation (Miao et al., 2003). SspH2 was 
shown to bind to the eukaryotic protein profilin, which is known to enhance actin polymerization 
(Winder and Ayscough, 2005). Purified SspH2 inhibited the rate of actin polymerization in vitro, 
which suggests that its activity might counteract the effects of SteC inside host cells (Miao et al., 
2003). On the other hand, SrfH has been reported to influence cell migration of infected cells. It 
has been shown that SrfH interacts with the actin-crosslinking protein filamin and the thyroid 
receptor interacting protein 6 (TRIP6). These interactions might increase motility of infected 
cells and to promote cell-to-cell spreading of Salmonella (Worley et al., 2006). However, a more 
recent study contradicts these observations. McLaughlin and colleagues reported that SrfH 
affects cell adherence and that it actually decreases cell motility. In addition, the authors were 
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unable to confirm the interaction of SrfH to TRIP6 and claim that it binds to IQGAP1, a 
eukaryotic protein that has a role in cell migration (McLaughlin et al., 2009). Due to the 
discrepancies between the two reports, further studies are required to clarify the real influence 
of SrfH in cell motility. 
The T3SS-2 effector SpvB, encoded by the spv operon, has also been shown to interfere with 
the actin cytoskeleton. A Salmonella ∆spvB mutant leads to increased F-actin meshwork in 
infected cells (Miao et al., 2003). More recently, it has been shown that the C-terminal domain 
of SpvB is sufficient to depolymerise cellular F-actin, due to its actin ADP-ribosylating activity. 
This suggests that SpvB might counteract the actions of SteC. The ADP-ribosylating activity of 
SpvB was shown to be important for Salmonella virulence in mice (Lesnick et al., 2001). 
 
1.6.5. Modulation of the ubiquitin system  
Several T3SS-2 effectors are thought to interfere with the ubiquitin pathways of the host cell. 
The effectors SspH1, SspH2 and SlrP have been shown to possess E3 ubiquitin ligase 
activities. E3 ligases are responsible for attaching ubiquitin to a lysine on a target protein and 
therefore provide substrate specificity in protein degradation (Ardley and Robinson, 2005). The 
different cellular localization of the three effectors (SspH1 in the nucleus, SspH2 at the cell 
periphery, and SlrP in the cytoplasm) suggests that they interfere with the host in different ways 
(Figueira and Holden, 2012). SspH1 was shown to interact with the human serine/threonine 
protein kinase 1 (PKN1). This leads to downregulation of the NF-kB pathway, resulting in lower 
secretion of proinflammatory cytokines, such as IL-8 (Haraga and Miller, 2003). SspH2 localizes 
to the actin cytoskeleton and appears to be involved in actin polymerization, but little is known 
about the consequences of this activity during infection (Miao et al., 2003). Nonetheless, a 
Salmonella strain mutated in both sspH1 and sspH2 was shown to result in less mortality in 
calves (Miao et al., 1999). On the other hand, SlrP has been shown to interact with the small 
redox protein thioredoxin. Indeed, in cells infected with Salmonella, the levels of thioredoxin 
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increase and this correlates with increased cell death (Bernal-Bayard and Ramos-Morales, 
2009). Perhaps the E3 ligase activity of SlrP targets thioredoxin for degradation, resulting in less 
cell death, but this still needs to be fully demonstrated. Nonetheless, a ∆slrP mutant Salmonella 
strain is attenuated in mice virulence (Tsolis et al., 1999).  
Another T3SS-2 effector known to interfere with the ubiquitin system of the host is SseL. This 
effector has deubiquitinase activity and has a clear preference for K63-linked chains over K48 
linkages, which indicates that SseL does not prevent protein degradation by the proteasome 
(Rytkonen et al., 2007). In addition, SseL was shown to have a cytotoxic effect in macrophages 
and to be important for virulence in the systemic phase of infection in mice, although how SseL 
leads to cytotoxicity still needs to be determined (Rytkonen et al., 2007). Recently, another 
report from our laboratory disclosed more about the deubiquitinase activity of SseL in host cells. 
It was shown that SseL removes ubiquitin from large aggregates in the vicinity of the 
microcolony. In the absence of SseL activity, these ubiquitinated structures are recognized by 
the autophagy receptor p62 that targets them for autophagic degradation. It was shown that the 
activity of SseL lowers the cellular flux of autophagy and, importantly, favours intracellular 
replication of Salmonella (Mesquita et al., 2012).  
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2. The mammalian mitotic cell cycle 
 
2.1. Overview 
Cell division in mammals is an evolutionary conserved process that consists of a tightly ordered 
and regulated series of molecular events that enable one cell to become two. The basic 
components of the machinery required during cell cycle are conserved in all eukaryotes. 
Findings based on yeast genetics, biochemistry in frog eggs and tissue culture in mammalian 
cells have all come together to generate a substantial molecular knowledge on how the cell 
cycle is regulated. Lee Hartwell and Paul Nurse, for their research in yeasts, and Tim Hunt, for 
his findings in sea urchins, were awarded with the Nobel Prize in Medicine in the year 2001. 
During each division, cells complete a series of events that are collectively named the cell cycle. 
One way to simplify this complex process is to conceptually divide it in two: a mitotic 
chromosome cycle and a growth cycle (Tyson et al., 2002). The chromosome cycle consists of 
DNA replication and subsequent physical separation of the two complete genomes. It is crucial 
that the original DNA is accurately replicated and that the newly synthesised DNA is equally 
partitioned between the daughter cells. The growth cycle essentially guaranties that a minimum 
amount of organelles and machinery is present in both daughter cells, so they can subsist, even 
though small differences can be compensated by macromolecular synthesis directed by the 
genome. Nonetheless, the chromosome cycle and the growth cycle are coordinated, so cells 
grow equally in each generation. 
The chromosome cycle consists of two phases: a phase when the genome is precisely 
duplicated, by means of extensive DNA synthesis (S phase), and a phase when the duplicated 
DNA is condensed into two complete sets of chromosomes, followed by their equal segregation 
to each of the daughter cells (mitosis or M phase). The growth cycle consists of two “Gap” 
phases, G1 and G2. G1 starts after completion of mitosis and consists of resuming the 
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biosynthetic activities of the cell, which are slowed down considerably during mitosis. It is 
characterized by intensive protein synthesis, mainly of enzymes necessary for the next phase 
(S). In addition, G1 is the longest phase of the cell cycle and is characterized by extensive 
volume growth, thus G1 is also known as the growth phase. G2 comes after the S phase, and, 
similarly to G1, significant protein synthesis occurs in the cell, such as the production of 
microtubules, required for the M phase. G2 is much shorter than G1 and is thought to provide the 
cell with proteins that will ensure the condensation and appropriate segregation of the newly 
duplicated DNA. The generic cell cycle is hence constituted by four phases and always in the 
same order: G1-S-G2-M. Dependent on environmental or developmental signals, a cell in G1 
may temporarily or permanently exit the cell cycle and enter a quiescent or arrested state, which 
is known as G0. G1, S and G2 are collectively termed interphase. (Morgan, 2006). 
 
2.2. Mitosis 
Mitosis consists of the actual division of the DNA content into the two daughter cells, followed 
by their physical separation. In most cases, the two daughter cells are identical copies of the 
mother cell. Sometimes this process can also be asymmetrical. For example, division of stem 
cells gives rise to one stem cell and another daughter cell that can progress into differentiation.    
Mitosis is characterized by a dramatic reorganization of the nucleus and the cytoplasm. It is 
divided by six essential steps or stages that always take place in the same order: prophase, 
prometaphase, metaphase, anaphase, telophase and cytokinesis. 
Prophase is characterized by the first visible condensation of the chromosomes. In interphase 
the microtubule network is centred in the centrosome or MTOC in the cytoplasm, next to the 
nucleus. In prophase, the MTOC is converted into two radial arrays of short microtubules called 
“asters”. At the same time, the Golgi and the endoplasmic reticulum, as well as most 
intermediate filaments, disassemble. This is followed by the condensation of the chromosomes 
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into two threads, the “sister chromatids”, and the two asters migrate apart across the nucleus 
and localize to the cell poles, signalling the start of the mitotic spindle assembly, composed of 
hundreds of microtubule filaments. The dramatic changes of the cytoskeleton that take place at 
this point eventually lead into cell rounding, a hallmark of mitosis (Pollard et al., 2008). 
Prometaphase begins with the disassembly of the nuclear envelope. The microtubules, from the 
spindle make contact with the chromatids and attach to them in specialized structures called 
“kinetochores”. The interaction between the two opposing “kinetochores”, of paired sister 
chromatids, with microtubules coming from opposite poles, ultimately results in the alignment of 
the chromosomes in the middle of the two poles of the cell (Pollard et al., 2008).  
Metaphase is marked by the bilaterally symmetrical spindle with centrally aligned chromosomes. 
There are three different classes of microtubules present in the metaphase spindle: 
kinetochore-, interpolar- and astral microtubules. The so-called kinetochore microtubules have 
their plus ends embedded in the kinetochore and the minus ends at the spindle pole. The 
interpolar microtubules are distributed throughout the body of the spindle and do not attach to 
the kinetochores. Their minus and plus ends seem to be free. The astral microtubules project 
from the poles but do not interact with the chromosomes. Their plus ends interact with the cell 
cortex. The assembly, maintenance and function of the mitotic spindle is thought to depend on 
two basic mechanisms: the dynamic instability of microtubules, which is a stochastic event 
characterized by rapid growth and shrinkage of microtubules, and the organization of a bipolar 
structure by at least seven types of kinesins and by dynein, which together direct the movement 
and localization of both ends of the microtubules. The compact grouping of chromosomes at the 
middle of the spindle is referred to as the “metaphase plate” (Pollard et al., 2008).  
The separation of the sister chromatids is one of the most dramatic events of the cell cycle and 
marks the onset of anaphase. This is triggered by the action of the anaphase-promoting 
complex (APC/C), also called cyclosome. The APC/C is an E3 ubiquitin ligase that marks target 
cell cycle proteins for degradation by the proteasome. When APC/C is bound to Cdc20, an 
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activator of the complex that provides substrate specificity, key proteins are targeted for 
degradation. Three major factors regulate the separation of the sister chromatids: cohesins, 
separases and securins. The cohesins hold the sister chromatids together and securins form a 
stable complex with the separases. During anaphase, the APC/C-Cdc20 complex ubiquitinates 
the securins, tagging them for proteasomal degradation. As a result, the separases become free 
and cleave the cohesins, allowing instant separation of the sister chromatids. As a 
consequence, each one of the sister chromatids moves to opposing poles of the cell (Pollard et 
al., 2008).  
During telophase, the nuclear envelope re-forms on the surface of the separated sister 
chromatids, which typically cluster in a dense mass near the spindle poles (Pollard et al., 2008).             
   
2.2.1. Cytokinesis 
Cytokinesis is the process responsible for the physical division of the mitotic cell into two 
daughter cells. Cytokinesis includes signalling to specify the assembly of the division plane, 
regulation of the contractile apparatus, alterations of the plasma membrane and ultimately 
abscission, which is the final separation of the two daughter cells. The onset of mammalian 
cytokinesis happens during anaphase, since it is during this phase that the microtubules from 
the central spindle and spindle asters define the position of the division plane, which is always 
roughly situated between the segregated chromosomes. This is dependent on the small 
GTPase RhoA and results in the assembly of a contractile ring, mostly composed of myosin II 
and actin filaments, at the middle of the cell cortex. The contraction of the ring results in the 
ingression of the attached plasma membrane, forming the so-called “cleavage furrow”. 
Formation of the cleavage furrow leads to the partition of the cytoplasm into two. At this stage, 
the two emerging daughter cells remain connected by an intercellular bridge that contains 
dense bundles of microtubules overlapping at a central region, termed the “midbody” (or 
“Flemming body”, named after the scientist who first reported it). The physical separation of the 
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daughter cells is achieved by fission of the plasma membrane at the intercellular bridge, a 
process called abscission. Cytokinesis and chromosome segregation need to be tightly 
coordinated in time. This is achieved by the activation of the APC/C, which initiates both 
chromosome segregation and furrow ingression (Fededa and Gerlich, 2012). 
 
2.2.1.1. Formation of the contractile ring 
RhoA promotes assembly of the contractile ring by two main mechanisms: First, RhoA activates 
formins, which nucleate actin filaments. Second, RhoA promotes myosin II activation by the 
kinase ROCK, which activates myosin II directly by phosphorylation of the myosin light chain 
(MLC). Actin and myosin II bind to the middle of the cell cortex and accumulate there to form the 
contractile ring (Matsumura, 2005). Importantly, besides actin and myosin II, the contractile ring 
also contains the scaffolding protein anillin, which binds to actin, myosin and RhoA (Piekny and 
Glotzer, 2008). Therefore, anillin is thought to link the middle of the cortex with the signals from 
the central spindle, enabling ingression of the cleavage furrow. Anillin has also been proposed 
to form the link between the contractile ring and the plasma membrane, but this is still to be fully 
demonstrated. In addition, the organization and function of the contractile ring also involves 
actin crosslinking proteins, septin filaments and specific lipids (Fededa and Gerlich, 2012). 
 
2.2.1.2. Abscission 
The ingression of the cleavage furrow is thought to take place until the contractile ring has 
reached a diameter of about 1–2 μm. Before abscission, the two emerging daughter cells can 
remain connected by the intercellular bridge for several hours. The process of abscission 
includes removal of cytoskeletal structures from the intercellular bridge, constriction of the cell 
cortex, and fission of the plasma membrane. More than 100 different proteins localize at the 
intercellular bridge, but the specific role of many of those proteins during cytokinesis remains 
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unclear. The midbody is thought to be a targeting platform for the abscission machinery. After 
ingression, accumulation of Golgi and endosomal vesicles is observed at regions adjacent to 
the midbody, and they are thought to fuse with the plasma membrane before abscission. 
Several vesicle-targeting and tethering factors, including centriolin, the exocyst complex, 
Rab35, Rab11, v- and t-SNARES, BRUCE and the ESCRT-III complex are required for efficient 
abscission (Fededa and Gerlich, 2012). A scheme showing the major steps of cytokinesis is 
depicted in figure 1.6. Cytokinesis failure results in tetraploidy. Tetraploid cells derived from 
experimentally perturbed cytokinesis induce cancer in a mouse model (Fujiwara et al., 2005). In 
addition, tetraploid cells are common in all solid tumours and it has been well established that it 
contributes to aneuploidy and genomic instability, two hallmarks of cancer formation (Weihua et 
al., 2011). 
 
 
Figure 1.6. The major steps of cytokinesis. The start of cytokinesis is characterized by the formation of 
the contractile ring and by antiparallel microtubules emerging between the segregated chromosomes. In 
early cytokinesis, the cleavage furrow is narrowed and microtubules bind with proteins at the midzone. 
The intercellular bridge with the compacted microtubules connects the two daughter cells. The midbody 
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within the intercellular bridge contains overlapping microtubules and many other proteins. Abscission 
occurs adjacent to the midbody after multiple pathways orchestrate severing of the intercellular bridge. 
 
2.3. Cell cycle control 
Several studies made in various eukaryotes throughout the last decades have demonstrated 
that progression through the cell cycle is driven by the activation and inactivation of cyclin-
dependent kinases (CDKs). CDKs are small serine/threonine protein kinases that only become 
activated when bound to their cognate cyclin subunits. In the mammalian cell cycle, different 
CDKs bind to different cyclin subunits to promote progression through G1-S-G2-M. The complex 
and tight regulation of the cell cycle involves controlled expression and destruction of cyclins, 
phosphorylation and dephosphorylation of the CDKs, and expression and degradation of CDK 
inhibitor proteins (CKIs) (van den Heuvel, 2005). 
 
2.3.1. CDKs and cyclins 
CDKs are the key regulatory proteins of the cell cycle and are activated at different points. In 
mammals, there are at least nine CDKs and, of these, five are active during the cell cycle. 
CDK4/6 are active during G1, CDK2 is active during S phase and G2, and CDK1 is active 
during G2 and mitosis. Activated CDKs induce downstream processes by phosphorylation of 
selected proteins. However, full activation of CDKs requires two steps: first, the association with 
the corresponding cyclin subunit, and secondly, phosphorylation of a threonine residue in the 
CDK activation loop. This phosphorylation is carried out by the fifth CDK involved in the 
progression of the cell cycle, CDK7, which acts in combination with cyclin H as the CDK 
activating kinase (CAK) (Schachter et al., 2013). The remaining CDKs have not yet been shown 
to be relevant for the progression of the cell cycle. Interestingly, the levels of CDKs remain 
stable throughout the cell cycle. On the other hand, the levels of the majority of the different 
cyclins rise and fall, depending on the phase of the cycle, to activate the CDKs (Morgan, 2006). 
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Cyclins D1/2/3 bind to CDK4 and CDK6 to guarantee entry in G1 (Pines and Hunter, 1991; 
Sherr et al., 1994). Cyclin E associates with CDK2 to regulate progression from G1 to S phase 
(Ohtsubo and Roberts, 1993; Ohtsubo et al., 1995). During S phase, cyclin A binds to CDK2, 
ensuring its progress (Girard et al., 1991). Cyclin A also complexes with CDK1 in late G2 and 
promotes entry into mitosis, which is then controlled by the cyclin B-CDK1 complex (Nurse, 
1990). 
The activities of the different CDKs can be counteracted by the CKIs, known as the cell cycle 
inhibitory proteins. To inhibit the function of CDKs, the CKIs can bind to the CDKs alone or to 
the CDK-cyclin complexes. There are two distinct families of CKI proteins: the INK4 family and 
the Cip/Kip family (Sherr and Roberts, 1995). The INK4 family includes p15, p16, p18, p19 and 
p21, which specifically inactivate CDK4 and CDK6, during G1, by forming a stable complex with 
CDKs and therefore preventing their association with cyclin D (Carnero and Hannon, 1998). The 
second family of inhibitors, the Cip/Kip family, include p21, p27 and p57. They inhibit the 
CDK4/6-cyclin D complexes, in G1 and also CDK1-cyclin B complexes, during G2 or M phase. 
The expression of the different CKIs is regulated by internal or external signals. For example, 
p21 transcription is under the control of p53, a tumour suppressor gene. On the other hand, p15 
and p17 expression increases in response to the transforming growth factor β (TGNβ), 
contributing to growth arrest (el-Deiry et al., 1993; Harper et al., 1993; Polyak et al., 1994; 
Toyoshima and Hunter, 1994; Lee et al., 1995). 
 
2.3.2. Quality control: the checkpoints 
In 1974, Pardee published an article showing the first evidence for a point of no return during 
the cell cycle. The restriction point (R) exists in G1 and establishes the point of commitment of 
the cell to enter the cell cycle. Pardee showed that starving cells by critical amino acid or serum 
withdrawal before R induced G0, but starving them after R did not have an effect in the 
progression of their cell cycle (Pardee, 1974). Additional controls or checkpoints were found to 
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exist further in the cell cycle. They ensure that one phase is completed without mistakes before 
entering the next.  
At the G1/S transition, there is a checkpoint that ensures the DNA did not undergo any damage. 
This checkpoint is dependent on p53. Usually the levels of p53 in the cell are low, but DNA 
damage can lead to rapid induction of p53 activity. High levels of p53 in the cell activate the 
expression of different genes, including p21, which results in CDK inhibition and cell cycle arrest 
(Ko and Prives, 1996). This checkpoint prevents duplication of damaged DNA. If the DNA of the 
cell is severely damaged, high levels of p53 induce cell death, by activating genes involved in 
apoptosis (Gottlieb and Oren, 1998).  
Furthermore, if there is DNA damage during G2, cells are also able to induce an arrest, due to 
the activity of the G2/M checkpoint. Upon DNA damage, ATM (ataxia telangiectasia, mutated) 
and ATR (ATM and Rad3-related) phosphorylate the kinases Chk2 and Chk1, respectively, 
activating them (Peng et al., 1997). Upon activation, these kinases phosphorylate the 
phosphatase Cdc25C on position S216. Phosphorylation of this residue creates a binding site 
for the 14-3-3 proteins. The 14-3-3/Cdc25C complexes are then sequestered in the cytoplasm 
(Graves et al., 2000). This sequestration prevents Cdc25C from removing the T14 and Y15 
inhibitory phosphorylations of the cyclin dependent kinase Cdc2. The maintenance of these 
inhibitory phosphorylations on Cdc2 is essential for the G2/M checkpoint activation, as it 
maintains the Cdc2 bound to Cyclin B1. This prevents the formation of the cyclin B-CDK1 
complex, blocking entry into mitosis (Nurse, 1990; Sanchez et al., 1997; Zeng et al., 1998).  
The third well known checkpoint is the “spindle assembly checkpoint” (SAC). The activity of this 
checkpoint prevents the transition from metaphase to anaphase until all chromosomes are 
stably attached to the mitotic spindle (Lara-Gonzalez et al., 2012). Chromosomes attach to 
microtubules from the spindle through complex structures named “kinetochores” that comprise 
more than 80 different proteins assembled at the centromere of each sister chromatid 
(Cheeseman and Desai, 2008). In the presence of unattached chromosomes, the SAC is “ON”. 
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From the beginning of prometaphase, unattached kinetochores catalyse the formation of the 
mitotic checkpoint complex (MCC), composed of BubR1, Bub3, Mad2 and Cdc20. The MCC 
sequesters Cdc20, preventing it from activating the APC/C complex. In metaphase, once all the 
chromosomes are aligned and with their kinetochores attached to the spindle, the formation of 
MCC ceases, which allows free Cdc20 to bind and activate the APC/C. At this point, the SAC is 
switched “OFF”, as the APC/C-Cdc20 complex leads to the degradation of securins, allowing 
anaphase to occur (Musacchio and Salmon, 2007; Kops, 2008; Nezi and Musacchio, 2009).  
More recently, another checkpoint has been identified to occur during cytokinesis. It was first 
shown by different studies that abscission occurs only if no DNA is present at the division site, 
as the abscission machinery could otherwise damage unsegregated chromosomes (Gisselsson 
et al., 2000; Cimini et al., 2003). Later, reports showed that this is partially ensured by the 
Aurora B kinase, present at this point in the midbody, and kept active by sensing unsegregated 
or lagging chromosomes at the division plane. Active Aurora B inhibits abscission until the 
division plane is cleared. This process is considered to be a checkpoint and was termed the 
“NoCut pathway” (Norden et al., 2006; Steigemann et al., 2009). The Aurora B homologs, 
Aurora A and C, are also important during abscission, but their exact role is still to be 
determined (Marumoto et al., 2003; Sasai et al., 2004).      
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3. Bacterial interactions with the host cell cycle 
 
Like many viruses that perturb the host cell cycle, a growing number of pathogenic bacteria 
have been found to interfere with its progression. Bacterial proteins that modulate the eukaryotic 
cell cycle are termed cyclomodulins (Nougayrede et al., 2005). Cyclomodulins can be grouped 
as inhibitory or stimulatory, depending on their influence on the host cell cycle. In addition, 
several bacterial species have now been associated with cancer development and in most 
cases, including Salmonella, the molecular mechanisms underlying this are still unknown.  
  
3.1. Cyclomodulins 
Within the inhibitory cyclomodulins group we find the cytolethal distending toxin (CDT), a 
bacterial protein produced by a broad range of pathogenic bacteria, including S. Typhi, 
Escherichia coli, Shigella dysenteriae, Campylobacter spp., and many others. CDT was the first 
bacterial toxin shown to block the cell cycle at G1 or G2 (Peres et al., 1997). CDT is a tripartite 
holotoxin composed of CdtB, as the active subunit, and CdtA and CdtC, which together form a 
heterodimeric complex required to deliver CdtB into the host cell. Infection with CDT-producing 
bacteria leads to a cell cycle arrest as a result of induced DNA damage. CdtB is functionally 
homologous to the mammalian deoxyribonuclease I, but there is still no evidence showing direct 
binding of CdtB to the host cell DNA. However, it is well established that CdtB alone leads to 
breaks in double stranded DNA and consequently promotes DNA damage responses in the 
host cell (Guerra et al., 2011).  
Similarly to CDT, some bacterial proteins are known to affect the cell cycle, but little is known 
about their mechanisms of action. For example, Mycobacterium ulcerans, the causative agent 
of the Buruli ulcer, is known to secrete a polyketide-derived molecule, mycolactone, which 
induces cell rounding, inhibition of protein synthesis and cell cycle arrest in G1. These effects 
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were shown in cultured fibroblasts and macrophages but how they contribute to the Buruli ulcer, 
a debilitating skin disease found in Australia and West Africa, is unclear (Pahlevan et al., 1999). 
Perhaps the most famous example of an inhibitory cyclomodulin is found amongst the effector 
proteins of the extracellular enteropathogenic and enterohaemorrhagic Escherichia coli 
(EPEC/EHEC). Both EPEC and EHEC use a T3SS to inject an effector protein, named Cif 
(cycle-inhibiting factor), into host cells. Cif arrests the cell cycle at either G1/S or G2/M 
transitions. This is a result of an accumulation of CKIs, specifically p21 and p27, induced by the 
activity of Cif (Samba-Louaka et al., 2009). Very recently, three independent teams of 
researchers deciphered the molecular action of Cif that leads to the cell cycle arrest. In 
summary, they all show that Cif inhibits the ligase activity of the cullin-RING E3 ubiquitin ligase 
(CRL) by binding to its interacting partner NEDD8. The ubiquitination of several CRL substrates, 
including the CKIs p21 and p27, is therefore impaired, resulting in a cell cycle arrest (Cui et al., 
2010; Jubelin et al., 2010; Morikawa et al., 2010).    
In 2007, Iwai and colleagues provided evidence that Shigella influences epithelial cell cycle 
progression by delivering the effector IpaB into host cells. Once inside, IpaB prevents the 
binding of Mad2L2 to Cdh1, two important regulators of the cell cycle. Cdh1 is an activator of 
the APC/C, targeting specific substrates to proteasomal degradation. APC/C-Cdh1 complexes 
lead to the degradation of different cyclins (Reis et al., 2006; Li and Zhang, 2009). Once IpaB 
binds to Mad2L2 during the G2/M transition, free Cdh1 activates APC/C prematurely. This 
induces a cell cycle arrest at G2, preventing entry into mitosis. The activity of IpaB inside host 
cells seems to impair epithelial cell turnover by slowing down cell renewal during infection, 
enabling Shigella to persist longer in its replicative niche (Iwai et al., 2007). 
Another interesting example of a bacterial infection interfering with the host cell cycle is that of 
Chlamydia trachomatis. It was reported long ago that infection with these obligatory intracellular 
bacteria results in multinucleated host cells (Gupta et al., 1979), but only recently has the 
underlying mechanism been dissected. In 2011, Song Sun and colleagues reported that 
59 
 
multinucleation as a result of Chlamydia infection is due to the formation of an asymmetric 
cleavage furrow during cytokinesis, and subsequent ingression failure. The authors show that 
the host signalling proteins involved in this process, such as myosin IIB, anillin, RhoA, Ect2, 
Mklp1, Plk1 and Prc1, are displaced from regions of the cell cortex or from the cell equator due 
to the physical presence of the Chlamydia inclusion body (Sun et al., 2011). Later, in 2012, a 
report from a different group showed that in infected cells cytokinesis fails during abscission. 
The authors claim that the protease activity of the chlamydial effector CPAF cleaves cyclin B1 
and securin in infected mitotic cells. This allows chromosomes to separate prematurely, 
overriding the spindle assembly checkpoint (SAC). As a result, lagging chromosomes persist in 
the midbody and abscission fails due to the NoCut pathway (Brown et al., 2012).           
In contrast, infections caused by some bacteria can induce cellular proliferation, through the 
translocation of stimulatory cyclomodulins. Cytotoxin-associated antigen A (CagA) is an effector 
delivered by the type 4 secretion system (T4SS) of H. pylori into host cells and has been shown 
to have an essential role in virulence. It has been demonstrated that by 72 hours CagA 
promotes the rapid progression of cells from G1 into G2/M in a gastric cell line. Once inside the 
host cell, CagA is phosphorylated and activates the tyrosine phosphatase SHP-2. CagA 
activation of SHP-2 seems to induce cell proliferation by activation of the MAPK pathway. CagA 
has also been shown to activate the carboxy-terminal Src kinase (CSK), which then inactivates 
the Src kinases, reducing CagA phosphorylation. This is believed to attenuate CagA-SHP-2 
signalling. This mechanism of negative regulation might explain the chronicity of H. pylori 
infections (Oswald et al., 2005).  
Another means by which some bacteria stimulate the host cell cycle is to target the Rho 
GTPase family. The cytotoxic necrotizing factors (CNFs) of E. coli and Yersinia 
pseudotuberculosis and the dermonecrotic factors (DNT) from Bordetella species are 
transglutaminases that catalyze the deamidation or polyamination of glutamine residues of Rho, 
Rac and Cdc42, leading to their deactivation. Rho GTPases contribute to cell cycle progression 
by influencing the levels of cyclinD1 and of CKIs (Horiguchi, 2001). 
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Several other bacterial proteins seem to inhibit or stimulate the host cell cycle by interfering with 
its regulation at different phases (figure 1.7). Currently, the study of cyclomodulins seems to be 
of growing interest for microbiologists, but in most cases their mode of action and, importantly, 
their role in disease still needs further investigation. 
 
 
Figure 1.7. Bacterial cyclomodulins and their interference with the host cell cycle. Adapted from 
(Oswald et al., 2005) and updated. The eukaryotic cell cycle consists of four successive phases: G1 (2n 
chromosomes), S (DNA replication), G2 (4n chromosomes) and subsequent mitosis. Cells in G1 that are 
not yet committed to division can enter a differentiated or resting state called G0. Bacterial cyclomodulins 
actively deregulate the progression of the host cell cycle. Certain cyclomodulins promote cell proliferation 
whereas inhibitory cyclomodulins block the cell cycle.  
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3.2. Bacteria and cancer development 
Early in the 19th century it was proposed that bacterial infections might be associated with 
cancer development (Lax and Thomas, 2002). Indeed, chronic infections with bacteria known to 
perturb cell-signalling processes might contribute to cell transformation. For example, bacterial 
infections can lead to the promotion of anti-apoptotic proliferative states, DNA damage, or 
multinucleation in host cells. Any of these consequences can lead to tumour initiation. 
It is now well established that H. pylori infection is the most important environmental cause for 
the development of gastric carcinoma. In addition, epidemiological studies indicate that the 
production of CagA is associated with an increased risk of developing carcinoma of the stomach 
(De Luca and Iaquinto, 2004). Recently it was demonstrated that CagA interacts with ASPP2, a 
tumour suppressor protein. In case of DNA damage, it is known that ASPP2 binds to p53 and 
activates it, resulting in apoptosis of the cell. Interaction between CagA and ASPP2 impedes the 
activation of p53, leading to its degradation. As a result, the apoptotic response of the host cell 
is inhibited. Promotion of p53 degradation by CagA is nowadays thought to be a major 
contribution to the development of stomach cancer (Buti et al., 2011). 
It has been suggested that persistent Chlamydia pneumoniae infections correlate with 
increased risk of lung cancer. Elevated antibody titers against these bacteria are frequently 
observed in lung cancer samples (Laurila et al., 1997). Furthermore, it has been shown that 
individuals with high IgA antibody titers against Chlamydia pneumoniae have up to two-fold 
increased lung cancer risk (Littman et al., 2004). Epidemiological studies have shown that 
chronic infections of the upper genital tract caused by Chlamydia trachomatis are associated 
with increased risk of cervical cancer (Samoff et al., 2005; Madeleine et al., 2007). It is possible 
that cytokinesis failure and subsequent multinucleation caused by Chlamydia infections are 
involved in the development of these carcinomas. 
Several findings also suggest that Mycobacterium tuberculosis can cause cancer development. 
An old study showed that individuals with clinical history of tuberculosis have a five-fold higher 
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risk of developing lung carcinoma than control individuals (Steinitz, 1965). In the meantime, 
several other studies have also established an association between tuberculosis and lung 
cancer risk (Brownson and Alavanja, 2000; Song et al., 2002). Furthermore, bronchogenic 
carcinomas have been shown to frequently localize in the infected lung lobe (Farwell et al., 
1978). It has been hypothesised that the constant high levels of circulating VEFG (vascular 
endothelial growth factor) associated with Mycobacterium tuberculosis infections might result in 
carcinogenesis (Tamburini et al., 2007).  
One of the most striking cases of association of a bacterial infection and cancer formation 
concerns Salmonella. Several studies have helped to establish that individuals having chronic 
infections with S. Typhi have a greater risk of developing gallbladder carcinoma (Lazcano-
Ponce et al., 2001; Wistuba and Gazdar, 2004; Kumar, 2006). Epidemiological studies have 
shown that chronic carriers of S. Typhi have an approximately eight-fold excess risk of 
developing gallbladder carcinoma than non-carriers. In addition, chronic carriers also have an 
approximately 200-fold higher risk of developing hepatobiliary carcinoma, compared with people 
who have had typhoid fever and completely cleared the infection (Caygill et al., 1995; Shukla et 
al., 2000). In another study, Robbins and colleagues found a strong association between S. 
Typhi carriers and development of cholangiocarcinoma (Robbins et al., 1988). Furthermore, 
associations of typhoid carriage and cancer formation in the pancreas, lung and colorectum 
have also been found, but to a much less extent (Szu et al., 1994; Caygill et al., 1995). Despite 
the overwhelming association of S. Typhi infections with cancer formation, the pathogenic 
process by which this occurs is still unknown. One possible mechanistic explanation could be 
the activity of the toxin CDT, present in S. Typhi, although it seems unlikely that the activities of 
CDT could lead to transformation of host cells, since there are no associative studies between 
cancer formation and infections with the majority of the other CDT-producing bacteria, such as 
Escherichia coli, Shigella and Campylobacter.  
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4. Aims of this project 
 
Salmonella can invade, survive and replicate within host cells. Several host cell features are 
known to be targeted by this intracellular pathogen, such as the cellular cytoskeletal network, 
vesicular trafficking and control of apoptosis. The evidence of an association between S. Typhi 
infections and cancer formation, whose molecular mechanisms were not studied, suggested the 
hypothesis that Salmonella could interfere with the cell cycle of the host. Therefore, one 
objective of this study was to investigate the potential impact of the intracellular replication of 
Salmonella on the cell cycle of the host and to characterize these potential interactions by 
investigating the contributions of the T3SS-2 and host pathways affected. Although the 
association of Salmonella infections and cancer formation concerns only long-term infections of 
S. Typhi in humans, the experiments presented here were carried out using S. Typhimurium 
strains. Throughout the past decades, S. Typhimurium has been of invaluable use to 
understand S. Typhi infections, since S. Typhimurium and S. Typhi have similar phenotypes in 
cultured cells (Mills and Finlay, 1994), have most of their genomes in common (Sabbagh et al., 
2010) and cause similar systemic diseases in mice and in humans, respectively (Santos et al., 
2001).   
In addition, it was hypothesised that there might be phases of the cell cycle that are more 
susceptible and/or refractive to Salmonella invasion. Therefore, another aim of this study was to 
analyse whether the different phases of the host cell cycle had an effect on bacterial invasion 
and to study the potential molecular mechanisms involved, for example, the contribution of the 
T3SS-1. These investigations led to the initial findings of this study. Therefore, the impact of the 
host cell cycle on Salmonella invasion became the main focus of this research and those 
findings are presented firstly in the Results section.    
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4.1. Strategy regarding in vitro cell cultures 
For the present study, two different human epithelial cell lines were used: HeLa and hTERT-
RPE1 (human telomerase reverse transcriptase - human retinal pigment epithelial 1), 
henceforth also referred to as RPE1. HeLa cells are derived from an individual with cervical 
cancer. They have been used extensively in a broad variety of investigations, including those of 
Salmonella pathogenesis. However, as this study aims to focus on the interaction between 
Salmonella and the host cell cycle, HeLa cells are not suitable since they are cancer-derived, 
proliferate abnormally rapidly, even compared to other cancer cells, and were shown to be 
hypertriploid (≥3n) (Macville et al., 1999). Therefore, most of the experiments reported in this 
dissertation were carried out using RPE1 cells. These cells are also originated from a human 
epithelium, but importantly, they harbour a normal human karyotype (2n, 46 chromosomes). 
Although not transformed, RPE1 cells can be maintained in culture for extended times (>300 
generations). 
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CHAPTER 2 
MATERIALS AND METHODS 
 
2.1. Materials 
2.1.1. Bacterial strains 
The wild-type S. Typhimurium strains used in this study were 12023, SL1344 and LT2. All of the 
bacterial strains used in this study are listed in table 2.1. Strain listed as “∆invA + invasin” was 
kindly provided by Dr. F. García-del Portillo (Centro Nacional de Biotecnologia), Madrid, Spain. 
 
Table 2.1 – Bacterial strains used in this study 
Name Description Source or reference 
SL1344 Wild-type strain SL1344 NTCC 
12023 GFP 12023 pFPV25.1 (Amp) NTCC 
SL1344 GFP SL1344 pFPV25.1 (Amp) NTCC 
LT2 GFP LT2 pFPV25.1 (Amp) NTCC 
∆sopE/E2/B GFP SL1344 
∆sopE/sopE2/sopB/sptP (Kan) 
pFPV25.1 (Amp) 
Kate Unsworth (Holden lab) 
∆prgH GFP SL1344 ∆prgH pFPV25.1 (Amp) Kate Unsworth (Holden lab) 
∆sipB GFP SL1344 sipB::aphT (Kan)  
pFPV25.1 (Amp) 
This study 
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∆sipD GFP SL1344 sipD::aphT (Kan)  
pFPV25.1 (Amp) 
This study 
SL1344 + invasin SL1344 pRI203 This study 
∆invA + invasin SL1344 ∆invA pRI203 (Aiastui et al., 2010) 
∆ssaV GFP 12023 ssaV::aphT (Kan) 
pFPV25.1 (Amp) 
Junkal Garmendia (Holden lab) 
∆gogB GFP 12023 gogB::aphT (Kan) 
pFPV25.1 (Amp) 
Rita Figueira (Holden lab) 
∆pipB2 GFP 12023 pipB2::aphT (Kan) 
pFPV25.1 (Amp) 
Stephane Meresse 
∆slrP GFP 12023 slrP::aphT (Kan) 
pFPV25.1 (Amp) 
Rita Figueira (Holden lab) 
∆sseG GFP 12023 sseG::aphT (Kan) 
pFPV25.1 (Amp) 
(Deiwick et al., 2006) 
∆sseF GFP 12023 sseF::aphT (Kan) 
pFPV25.1 (Amp) 
(Deiwick et al., 2006) 
∆sopD2 GFP 12023 sopD2::aphT (Kan) 
pFPV25.1 (Amp) 
Junkal Garmendia (Holden lab) 
∆spvC GFP 12023 ∆sopD2 pFPV25.1 
(Amp) 
Jessica Thompson (Holden lab) 
∆sseJ GFP 12023 ∆sseJ pFPV25.1 (Amp) Xiu Jun Yu (Holden lab) 
∆sseL GFP 12023 sseL::aphT (Kan) 
pFPV25.1 (Amp) 
(Rytkonen et al., 2007) 
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∆steB GFP 12023 steB::aphT (Kan) 
pFPV25.1 (Amp) 
Rita Figueira (Holden lab) 
∆steC GFP 12023 steC::aphT (Kan) 
pFPV25.1 (Amp) 
Rita Figueira (Holden lab) 
∆steA GFP 12023 steA::aphT (Kan) 
pFPV25.1 (Amp) 
Rita Figueira (Holden lab) 
∆avrA GFP 12023 avrA::aphT (Kan) 
pFPV25.1 (Amp) 
Rita Figueira (Holden lab) 
∆pipB GFP 12023 ∆pipB pFPV25.1 (Amp) Kate Unsworth/Leigh Knodler 
(Holden lab) 
∆sopD GFP 12023 sopD::aphT (Kan) 
pFPV25.1 (Amp) 
Junkal Garmendia (Holden lab) 
∆sifA GFP 12023 sifA::mTn5 (Kan) 
pFPV25.1 (Amp) 
(Beuzon et al., 2000) 
∆srfH GFP 12023 srfH::aphT (Kan) 
pFPV25.1 (Amp)  
Rita Figueira (Holden lab) 
∆sspH1 GFP 12023 ∆sspH1::aphT (Kan) 
pFPV25.1 (Amp) 
Rita Figueira (Holden lab) 
∆sspH2 GFP 12023 ∆sspH2::aphT (Kan) 
pFPV25.1 (Amp) 
Rita Figueira (Holden lab) 
∆sseFG GFP 12023 ∆sseFsseG pFPV25.1 
(Amp) 
(Deiwick et al., 2006) 
∆sseG, pWSK29sseG-HA  
 
pWSK29sseG(HA) (Amp)  in 
12023 sseG::kan 
(Kuhle et al., 2004) 
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∆sseF, pWSK29sseF-2HA  
 
pWSK29sseF(HA)2 (Amp)  in 
12023 sseF::kan 
Mei Liu (Holden lab) 
∆sseL, pWSK29sseL-2HA  
 
pWSK29sseL(HA)2 (Amp)  in 
12023 sseL::kan  
(Rytkonen et al., 2007) 
∆aroCpurD pWSK29sseJ-2HA pWSK29sseL(HA)2 (Amp) in 
wild-type 12023 
Xiu Jun Yu (Holden lab) 
12023 mCherry 12023 pFCcGI (Amp) Kathryn Watson (Holden lab) 
∆sseG mCherry 12023 sseG::aphT (Kan) 
pFCcGI (Amp) 
Rita Figueira 
∆sseF mCherry 12023 sseF::aphT pFCcGI 
(Amp) 
Rita Figueira 
E. coli DH5α  Invitrogen 
 
 
2.1.2. Plasmids 
The plasmids used in this work are listed in table 2.2. The plasmids were purified using a 
QIAfilter plasmid mini-prep kit (Qiagen). The plasmid pRI203 was a gift from Dr. F. García-del 
Portillo (Centro Nacional de Biotecnologia), Madrid, Spain. 
 
Table 2.2 – Plasmids used in this study 
Name Description Source or reference 
pFPV25.1 rpsM::gfpmut3a promoter fusion 
in pFPV25  
(Valdivia et al., 1996) 
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pKD46 Plasmid encoding the arabinose 
inducible λ red recombinase; 
retained only at 30˚C. Cured at 
≥ 37˚C (Ampicilin resistant) 
(Datsenko and Wanner, 2000) 
pKD4 Kanamycin resistance cassette 
flanked by FLP sites 
(Kanamycin resistant) 
(Datsenko and Wanner, 2000) 
pRI203 Plasmid containing Yersinia 
pseudotuberculosis invasion 
region (Ampicilin resistant) 
(Aiastui et al., 2010) 
pWSK29sseG-HA Plasmid containing sseG(HA) 
(Ampicilin resistant) 
(Kuhle et al., 2004) 
pWSK29sseF-2HA Plasmid containing sseF(HA)2 
(Ampicilin resistant) 
Mei Liu (Holden lab) 
pWSK29sseL-2HA Plasmid containing sseL(HA)2 
(Ampicilin resistant) 
(Rytkonen et al., 2007) 
pWSK29sseJ-2HA Plasmid containing sseJ(HA)2 
(Ampicilin resistant) 
 
Xiu Jun Yu (Holden lab) 
pFCcGI rpsM::mCherry and 
PBAD::gfpmut3α promoter 
fusions in pFPV25 (Ampicilin 
resistant) 
(Figueira et al., 2013) 
pCMV-EGFP-Cdc42 EGFP fused with Cdc42 in 
pCMV 
Emmanuel Boucrot (Institute of 
Structural and Molecular 
Biology), University College 
London 
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pCMV-EGFP-RhoA EGFP fused with RhoA in 
pCMV 
Emmanuel Boucrot (Institute of 
Structural and Molecular 
Biology), University College 
London 
pCMV-EGFP-Rac1 EGFP fused with Rac1 in pCMV Emmanuel Boucrot (Institute of 
Structural and Molecular 
Biology), University College 
London 
 
 
2.1.3. Bacterial growth conditions 
S. Typhimurium and E. coli strains (used to generate the mutants ∆sipB and ∆sipD) were 
routinely grown in Luria‐Bertani (LB) broth or agar (Sambrook and Russell, 2001). 
Electroporated bacteria were recovered in SOC medium containing 20 g/L bacto‐tryptone, 5 g/L 
yeast extract, 0.5 g/L NaCl, 2.5 mM KCl, 10 mM MgCl2 and 20 mM glucose (Sambrook and 
Russell, 2001). When appropriate, growth medium was supplemented with antibiotics at the 
following concentrations: carbenicillin, for ampicilin resistance selection, (50 μg/ml) or 
kanamycin (50 μg/ml). Bacteria in liquid culture were routinely grown at 37˚C in a shaking 
incubator at 200 rpm and agar plates were incubated at 37˚C. Bacteria harbouring the 
temperature‐sensitive plasmid pDK46 were instead grown at 30˚C for plasmid retention and at 
42˚C for plasmid curing. 
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2.1.4. Electrocompetent bacterial cells  
First, the bacteria were grown overnight at 37ºC in LB with aeration. The overnight culture was 
diluted 1:100 in 5 ml of fresh LB and sub-cultured under the same conditions until the new 
culture reached an OD600 of 0.6. Next, bacteria were left on ice for 30 min and then centrifuged 
at 4000 rpm for 10 min and the supernatant was discarded. The bacterial pellet was washed in 
20 ml of ice-cold sterile MilliQ water before further centrifugation. This step was repeated two 
times. After the last centrifugation, the supernatant was discarded and the bacterial pellet was 
resuspended in 20 ml of ice-cold sterile 10% glycerol and again centrifuged. After, the pellet 
was resuspended in 250 µl of ice-cold sterile 10% glycerol and the total volume was aliquoted to 
use immediately or stored at -80ºC. Electrocompetent bacteria were transformed by 
electroporation by incubating 50 μl of bacterial cells with approximately 25 ng of DNA in a 2 mm 
electroporation cuvette (Molecular Bioproducts) on ice for 5 min. Electroporation was performed 
at 2.5 kV, 200 Ω, 25 mF for 5 milliseconds using a GenePulser II (BioRad). Bacteria were then 
incubated in 1 ml SOC medium and incubated at 37ºC for 1 h. Transformants were selected by 
plating on LB agar containing the appropriate antibiotic. 
 
2.1.5. Construction of deletion mutants of sipB and sipD 
Deletion of sipB and sipD in S. Typhimurium SL1344 was carried out using the λ red 
recombinase method (Datsenko and Wanner, 2000). A scheme explaining this method is 
depicted in figure 3.10A. Briefly, primers were designed to amplify a kanamycin resistance 
cassette from the template plasmid pKD4. The primers were designed to contain also a 
sequence of 40 nucleotides that were homologous to the regions flanking the target gene on the 
chromosome, in this case sipB or sipD.   
Primers designed for deletion of sipB were: 5’-
CGGAGACAGAGCAGCACAGTGAACAAGAAAAGGAATAATTGTGTAGGCTGGAGCTGCTTCG and 5’-
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GCGGCGGGATTTATTCCCACATTACTAATTAACATATTTTCATATGAATATCCTCCTTAG; and for sipD were: 
5’-TGTGATTTAATCGCGCTCCTGATGGCGAACTGGGGATATTGTGTAGGCTGGAGCTGCTTCG and 5’-
GAGTCCTTACACTTGTAACCATTATTAATATCCTCTTCTGCATATGAATATCCTCCTTAG.  
PCR products were electroporated into S. Typhimurium SL1344 strains carrying pKD46 and 
expressing the λ red recombinase enzyme. Transformants were selected on the basis of their 
kanamycin resistance. Confirmation of mutant genotype was performed by colony PCR with 
primers homologous to regions upstream and downstream of the sipB or the sipD gene or to 
regions within the kanamycin resistance cassette and subsequent measurement of the size of 
the fragments by electrophoresis. 
 
2.1.6. Eukaryotic cell culture 
HeLa cells were grown in Dulbecco’s modified Eagle medium (DMEM, PAA laboratories) 
supplemented with 10% heat inactivated foetal calf serum (FCS, PAA laboratories) at 37ºC in 
5% CO2. All experiments with HeLa cells refer to the clone HtA1, obtained from the European 
Collection of Cell Cultures, Salisbury, UK, except for the experiments presented in figure 4.2, in 
which the HeLa cells used were obtained from the European Collection of Animal and Cell 
Cultures (ECACC), catalogue no. 93021013.   
RPE1 cells were grown at 37°C in 5% CO2 in Dulbecco’s modified Eagle medium/Nutrient F-12 
Ham (DMEM:F12 HAM, Sigma) supplemented with 0.25% (w/v) sodium bicarbonate (Sigma), 1 
mM Glutamine (Sigma) and 10% FCS. RPE1 cells were obtained from the American Type 
Culture Collection (ATCC), catalogue no. CRL-4000.  
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2.1.7. Antibodies and dyes 
A list of dyes and primary antibodies used in this study are listed in table 2.3, except for the live 
staining with DHE, which is described in detail below. Working dilutions for each individual 
application are also displayed. The secondary antibodies Alexa Fluor 488- (Invitrogen), Alexa 
Fluor 555- (Invitrogen), Alexa Fluor 633- (Invitrogen) and Alexa Fluor 647- (Invitrogen) 
conjugated donkey anti-goat, -rabbit or –mouse were used for immunofluorescence or flow 
cytometry at a dilution of 1:1000. For western-blot analysis, a goat anti-rabbit IgG HRP antibody 
(Santa Cruz Technologies) was used at a dilution of 1:10000.  
 
Table 2.3 – Antibodies and dyes used in this study 
Antibody / Dye Species Application / Dilution or 
concentration 
Source or reference 
Propidium Iodide N/A Flow cytometry / 2.5 µg/ml  Sigma 
Anti-α-tubulin Mouse Immunofluorescence / 1:500 Sigma 
Wheat Germ Agglutinin 
(WGA), texas-red-X 
conjugate 
N/A Immunofluorescence / 1:500 Invitrogen 
DRAQ5 N/A Immunofluorescence and flow 
cytometry / 1:1000 
Biostatus 
Anti-phospho-Histone H3 Rabbit or 
Mouse 
Immunofluorescence / 1:500 
and flow cytometry / 1:250 
Cell Signaling Technology 
Anti-MPM-2 Mouse Immunofluorescence / 1:500 
and flow cytometry / 1:250 
Millipore 
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Phalloidin-rhodamine 
conjugate 
N/A Immunofluorescence / 1:1000 Invitrogen 
Anti-Salmonella (CSA1) Goat Immunofluorescence / 1:500 KPL 
Filipin III N/A Immunofluorescence and flow 
cytometry / 5 µg/ml 
Sigma 
fPEG-cholesterol N/A Immunofluorescence and flow 
cytometry / 1 µg/ml 
(Madenspacher et al., 
2010) 
Annexin V-FITC N/A Immunofluorescence 1:25 Cell Signaling Technology 
Anti-RhoA 26C4 Mouse Immunofluorescence 1:200 Santa Cruz Technologies 
Anti-Cdc42 P1 Rabbit Immunofluorescence 1:200 Santa Cruz Technologies 
Anti-Rac1 Mouse Immunofluorescence 1:200 BD Biosciences 
Anti-phospho-ERM (Ezrin, 
Radixin, Moesin) 
Rabbit Immunofluorescence 1:400  Cell Signaling Technology 
Anti-PIP2 2C1 Mouse Immunofluorescence 1:200 AbCam 
Anti-HA (HA.11 Clone 
16B12) 
Mouse Immunofluorescence 1:500 Covance 
Anti-γ-tubulin Mouse Immunofluorescence 1:500 Sigma 
Anti-Aurora B Rabbit Immunofluorescence 1:500 AbCam 
Anti-phospho-Aurora B Rabbit Western Blot 1:500 AbCam 
Anti-actin Rabbit Western Blot 1:2000 Sigma 
DAPI (4’,6’-diamidino-2- N/A Immunofluorescence and Invitrogen 
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phenylindole) histochemistry / 1.5 µg/ml 
Alexa Fluor 488-Phalloidin N/A Histochemistry / 1:1000 Invitrogen 
  
 
2.2. Methods 
2.2.1. Bacterial infections of HeLa and RPE1 cells  
Bacteria were grown overnight in LB at 37ºC with aeration. The overnight bacterial cultures 
were then diluted 1:33 in 3 ml of fresh LB and sub-cultured under the same conditions until the 
culture reached OD600 of 1.5 – 2.0. Bacteria were then diluted in Earl’s buffered salt solution 
(EBSS, Gibco) and added to cell monolayers at a MOI of approximately 100, unless indicated 
otherwise (this corresponds to about 2.5 μl of bacterial sub-culture to 5 x 104 of HeLa or RPE1 
cells). Bacterial infections described in chapter 3 and 4 of this thesis were done by incubating 
the bacteria with the eukaryotic cells for 10 min at 37ºC, 5% CO2, followed by immediate fixation 
(see below). In some experiments, cells were detached using 0.025% Trypsin-EDTA (Sigma) 
just before infection.  
In chapter 5, infections described were done by incubating the bacteria with the eukaryotic cells 
for 15 min at 37ºC, 5% CO2, followed by 2 washes with phosphate buffered saline (PBS) and 
incubation with the same medium used for growth, supplemented with 100 μg/ml of gentamicin 
for 30 min - 1 h. For the remainder of the experiment the concentration of gentamicin was 
decreased to 20 μg/ml, after washing once with PBS. 
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2.2.2. Manipulation of cholesterol levels 
RPE1 cells were grown for 30 min at 37°C in 5% CO2 in serum-free DMEM:F12 HAM, 
supplemented with 0.25% (w/v) sodium bicarbonate, 1 mM Glutamine and 15 µM methyl-beta-
cyclodextrin (MβCD, Sigma), for cholesterol depletion, or with 16 mg/mL water soluble 
cholesterol (Sigma) for cholesterol enrichment. For infection experiments, these treatments 
were done right before incubating the cells with S. Typhimurium, as described above.  
 
2.2.3. Transfection of RPE1 cells 
RPE1 cells were transfected using Lipofectamine 2000 transfection reagent (Invitrogen). RPE1 
cells were seeded in coverslips at a density of approximately 5 x 104 cells per well (in 24-well 
plates) 24 h prior to transfection. The transfection reagent was used at a ratio of 2 µl of reagent 
to 1 µg of plasmid DNA. For each well, the lipofectamine reagent and the DNA were mixed with 
50 µl of Optimem medium (Gibco). Both solutions were combined and incubated for 20 min at 
room temperature. Then, the resulting DNA-Lipofectamine complexes were added to the cells 
cultured in 500 µl of normal growth medium and incubated at 37˚C, 5% CO2 for 6 h. Then, the 
cells were washed and incubated in the same condition with fresh medium for 16 h.  
 
2.2.4. Immunofluorescence microscopy 
2.2.4.1. Sample preparation for microscopy analysis of fixed cells  
Coverslips with cells infected or treated as described above were fixed with 3.7% 
paraformaldehyde (PFA) in PBS for 20 min at room temperature. Then the cells were washed 3 
times with PBS and the remaining free PFA was quenched by incubation with 1 mM NH4Cl for 
30 min. After washing with PBS for 3 times, the antibodies or dyes were diluted to the 
appropriate concentration with 10% horse serum in PBS containing 0.1% saponin (for 
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permeabilization) and left incubating with the cells for the appropriate time (depending on the 
antibody or dye used). For γ-tubulin labelling, instead of PFA, cells were fixed by incubation with 
ice-cold methanol at -20˚C for 5 min. Between primary and secondary antibody (or dye) 
incubation, the coverslips were washed 3 times with PBS. After the last incubation, coverslips 
were washed 3 times with PBS, one time with MilliQ H2O and mounted using Aqua polymount 
(Polysciences Inc.). Samples were imaged using a confocal laser-scanning microscope 
(LSM510 or LSM710, Zeiss). In some experiments, cells infected with EGFP-expressing 
Salmonella were labelled without permeabilization with CSA-1 to label extracellular bacteria. 
 
2.2.4.1.1. Image acquisition and processing  
All images were acquired using a confocal laser scanning microscope (Zeiss Axiovert LSM510 
or LSM710). The images acquired were processed and false-coloured using the Zeiss image 
software or Adobe Photoshop software. Total fluorescence (sum of the Integrated Density of 
each image in 3D stacks) of cholesterol, Rho GTPases, pERM and Pi(4,5)P2 was quantified 
using ImageJ. Volumes of metaphase cells were measured using Huygens software (Scientific 
Volume Imaging) and visualized (3D rendering) using Volocity 5.0 (PerkinElmer). Volocity 5.0 
(PerkinElmer) software was also used to determine the co-localization coefficient (Pearson) 
between the HA-epitope tagged effectors and the microtubules at the intercellular bridge. 
 
2.2.4.1.2. Phosphatidylinositol-4,5-bis-phosphate (Pi(4,5)P2) extraction with 1-
butanol  
RPE1 cells grown on coverslips were incubated with 2% 1-butanol (Sigma) in culture medium 
for 5 min, quickly aspirated, and fixed with 3.7% PFA (no washes with PBS were done before 
adding the fixative agent). The cells were then immunolabelled against Pi(4,5)P2 and incubated 
with DRAQ5 and analysed by confocal microscopy as described above. 
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2.2.5. Flow cytometry  
HeLa or RPE1 cells were infected with appropriate strains of S. Typhimurium as described 
previously. At selected times, cells were washed three times with PBS, subjected to scraping or 
treatment with trypsin for 5 min to detach them from the dishes. The cells were recovered with 
complete medium and centrifuged at 200 x g for 5 min (except for infections of cells in 
suspension). The supernatant was discarded, and the cells were resuspended in 3.7% PFA in 
PBS for 20 min, for fixation. After another centrifugation at 200 x g for 5 min, the cells were 
resupended in PBS containing 50 mM NH4Cl for 30 min to quench the PFA. Cells were 
centrifuged and resuspended in 0.08% Triton X-100 in PBS for 10 min, for permeabilization. In 
the case of labelling with antibodies, pellets were resuspended and incubated with the primary 
antibody for 1 h and the secondary antibody for 40 min, in solutions containing 10% horse 
serum prepared in PBS. For DNA staining, cells were centrifuged and resuspended with 
propidium iodide (in PBS 0.5 mg/ml RNAseA) or DRAQ5 and incubated for 10 min at room 
temperature. Flow cytometry analysis was carried out on a two-laser, four-colour FACS 
CaliburTM flow cytometer (BD Biosciences). Collected data were analysed with FlowJo software 
version 7.6 (TreeStar). 
 
2.2.6. Cell surface cholesterol and asymmetry measurements 
2.2.6.1. Filipin staining of live cells 
Cells detached (for flow cytometry analysis) or grown on glass bottom dishes (for microscopy 
analysis) were successively incubated in imaging buffer (DMEM without phenol red, 5% FBS, 
15 µM Hepes) containing 5 μM DRAQ5 (10 min, 37°C) and 5 µg/mL filipin for one minute (to 
limit the staining to the plasma membrane) before measuring each sample live. Live-cell 
imaging was performed on a spinning-disk confocal microscope (Eclipse TE-2000, Nikon; 
UltraVIEW VoX, Perkin-Elmer) controlled by Volocity 5.0. 
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2.2.6.2. Cell surface cholesterol measurement (with fPEG-cholesterol) 
RPE1 cells grown on dishes or coverslips were stained successively with 5 μM DRAQ5 (10 min, 
37°C) and with 1 µg/mL fPEG-cholesterol for 20 sec before fixation with 3.7% PFA. The fPEG-
cholesterol was synthesised in the Fessler lab, as described before (Madenspacher et al., 
2010). Cells were then immunolabelled and prepared for flow cytometry or confocal microscopy. 
Flow cytometry and fixed-cell microscopy were performed on the instruments described above.  
 
2.2.6.3. Cell surface phophatidylserine (PS) staining (with Annexin V-FITC) 
RPE1 cells grown on coverslips, in 24-well plates, were stained successively with 5 μM DRAQ5 
(10 min, 37°C) and with 10 µL/well of Annexin V-FITC and 250 µL/well of Annexin binding buffer 
(1x) (10 min on ice and in the dark), before fixation with 3.7% PFA. Cells were then analysed by 
confocal microscopy as described above. 
 
2.2.6.4. Staurosporine treatment of cells 
RPE1 cells grown on coverslips, in 24-well plates, were incubated with 1 µM of staurosporine 
(Sigma), diluted in culture medium, for 6 h at 37°C. After, the cell surface PS was determined as 
described in 2.2.6.3. 
 
2.2.6.5. Cholesterol asymmetry measurements  
Quenching of DHE by TNBS was done as in. Each MatTek dish was placed onto the 
microscope stage (37°C chamber) and a field of view containing mitotic cells selected (bright-
field). Cells were incubated for 1 min in imaging medium containing 0.5 mM DHE-MβCD 
complexes (DHE in ethanol dried under argon and dissolved in buffer containing MβCD and 
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DHE at 8:1 mol:mol ratio, sonicated and incubated overnight at 37°C under gentle agitation), 
washed once and rapidly imaged (3D stacks) using an epifluorescence microscope equipped 
with 350/50 and 420LP filters (Chroma). 10 mM TNBS were added and another set of images 
taken after 1 min. In some experiments, the cells were permeabilized using 40 mg/mL digitonin 
(Sigma).  
 
2.2.7. Immunoblot 
For western-blot analysis of the levels of phosphorylated Aurora B in infected or uninfected 
RPE1 cells, the cells were seeded at density of 1.5 x 105 cells per dish 16 h prior to infection. 
One dish was used for each bacterial strain infection or for uninfected sample. Cells were 
infected with the indicated S. Typhimurium strain and collected after 12 h by scraping into the 
growth medium. After centrifugation at 200 x g for 5 min, the cells were washed once with PBS 
and centrifuged again at 200 x g for 5 min. After, the cells were lysed in sample buffer (0.25 mM 
Tris-Cl pH 6.8, 10% SDS, 50% glycerol, 5% β-mercaptoethanol) and boiled at 100ºC for 10 min. 
The samples were used immediately or stored at -20ºC. The proteins from the resultant lysate 
were separated using 10% polyacrylamide gels by SDS-PAGE. Protein transfer from the gels 
into polyvinyldene fluoride (PVDF) membranes was done using a semi-dry transfer cell (BioRad) 
at a constant of 15 V for 25 min. Membranes were blocked with TBS (20 mM Tris-Cl, pH 7.5 150 
mM NaCl) containing 5% milk powder and 0.1% Tween for at least 1 h. Then, the membranes 
were incubated with the primary antibody overnight in TBS 2.5% milk 0.1% Tween, at 4ºC. 
Following incubation with the primary antibody, the membranes were washed at least 6 times 
for 10 min in TBS containing 0.1% Tween. Membranes were incubated with the secondary 
antibody diluted in TBS containing 2.5% milk powder, 0.1% Tween for 1 h at room temperature. 
Following at least 6 further washes of 10 min with TBS 0.1% Tween, proteins were detected 
using enhanced chemiluminescence ECL (GE Healthcare). 
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2.2.8. In vivo studies 
2.2.8.1. Mouse infections 
To prepare the bacterial inoculums, indicated S. Typhimurium strains were grown in LB broth 
with carbenicillin (50 μg/ml) for 16 h at 37ºC with aeration. Then, the bacterial cultures were 
diluted 1:33 in 50 ml of fresh medium (also containing carbenicillin) and sub-cultured under the 
same conditions until the culture reached OD600 of 1.5 – 2.0. The bacterial cultures were then 
concentrated in PBS to an estimated final concentration of 3 x 108 (CFUs)/ml.  Female BALB/c 
mice (B and K Universal Ltd. UK) of approximately 20 g each were inoculated with 200 μl of the 
bacterial solution by oral gavage. Control mice were not inoculated. Mice were sacrificed at the 
indicated time points and their small intestines collected. Serial dilutions of the remaining 
bacterial solutions were prepared and plated onto LB agar plates to determine the exact 
bacterial CFUs used.  
 
2.2.8.1.1. Histology 
The small intestines from infected mice were divided in approximately 1 cm portions and each 
portion was opened with a longitudinal cut. After several washes with PBS, the samples were 
fixed with 3.7% PFA for 4 h at 4˚C. Tissue embedding and sectioning was done with the help of 
Ms Lorraine Lawrence, a member of the Leukocyte Biology group at Imperial College London. 
Paraffin embedded blocks were sectioned at 0.5 mm and placed in coverslips. The samples 
were then permeabilized for 30 min with 0.08% Triton X-100 in PBS and stained with DAPI and 
Alexa Fluor 488-Phalloidin for 1 h. The coverslips were then washed three times with PBS and 
two times with MilliQ H2O. The samples were analysed by confocal microscopy (LSM710).  
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2.2.8.1.2. Small intestine disaggregation for flow cytometry analysis 
The small intestines from infected or control mice were prepared as described above. After 
several washes with PBS, the samples were left incubating with Accutase (eBioscience) for at 
least 16 h at 4˚C to disaggregate the tissue and obtain individual cells. After incubation, the 
supernatant (with single cells) was collected and centrifuged for 5 min at 200 x g. The cells were 
resuspended in PBS and the centrifugation was repeated to wash the cells. This procedure was 
done three times. For DNA staining, cells were centrifuged again and resuspended with DRAQ5 
and incubated for 10 min at room temperature. Flow cytometry analysis was carried out on a 
four-laser, 18-colour LSRFortessa cell analyzer (BD Biosciences). Collected data were 
analysed with FlowJo software version 7.6 (TreeStar). 
 
2.2.9. Statistical analysis 
Results shown are mean ± standard error of the mean (s.e.m.). Statistical testing was 
performed using Student’s t-test (continuous data, 2 groups), chi-square test (binomial data) or 
one-way ANOVA and Dunnett’s test (continuous data, 3+ groups), as appropriate. ns, not 
significant; * P<0.05; ** P<0.01; *** P<0.001. 
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CHAPTER 3 
SALMONELLA PREFERENTIALLY INVADES MITOTIC EPITHELIAL 
CELLS IN A T3SS-1 DEPENDENT MANNER 
 
3.1. Introduction 
Invasion of epithelial cells by Salmonella requires the injection of bacterial effectors, encoded by 
the T3SS-1. Upon assembly of the secretion apparatus, a group of proteins, known as 
translocases, are secreted. These proteins are proposed to form a pore in the host cell 
membrane and enable the passage of effectors into the host cell cytosol. In the case of the 
T3SS-1, the translocases are SipB, SipC and SipD (Collazo and Galan, 1997). Once the 
translocon is formed, the combined activity of effectors stimulates the formation of actin-rich 
membrane ruffles that mediate bacterial internalisation (Galan, 2001). Among these effectors 
are SopE, SopE2 and SopB (Patel and Galan, 2006). 
Internalization is now a well understood process, but prior steps are equally important for 
efficient invasion of host cells by Salmonella. Reversible bacterial adhesion to the target cell is 
thought to be an important step of invasion, mediated by the binding of fimbriae to terminal 
sugars, such as sialic acid, or internal carbohydrate motifs present in proteins in the host cell 
membrane (Sakarya et al., 2010). Following adhesion, the T3SS-1 complex mediates stable 
host cell binding. The translocases are co-ordinately deployed to mediate intimate attachment of 
Salmonella to the host cell. SipB binds to host cell membrane cholesterol (Hayward et al., 2005) 
and SipD is thought to function as a sensor for host cell contact, promoting T3SS-1-dependent 
binding to cell membranes (Lara-Tejero and Galan, 2009).  
Adhesion, intimate attachment and internalization are the three main steps leading to bacterial 
invasion of host cells, and each one implies different molecular mechanisms. Most 
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investigations of Salmonella invasion have employed epithelial cells in culture. These cells are 
constantly undergoing division and therefore constitute a heterogeneous population where each 
cell is going through one of the four stages of the cell cycle: G1, S, G2 and mitosis. Since each 
stage represents a different physiological state of the cell, it was hypothesised that they 
influence the ability of bacteria to invade. The aim of this study was to determine if there are 
stages of the cell cycle more susceptible or refractory to Salmonella invasion and to investigate 
the corresponding molecular mechanisms involved.  
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3.2. Results 
3.2.1. Salmonella does not invade 100% of epithelial cells in culture even at very 
high MOIs 
To assess if the cell cycle stages of epithelial cells affect the invasion capacity of Salmonella, 
the infection rates of HeLa and RPE1 cells were measured using various values of multiplicity of 
infection (MOI). The cells were seeded and grown in culture in an asynchronous manner, 
representing a heterogeneous population where each cell is in one of the four stages of the cell 
cycle. S. Typhimurium SL1344 expressing EGFP constitutively from the plasmid pFPV25.1 was 
grown until mid-log phase, in which the T3SS-1 is expressed (Hansen-Wester and Hensel, 
2001). Then, these bacteria were incubated for 10 min at different MOIs with both epithelial cell 
lines (figure 3.1). After this period, the cells were washed, fixed and analysed by flow cytometry. 
Infected cells were analysed by gating for EGFP signal. 
Surprisingly, in both HeLa and RPE1 cells, even at a ratio of 500 bacteria per cell (MOI 500), 
100% of infection was not achieved. At this ratio, only approximately 88% of cells were invaded 
by Salmonella (figure 3.1). In addition, at an MOI of 100, only approximately 50% of cells were 
infected by Salmonella. A maximum of infectivity was reached at MOI 200, since it did not 
increase significantly when an MOI of 500 was applied (figure 3.1). This indicated that these 
“saturating” levels of approximately 88% infectivity might be due to a property of the host cell 
and not to the invasive ability of the bacteria.  
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Figure 3.1. Infection rates of epithelial cells using different MOIs of S. Typhimurium. HeLa (black 
line) and RPE1 (blue line) cells were incubated with EGFP-expressing S. Typhimurium SL1344 for 10 min 
and fixed. The percentages of infected cells were determined by flow cytometry analysis. Infected cells 
were identified by gating for EGFP-positive cells. 
 
3.2.2. Salmonella invasion in relation to the host cell cycle  
To assess the invasion efficiency of Salmonella in relation to the host cell cycle, asynchronous 
populations of HeLa and RPE1 cells were incubated for 10 min with three different wild-type 
strains of S. Typhimurium - 12023, SL1344 or LT2, all expressing EGFP. This incubation period 
was chosen as it is of sufficient duration to allow bacterial invasion to occur without any 
subsequent replication; it is also of insufficient duration for any of the cell cycle stages to be 
completed. Quantifying the DNA content of host cells, by propidium iodide staining and flow 
cytometry analysis, provides an indication of the cell cycle phase of a given cell. This is because 
cells in G2 or mitosis contain double the amount of DNA (4n) as cells in G1 (2n). Cells in S 
phase, undergoing DNA replication, contain between 2n and 4n DNA.  
This experiment showed that all three wild-type strains of S. Typhimurium (12023, SL1344 and 
LT2) invaded epithelial cells (HeLa and RPE1) with 4n DNA content, thus in G2/M phases, more 
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efficiently. Uninfected cells in G2/M ranged approximately from 27% to 40% in all experiments 
performed, whilst infected cells in G2/M ranged from 40% to 58%. Importantly, in each 
experiment an enrichment of G2/M cells in the infected sample and a corresponding depletion in 
the uninfected population was always observed. This enrichment was measured by calculating 
the ratio of the percentage of infected to uninfected G2/M cells. The ratios calculated for the 
three wild-type strains in both epithelial cell lines used were statistically significant and ranged 
from 1.4 to 1.8. These ratios are indicated in figure 3.2 along with representative flow cytometry 
histograms given by infected and uninfected populations. Since these experiments were 
performed only after 10 min of incubation of bacteria and cells, these results showed that host 
cells in G2 or in mitosis were preferentially targeted for invasion by Salmonella. 
 
3.2.3. Salmonella invades mitotic cells preferentially 
As propidium iodide cannot be used to distinguish between cells in G2 or mitosis by flow 
cytometry analysis (they have both the same DNA content, 4n) immunofluorescence 
microscopy was used to distinguish between these two stages. Mitotic cells are easily identified 
by microscopy without the use of a specific mitotic marker, as DNA staining reveals 
chromosomal condensation and segregation, two processes that only take place during mitosis 
(Pollard et al., 2008). DNA staining can also be used by immunofluorescence microscopy to 
identify G2 cells since their nuclei fluoresce with approximately double intensity than the ones of 
cells in the other stages of interphase. 
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Figure 3.2. Histograms of DNA content in epithelial cells incubated with S. Typhimurium strains. 
Asynchronous populations of HeLa or RPE1 cells exposed to EGFP-expressing S. Typhimurium strains 
12023, SL1344 or LT2 (MOI 100) for 10 min, fixed, stained with propidium iodide (DNA) and analysed by 
flow cytometry. Uninfected and infected cells were identified by gating for EGFP-positive cells (not 
shown). DNA profiles of uninfected and infected cells are shown. ‘*’ show the enrichment in G2/M cells in 
the infected samples and its corresponding depletion in the uninfected population and the side numbers 
show the average of the ratios calculated of infected to uninfected cells in G2/M. N>3 experiments, 
n>30’000 cells per experiment. 
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RPE1 cells were infected with S. Typhimurium wild-type strains 12023, SL1344 or LT2 for 10 
min, washed and fixed. Counterstaining of the DNA and microtubules (to visualize the mitotic 
spindle and interphase cell margins) was performed with DRAQ5 and an antibody against α-
tubulin, respectively. Salmonella was found more frequently and in higher numbers in mitotic 
cells than in cells in interphase. A characteristic example of this targeting of mitotic cells by S. 
Typhimurium 12023 is shown in figure 3.3A. Three-dimensional reconstructions of serial optical 
sections of mitotic cells associated with Salmonella, after staining for DNA and plasma 
membranes, confirmed that the bacteria were intracellular and not simply adhering to the cell 
surface (figure 3.3B). 
Cells in interphase or mitosis were identified and counted by immunofluorescence microscopy 
analysis of DNA staining. Cells cultured in an exponential growth manner are at different stages 
of their cell cycle and therefore constitute an ‘asynchronous’ population. Because mitosis lasts 
about 1 h in a total cycle of 20-24 h, there was an average of 4% of cells undergoing mitosis at 
any given time (figure 3.3C). The numbers of intracellular bacteria in mitotic and interphase cells 
were counted and the percentage of the total bacterial number contained within each group was 
calculated. If there had been no preference for mitotic cells, the distribution of bacteria amongst 
interphase and mitotic cells would be expected to reflect the distribution of host cells across the 
two groups: 96% and 4%, respectively. However, analysis of infected cells revealed a 
significantly higher percentage of intracellular bacteria in mitotic cells: 33% of strain 12023, 34% 
of SL1344 and 26% of LT2 (figure 3.3C). In another experiment, interphase and mitotic cells 
infected with each S. Typhimurium strain were scored for the number of intracellular bacteria 
that they contained. This analysis revealed that cells in mitosis were statistically more frequently 
invaded by more than 1 bacterium per cell than interphase cells. The most frequent number of 
bacteria found per mitotic cell was 2, although cells containing 3, 4 and 5 or more bacteria were 
also found. In contrast, more than 80% of the infected cells in interphase contained a single 
bacterium; very few cells in interphase had been invaded by more than 2 bacteria in these 
conditions (figure 3.3D).  
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Figure 3.3. S. Typhimurium preferentially invades mitotic cells. RPE1 cells were incubated with 
EGFP-expressing S. Typhimurium for 10 min and fixed. (A) Images taken by confocal 
immunofluorescence microscopy showing EGFP-expressing S. Typhimurium 12023 (green), DNA stained 
with DRAQ5 (blue) and cells immunolabelled for α-tubulin (red). Bar represents 10 µm. (B) 3D stacks of 
images of a mitotic cell infected with EGFP-expressing S. Typhimurium (green) and stained with WGA-
texas red X (red) and for DNA (blue), taken by confocal fluorescence microscopy. Side views (XZ and ZY) 
show that several bacteria are inside the metaphase cell. (C) Scoring of percentages of cells in 
interphase or mitosis in uninfected asynchronous populations of RPE1 cells (blue bars) and of the 
percentages of bacteria being in cells undergoing mitosis (red bars), determined by immunofluorescence 
microscopy (n ≥ 600). (D) Percentage of interphase cells (left) or mitotic cells (right) infected by 1, 2, 3, 4 
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or 5 or more EGFP-expressing S. Typhimurium wild-type LT2 (light grey), 12023 (grey) or SL1344 (dark 
grey) after 10 min, scored by immunofluorescence microscopy. N>3 experiments, n>50 cells per 
experiment. 
 
3.2.4. Flow cytometry analysis of mitotic cell preference by Salmonella 
To distinguish between G2 and mitosis by flow cytometry, an established mitotic cell marker was 
used, phospho-histone H3, and cells were labelled with a specific antibody that recognizes this 
protein when it is phosphorylated at Serine 10. Phosphorylation of histone H3 at Serine 10 was 
shown to be tightly correlated with chromosome condensation during mitosis (Goto et al., 1999). 
This, in conjunction with propidium iodide staining, allows differentiation between cells in 
interphase (which includes cells in G2) and mitotic cells.  
RPE1 cells were infected with EGFP-expressing S. Typhimurium SL1344 for 10 min and fixed. 
With an MOI of 100, approximately 60% of the cells were infected (figure 3.4A). The mitotic cell 
population was analysed, comparing invaded with non-invaded cells.  In a representative 
example from more than five independent experiments, shown in figure 3.4B, a much higher 
percentage of mitotic cells (91.6%) were invaded by S. Typhimurium compared with cells in 
interphase (56.9%). 
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Figure 3.4. Mitotic cell markers confirm S. Typhimurium preferential targeting of mitotic cells. 
Asynchronous populations of RPE1 cells were exposed to EGFP-expressing S. Typhimurium SL1344 for 
10 min and fixed. (A) Asynchronous populations of RPE1 cells exposed to EGFP-expressing S. 
Typhimurium SL1344 (MOI 100) for 10 min, fixed, stained with propidium iodide (DNA) and analysed by 
flow cytometry. Uninfected and infected cells were identified by gating for EGFP-positive cells (left). DNA 
profiles of total, uninfected and infected cells are shown (middle and right). N>3 experiments, n>30’000 
cells per experiment. (B) Interphase and mitotic cells (phospho-Histone H3-negative and positive, 
respectively) were gated and infected and uninfected cells were identified as in (A). (C) interphase and 
mitotic cells (MPM-2-negative and positive, respectively) were gated and infected and uninfected cells 
were identified as in (A). (D) Confirmation that phospho-Histone H3 (red) stains mitotic RPE1 cells 
infected with EGFP-expressing S. Typhimurium and stained for DNA (DRAQ5, blue). Bar, 10 µm. (E) 
Confirmation that MPM-2 (red) stains mitotic RPE1 cells infected with EGFP-expressing S. Typhimurium 
and stained for DNA (DRAQ5, blue). Bar, 10 µm. 
 
Next, another established mitotic cell marker, MPM-2 was used. This specifically recognises 
cells in mitosis as it recognizes a phosphorylated epitope, (S/T)P, found in numerous proteins 
phosphorylated at the onset of mitosis (Tapia et al., 2006). After infection of RPE1 cells for 10 
min, the mitotic cell population was analysed as before. Results shown in figure 3.4C confirm 
invasion preference of mitotic cells by Salmonella. In the representative example given, from 
more than three independent experiments, only 59.2% of cells in interphase were infected 
compared to 92.4% of mitotic cells (figure 3.4C). 
Importantly, RPE1 cells were also examined by immunofluorescence microscopy after infection 
for 10 min with S. Typhimurium SL1344, fixation, DNA staining and immunolabelling with 
Phospho Histone H3 and MPM-2 antibodies. As expected, both antibodies specifically labelled 
mitotic cells identified under the microscope by their characteristic DNA structure (figure 3.4D 
and E). 
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3.2.5. Infection rates of S. Typhimurium for each stage of the host cell cycle  
To assess the specific invasion efficiency of S. Typhimurium in each stage of the host cell cycle, 
asynchronous populations of RPE1 cells were infected with EGFP-expressing wild-type strains 
12023, SL1344 and LT2, as before. After fixation, the cells were stained with propidium iodide, 
to measure the DNA content, and labelled for the mitotic cell marker Phospho-Histone H3. The 
combination of these two staining procedures, followed by flow cytometry analysis, allowed 
accurate determination of number of cells in each stage of the cell cycle. Uninfected and 
infected cells were isolated by gating for EGFP-positive cells and for each stage of the cell cycle 
the ratio of infected to uninfected cells was determined (figure 3.5A). A dotted red line was 
drawn on the graph to indicate ratio 1, which corresponds to what would be the anticipated ratio 
if the number of infected cells was the same as the uninfected. As expected, each wild-type 
strain showed preferential invasion of mitotic cells compared to invasion of cells in G2, S or G1. 
For strain 12023, approximately 4.5 times more mitotic cells were infected than not infected. 
This ratio was approximately 3.3 for strain LT2. Strikingly, for strain SL1344 the ratio of infected 
to uninfected cells during mitosis was of 12.1. In contrast, analysis of cells at G1, S and G2 
revealed ratios of infected to uninfected cells close to 1 for every strain, at an MOI of 100 (figure 
3.5A).  
In another experiment, following the same invasion protocol as before (MOI 100) and the same 
method to identify the stages of the host cell cycle, a more direct analysis of the invasion 
efficiency of Salmonella in each stage was made, this time by plotting the percentages of 
infected cells. Each wild-type strain infected from 80% to 95% of the mitotic population of host 
cells, whereas the infection rate for G1 cells was only of 45-55%; it was of 50-60% for S phase; 
and approximately of 55-65% for G2 (figure 3.5B). This examination fully establishes that 
Salmonella preferentially invades mitotic epithelial cells. 
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Figure 3.5. Infection rates of S. Typhimurium in each stage of the cell cycle of epithelial cells. 
Asynchronous populations of RPE1 cells were incubated with EGFP-expressing S. Typhimurium strains 
12023, SL1344 and LT2 for 10 min and fixed. Staining of cells with propidium iodide, to measure DNA 
content, and labelling with the mitotic cell marker Phospho-Histone H3, was used to determine each 
stage of the cell cycle by flow cytometry analysis. Infected cells were distinguished from uninfected by 
gating for EGFP-positive cells. (A) Ratios of infected to uninfected cells in each stage of the cell cycle (B) 
Percentage of infection in each stage of the cell cycle. At least 30,000 cells were analysed in each 
sample. 
  
 
96 
 
3.2.6. Salmonella targets mitotic cells independently of their size or shape 
The results obtained showed that Salmonella preferentially targets mitotic cells, even though 
these cells only constituted a very small proportion of the total in an asynchronous population of 
cells (figure 3.3C). Mitotic cells have smaller volume and surface area than interphase cells 
(Boucrot and Kirchhausen, 2007, 2008). This was confirmed in the conditions used for this 
study by visualisation of cells by immunofluorescence microscopy. Example images of RPE1 
cells are shown in figure 3.6A. If invasion was a stochastic event resulting from a random 
encounter, these properties of mitotic cells would give rise to a lower probability of their invasion 
by Salmonella. Therefore, the data reported here strongly suggests a specific targeting of 
mitotic cells by Salmonella. 
To investigate the hypothesis that mitotic cells are more susceptible to Salmonella invasion 
because they are more spherical than cells in interphase, an invasion assay was carried out 
using cells in suspension: when detached from the substrate, cells adopt a spherical shape 
independently of the cell cycle phase they are in. Results were compared to those obtained 
using adhered cells grown in parallel. Following infection of RPE1 cells with S. Typhimurium 
strain 12023 under both conditions, flow cytometry analysis was done and the ratio of infected 
mitotic to interphase cells was calculated.  As shown in figure 3.6B, both in adhered cells and 
cells in suspension, there was a higher proportion of infected mitotic cells when compared to 
infected interphase cells. A red line was drawn on the graph to indicate ratio 1, which 
corresponds to what would be the expected ratio in the absence of preferential invasion of 
mitotic cells by Salmonella. Approximately 1.7 times more adhered mitotic cells than interphase 
cells were infected by Salmonella and 1.5 times more when cells were infected in suspension. 
Although cells in suspension had lower infection rates overall (figure 3.6C), this result shows a 
skewing of the proportion of infection towards mitotic cells, since these constitute an average of 
4% of the total population in the conditions used and yet they were more infected at the MOI 
used (100) (figure 3.3C). These results demonstrate that mitotic cells are preferentially invaded 
regardless of their three-dimensional shape. 
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Figure 3.6. S. Typhimurium targets mitotic cells independently of their size or shape. (A) 
Fluorescence staining of RPE1 cells in mitosis or interphase, infected for 10 min with S. Typhimurium 
strain SL1344, showing EGFP-expressing S. Typhimurium (green), DNA stained with DRAQ5 (blue) and 
F-actin stained with phalloidin-rhodamine (red). Bars represent 10 µm. (B) Ratios of infected cells in 
mitosis to infected cells in interphase, adherent or in suspension. (C) Percentage of infected cells 
adherent or in suspension. Infected cells were identified by gating for EGFP-positive cells. Mitotic and 
interphase cells were isolated using the mitotic cell marker MPM-2 and an Alexa 647-conjugated 
secondary antibody. *P<0.05; **P<0.01. At least 30,000 cells were analysed in each sample. 
 
3.2.7. Targeting of mitotic cells by Salmonella is dependent on the T3SS-1 
As mitotic cells have less surface area and smaller volume than cells in interphase, and 
constitute less than 5% of the whole cell population in standard in vitro exponential growth, 
random encounters between mitotic cells and Salmonella are far less likely than those between 
interphase cells and the bacteria. This suggested that an active mechanism underlies the 
observed preferential targeting of mitotic cells by Salmonella. 
To investigate the mechanism by which Salmonella preferentially invades mitotic epithelial cells, 
three strains of S. Typhimurium were used: the wild-type strain SL1344, the isogenic triple 
mutant ∆sopB/E/E2 and the isogenic mutant ∆prgH, all carrying the plasmid pFPV25.1 for 
constitutive EGFP expression. The triple mutant ∆sopB/E/E2 is unable to induce its own 
internalization by an epithelial cell, since it lacks three effectors that are essential for actin 
reorganization and subsequent membrane ruffling (Zhou et al., 2001). Nevertheless, this triple 
mutant is still able to efficiently adhere and attach to the host cell membrane (Misselwitz et al., 
2011b). The ∆prgH mutant lacks a gene required for the assembly of the T3SS-1, and therefore 
is able to adhere but not to attach or internalize the host cell (Misselwitz et al., 2011b). To 
assess whether the T3SS-1 of Salmonella is involved in the preferential targeting of mitotic 
cells, invasion assays were carried out as before with the use of the wild-type and the two 
mutant strains. The rationale of the following investigations was that if preferential invasion of 
mitotic cells was dependent on SopB, SopE or SopE2, the triple mutant would not retain this 
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phenotype. On the other hand, if preferential targeting of mitotic cells was dependent on other 
properties of the T3SS-1, such as its ability to mediate the intimate attachment to host cells, the 
∆prgH mutant would lose this phenotype. If both mutant strains retained the tropism towards 
mitotic cells, another mechanism must be involved, most likely an adhesion mechanism. A 
model of Salmonella invasion of epithelial cells (Misselwitz et al., 2011b) and the strategy used 
to investigate the preferential targeting of mitotic cells by these bacteria is illustrated in figure 
3.7. 
To assess if the mutant strains maintained the ability to target mitotic cells preferentially, RPE1 
cells were incubated with the wild-type strain or the mutant strains for 10 min. Next, the cells 
were washed with PBS several times, to remove most bacteria not associated with cell 
membranes, and fixed. Immunofluorescence microscopy analysis was carried out after staining 
of the DNA, along with labelling for α-tubulin and specific labelling for extracellular bacteria. As 
previously observed, the wild-type strain targeted mitotic cells strongly and most bacteria were 
intracellular. As expected, the triple mutant ∆sopB/E/E2 was unable to enter into the host cells. 
However, these bacteria localized to the surface of mitotic cells more frequently than they did to 
interphase cells. This indicated that the triple mutant, as the wild-type strain, preferentially 
targets mitotic cells. On the other hand, the ∆prgH mutant was equally distributed on the 
surfaces of mitotic and interphase cells and, as expected, these bacteria were deficient in 
internalization. Representative immunofluorescence images of the phenotypes given by the 
wild-type and the mutant strains tested are shown in figure 3.8A. 
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Figure 3.7. Model of Salmonella invasion into epithelial cells and the strategy used to investigate 
the mechanism of its preferential targeting of mitotic cells. Adapted from (Misselwitz et al., 2011b). 
 
These phenotypes were quantified by counting the number of bacteria localizing to mitotic or 
interphase cells. On average, 2 wild-type bacteria were found localizing to one interphase cell 
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and approximately 5 bacteria localizing to one mitotic cell. Similarly, with the use of the 
∆sopB/E/E2 mutant, more bacteria were found localizing to mitotic cells than interphase cells, 
although the overall number of bacteria found was lower (figure 3.8B). To assess the preference 
for mitotic cells independently of bacterial numbers, the ratio of bacteria per mitotic cell to 
bacteria per interphase cell was calculated. Both the wild-type and the ∆sopB/E/E2 mutant 
localized approximately 3 times more frequently to mitotic cells than to interphase cells (figure 
3.8C). In the case of the ∆prgH mutant, very few bacteria were found localizing to cells and 
those localized to the same extent to interphase cells or to mitotic cells (figure 3.8B). The ratio 
of bacteria per mitotic cell to bacteria per interphase cell calculated for the ∆prgH mutant was 
approximately 1, which confirms that this mutant does not preferentially target mitotic cells 
(figure 3.8C). These results show that mitotic cells are more susceptible to targeting by the wild 
type bacteria and by the ∆sopB/E/E2 mutant, but not by the ∆prgH mutant, demonstrating that 
the preference for mitotic cells is dependent on the presence of a T3SS-1 apparatus. 
 
3.2.8. Yersinia invasin-mediated invasion of epithelial cells by S. Typhimurium did 
not show preference towards mitotic cells     
Since the mutant strains of S. Typhimurium do not invade epithelial cells, flow cytometry 
analysis was not suitable as an independent measure of mitotic cell targeting. The sample 
preparation required for flow cytometry analysis includes trypsinization of cells and several 
rounds of washing and various centrifugation and resuspension steps, which are likely to shed 
most of the bacteria merely adhered or attached to the host cell membrane. To circumvent this 
limitation, the wild-type and a ∆invA mutant strain were transformed with the plasmid pRI203, 
which allows constitutive expression of the Yersinia invasin. The ∆invA mutant lacks an 
essential gene for the assembly of the T3SS-1, like the ∆prgH mutant. But the expression of the 
Yersinia invasin permits internalization into epithelial cells even by T3SS-1 mutants of 
Salmonella. Invasin promotes entry into eukaryotic cells by binding to different members of the 
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β1 integrin receptor superfamily, found on most mammalian cell types (Isberg and Leong, 
1990). 
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Figure 3.8. S. Typhimurium targeting of mitotic cells is dependent on the T3SS-1. (A) 
Immunofluorescence staining of RPE1 cells infected for 10 min with the wild-type S. Typhimurium strain 
SL1344, and the mutants ∆sopE/E2/B and ∆prgH. EGFP-expressing bacteria are shown in green, DNA 
stained with DRAQ5 is shown in blue, cells immunolabelled for α-tubulin appear in red and extracellular 
bacteria immunolabelled with CSA-1 are shown in yellow (green and red double staining). (B) 
Quantification of the number of bacteria per cell undergoing interphase or mitosis as determined by 
immunofluorescence microscopy. (C) Ratios of bacteria adhered to cells in mitosis to bacteria adhered to 
cells in interphase. At least 200 cells were analysed for each strain.  
 
RPE1 cells were incubated for 10 min with a non-transformed wild-type strain and the wild-type 
and the ∆invA mutant strain carrying the plasmid pRI203 at MOI 100. After fixation, the cells 
were stained with propidium iodide (to measure DNA content) and labelled for Phospho-Histone 
H3 (to identify mitotic cells). Uninfected and infected cells were identified by labelling the 
bacteria with the anti-Salmonella antibody CSA-1 and a secondary antibody.  
The percentages of mitotic or interphase cells infected by each strain are shown in figure 3.9A. 
As expected, the non-transformed wild-type strain and the wild-type strain carrying the pRI203 
plasmid showed preferential targeting of mitotic cells, both invading approximately 40% of 
interphase cells and around 80% of mitotic cells. On the other hand, the ∆invA mutant strain, 
also carrying pRI203, invaded interphase and mitotic cells with the same efficiency – 20% 
(figure 3.9A). A representative immunofluorescence image of RPE1 cells infected for 10 min 
with the S. Typhimurium ∆invA mutant, carrying the plasmid pRI203, is shown in figure 3.9B. 
The labelling of extracellular bacteria (red), shown in contrast with the intracellular bacteria 
(green), confirms that the T3SS-1 mutant was able to invade the cells due to the expression of 
the Yersinia invasin. 
A mutant strain of Salmonella invading the host cells through a different mechanism than the 
T3SS-1 failed to show a tropism towards mitotic cells. Therefore, the experiments carried out 
with the plasmid pRI203 support that the preferential targeting of mitotic cells by Salmonella is 
dependent on the T3SS-1. 
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Figure 3.9. Yersinia invasin-mediated internalization into epithelial cells by S. Typhimurium. h-
TERT-RPE1 cells were incubated with the wild-type S. Typhimurium strain SL1344, or the wild-type and 
the ∆invA mutant carrying the plasmid pRI203 which allows constitutive expression of the Yersinia 
invasin. (A) Percentages of infected cells in mitosis or in interphase measured by flow cytometry analysis. 
Staining of cells with propidium iodide, to measure DNA content, and labelling with the mitotic cell marker 
Phospho-Histone H3, was used to identify mitotic from interphase cells. Uninfected and infected cells 
were isolated by identified the bacteria with CSA-1 and a conjugated secondary antibody.*P<0.05; 
**P<0.01. (B) Immunofluorescence staining of RPE1 cells, infected for 10 min with the ∆invA mutant 
strain carrying the pRI203 plasmid. Intracellular bacteria were immunolabelled once with CSA-1 (green), 
DNA was stained with DRAQ5 (blue), cells were immunolabelled for α-tubulin (red) and extracellular 
bacteria were immunolabelled twice with CSA-1 (green and red double staining). 
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3.2.9. Generation of Salmonella sipB and sipD mutant strains 
Since the targeting of Salmonella to mitotic cells was mediated by the T3SS-1, two mutant 
strains were constructed in strain SL1344, deleting the translocon-encoding genes known to be 
important for the attachment of the bacteria to host cells, sipB and sipD. The deletions were 
carried out using the λ red recombinase method, illustrated in figure 3.10A (Datsenko and 
Wanner, 2000). The sipB and sipD sequences were obtained from the S. Typhimurium LT2 
genome and used to design primers to amplify an antibiotic resistance cassette. The mutant 
strains were generated by a recombination event that replaces the chromosomal allele with a 
kanamycin resistance sequence. Figure 3.10B shows the confirmation of the mutant genotypes 
by PCR amplification with primers homologous to the kanamycin resistance cassette or the 
chromosomal region flanking sipB or sipD. 
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Figure 3.10. Generation of S. Typhimurium sipB and sipD mutant strains using the λ red 
recombinase system. (A) Schematic of the λ red recombination method (Datsenko and Wanner, 2000). 
Primers made of sequences homologous to the 5’‐ and 3’‐ end sequences (H1 and H2) on either side of 
the target gene are used to amplify an antibiotic resistance cassette flanked by FRT sites. Upon 
transformation, homologous recombination occurs between the amplified product and the chromosomal 
region containing the target gene in a strain expressing the λ red recombinase, thus replacing the target 
gene with the antibiotic resistance cassette. Deletion mutants can be confirmed with the use of primers 
homologous to regions flanking the target gene (FRW (Forward) and RV (Reverse)) (B) Confirmation of 
the mutant genotype by PCR of wild-type S. Typhimurium SL1344 and mutant strains. Lane 1- wt - 
primers for sipB amplification (~ 1822 bp); 2- wt - primers for sipD amplification (~ 1072 bp); 3- wt - FW 
primer for sipB amplification and RV primer for Kan cassette amplification; 4- wt - FW primer for sipD 
amplification and RV primer for Kan cassette amplification; 5- ∆sipB - primers for sipB amplification (~ 
956 bp); 6- ∆sipB - FW primer for sipB amplification and RV primer for Kan cassette amplification; 7- 
∆sipD - primers for sipD amplification (~ 956 bp) ; 8- ∆sipD - FW primer for sipD amplification and RV 
primer for Kan cassette amplification. 
 
3.2.10. Preferential targeting of S. Typhimurium to mitotic cells is dependent on 
the translocon proteins SipB and SipD 
To assess the contribution of SipB and SipD to the preferential targeting of mitotic cells by 
Salmonella, RPE1 cells were incubated for 10 min with the following strains: wild-type, ∆sipB or 
∆sipD. The cells were then fixed and immunofluorescence microscopy analysis was carried out 
as described in 3.2.7. 
As before, the number of bacteria localizing to mitotic or interphase cells was quantified and the 
ratio of bacteria per mitotic cell to bacteria per interphase cell was calculated for each strain 
used. Similarly to the ∆prgH mutant, the ∆sipB and ∆sipD mutants localized equally to mitotic 
cells and to interphase cells, indicating no preference for one cell cycle phase (figure 3.11B).  
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Figure 3.11. S. Typhimurium targeting of mitotic cells is dependent on the translocon proteins 
SipB and SipD. (A) Immunofluorescence staining of RPE1 cells, infected for 10 min with the wild-type S. 
Typhimurium strain SL1344, and the mutants ∆sipB and ∆sipD. EGFP-expressing bacteria are shown in 
green, DNA stained with DRAQ5 is shown in blue, cells immunolabelled for α-tubulin appear in red and 
extracellular bacteria immunolabelled with CSA-1 are shown in yellow (green and red double staining). 
Bars represent 10 µm. (B) Quantification of the number of bacteria cell undergoing interphase or mitosis, 
as determined by immunofluorescence microscopy. (C) Ratios of bacteria adhered to cells in mitosis to 
bacteria adhered to cells in interphase. At least 300 cells were analysed for each strain, in three 
independent experiments. **P<0.01, ***P<0.001 
 
Additionally, the ratio of bacteria per mitotic cell to bacteria per interphase cell for ∆sipB was 1.3 
and for ∆sipD approximately 0.6. These values are significantly lower than the ones determined 
for the wild-type strain, which were approximately of 3.3 (figure 3.11C). Representative 
immunofluorescence images of the wild-type strain and of the ∆sipB and ∆sipD mutants, 
corresponding to this phenotype, are shown in figure 3.11A. This indicates that the preference 
for mitotic cells is dependent on the translocon proteins SipB and SipD. 
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CHAPTER 4 
PREFERENTIAL INVASION OF MITOTIC CELLS BY SALMONELLA 
REVEALS A CHANGE IN PLASMA MEMBRANE CHOLESTEROL 
DURING CELL DIVISION 
 
4.1. Introduction 
The intimate attachment of the T3SS-1 to the plasma membrane, allowing the delivery of the 
T3SS-1 effectors into the host cell cytosol, depends on the presence of cholesterol. This is 
mediated by the SipB translocon protein of Salmonella, which is exposed at the tip of the T3SS 
and binds directly to surface cholesterol of host plasma membranes to form the translocon pore 
(Garner et al., 2002; Hayward et al., 2005). Cholesterol is vital to eukaryotic cell functions as a 
metabolic precursor to fat-soluble vitamins and steroid hormones, a determinant of membrane 
fluidity and as a mediator of plasma membrane and lipid lateral clustering (Ikonen, 2008; 
Lingwood and Simons, 2010; Maxfield and van Meer, 2010). It is known that the total levels of 
cellular cholesterol vary during the cell cycle, doubling between G1 and G2 (Fielding et al., 
1999), but no studies were done regarding the cholesterol changes specifically at the plasma 
membrane. Since the preferential targeting of mitotic cells by Salmonella is dependent on SipB 
further studies were carried out to characterize the cholesterol composition at the plasma 
membrane along the cell cycle. 
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4.2. Results 
4.2.1. The levels of cholesterol in the plasma membrane mediate the preferential 
targeting of mitotic cells by Salmonella 
The data reported in chapter 3 showed that the preferential targeting of Salmonella to mitotic 
cells was dependent on the T3SS-1 and on SipB. Since SipB binds directly to cholesterol at the 
surface of the host cell membrane, the cholesterol levels of host cells were manipulated to 
assess whether it would change the targeting of Salmonella to mitotic cells. To extract the 
cholesterol from the plasma membrane, the compound Methyl-β-cyclodextrin (MβCD) was 
used. MβCD is a cyclic sugar shown to be the extremely effective in binding and extracting 
cholesterol from biological membranes and therefore has been widely used to determine if a 
process is cholesterol dependent (Kilsdonk et al., 1995; Atger et al., 1997; Christian et al., 1997; 
Hayward et al., 2005). For efficient addition of exogenous cholesterol to plasma membranes, 
complexes of cholesterol-MβCD were used as previously described (Jutras et al., 2003). 
RPE1 cells were incubated for 30 min with serum-free medium supplemented with MβCD or 
cholesterol-MβCD complexes, to decrease or increase the total cellular levels of cholesterol, 
respectively. Control cells were incubated for the same period of time with serum-free medium 
without supplements. After several washes, the cells were infected with EGFP-expressing S. 
Typhimurium wild-type strain SL1344 for 10 min, washed and fixed. Flow cytometry analysis 
was carried out after the cells were stained with propidium iodide and labelled against phospho-
histone H3, to detect mitotic cells. As expected, extraction of cholesterol from the host plasma 
membrane with MβCD decreased the percentage of infected cells, compared to the control 
(figure 4.1A). This treatment also abolished the preferential targeting of mitotic cells, as 
measured by the ratio of infected mitotic to interphase cells (figure 4.1B). Interestingly, pre-
loading cells with cholesterol complexes did not have an impact on the infection of Salmonella 
(figure 4.1A), but also abolished the preferential targeting of the bacteria to mitotic cells (figure 
4.1B). 
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Cellular cholesterol can be visualised by fluorescence microscopy with the use of filipin III, a 
cholesterol-binding compound that is naturally fluorescent (Drabikowski et al., 1973). To 
validate the expected reduction and increase in the cholesterol levels after treatment with MβCD 
and cholesterol-MβCD complexes, respectively, cells were fixed, permeabilized and stained 
with filipin III. The cells were then examined by fluorescence microscopy and Z-stacks were 
acquired to quantify the total levels of filipin in the plasma membrane, distinguishing between 
interphase and mitotic cells. For this examination, the DNA was stained with DRAQ5, to allow 
detection of mitotic cells by microscopy, and actin was stained with phalloidin, to visualize cell 
margins.  
As expected, the treatment with MβCD reduced the total levels of cholesterol in the plasma 
membrane, both in interphase and in mitotic cells (figure 4.1C). The treatment with cholesterol-
MβCD complexes also showed to be effective, since interphase and mitotic cells displayed 
increased levels of cholesterol in the plasma membrane compared to control cells (figure 4.1C). 
Importantly, in control cells the quantification of filipin at the plasma membrane showed that the 
levels of cholesterol are higher in mitotic cells when compared to cells in interphase. 
Interestingly, pre-loading cells with cholesterol-MβCD complexes resulted in similar levels of 
cholesterol between interphase and mitotic cells (figure 4.1C). Example images of control or 
treated RPE1 cells stained with filipin are shown in figure 4.1D.  
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Figure 4.1. Cell surface cholesterol mediates the targeting of S. Typhimurium to mitotic cells. (A-
B) RPE1 cells were incubated with EGFP-expressing S. Typhimurium for 10 min and fixed (A) 
Percentage of infected cells and (B) Ratios of infected cells in mitosis to infected cells in interphase  in 
control, ‘- cholesterol’ or ‘+ cholesterol’ samples, determined by flow cytometry. At least 30,000 cells were 
analysed per experiment. (C) Total cellular cholesterol levels measured by filipin staining upon cholesterol 
depletion using MβCD (‘-cholesterol’) or loading using MβCD-cholesterol complexes (‘+ cholesterol’) in 
interphase or metaphase cells (‘Mitosis’). (D) Confocal microscopy images showing the total cellular 
cholesterol levels (filipin, green) in interphase and mitotic cells upon cholesterol depletion using MβCD (ʻ-
cholesterolʼ) or loading using MβCD-cholesterol complexes (ʻ+ cholesterolʼ). Cells were counterstained for 
actin (red) and DNA (blue). Bar, 20 μm.   
 
Treatment of cells with cholesterol-MβCD complexes abolished the preferential targeting of 
mitotic cells by Salmonella (figure 4.1B). Further examination showed that this treatment 
resulted in similar levels of cholesterol in the plasma membrane of interphase and mitotic cells, 
abolishing the increase observed during mitosis in control cells (figure 4.1C). Together, these 
results strongly suggest that the preferential targeting of mitotic cells by Salmonella results from 
the increase in the cholesterol levels at the plasma membrane during mitosis, as additional 
cholesterol molecules are available for binding to SipB.                     
 
4.2.2. Cell surface cholesterol increases during mitosis 
Classical staining of cells with filipin after fixation and permeabilization provides a readout of the 
total levels of cholesterol at the plasma membrane, as the dye binds to cholesterol in both outer 
and inner leaflets of the plasma membrane, as well as internal membranes. In the absence of 
permeabilization, labelling of cells with antibodies is routinely used to measure the levels of 
surface receptors. But small compounds such as filipin, phalloidin or DNA dyes can enter cells 
after fixation and stain intracellular components, even in the absence of subsequent 
permeabilization. This was confirmed by fixation of HeLa and RPE1 cells followed by staining 
with filipin, phalloidin and DRAQ5 without permeabilization. Immunofluorescence images taken 
after this staining procedure are shown in figure 4.2A. Furthermore, recent studies showed that 
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a brief incubation of approximately 1-2 min of membrane lipophilic dyes with live cells provides 
a quantitative readout of the amount of lipids present at the outer leaflet of the plasma 
membrane (Boucrot and Kirchhausen, 2007). Therefore, very short incubation of filipin on live 
cells is likely to provide a readout of the cholesterol levels at the surface (outer leaflet) of the cell 
membrane (figure 4.2B).    
From the total levels of cholesterol in the plasma membrane, only the cholesterol at the surface 
is exposed to and targeted by Salmonella. Therefore, to assess the levels of cholesterol at the 
surface of the plasma membrane, live HeLa and RPE1 cells were incubated with DRAQ5 for 5 
min (to stain the DNA), washed and incubated with filipin for 1 min. Subsequent flow cytometry 
analysis showed that the cell surface levels of cholesterol in both cell lines significantly 
increased along the cell cycle and were maximal during G2/M (figure 4.2C, D and E). In parallel, 
fast immunofluorescence 3D stacks of images were taken within the first minute of filipin 
addition before flow cytometry analysis. A representative image of one cell in mitosis and 
several cells in interphase is shown in figure 4.2F.   
Discriminating between G2 and mitotic cells could not be achieved by flow cytometry analysis as 
they have the same DNA content (4n). Furthermore, counterstaining with specific mitotic 
markers, such as MPM-2 or phospho-Histone H3, was not possible as it requires 
permeabilization of cells after fixation. Therefore, to determine whether mitotic cells had more 
surface cholesterol than cells in G2, the cells were examined by confocal fluorescence 
microscopy.  
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Figure 4.2. Cell surface cholesterol is maximal during mitosis. Experiments shown here were carried 
out by Dr. Emmanuel Boucrot. (A) Confocal microscopy images of HeLa and RPE1 cells fixed, but not 
permeabilized, and stained with phalloidin (red), filipin (green) and DAPI (blue). (B) Scheme highlighting 
the differences in cholesterol staining by filipin at the plasma membrane between total staining (fixed and 
permeabilized cells) which labels both inner and outer leaflets and surface staining (brief incubation on 
live cells), which labels mostly cholesterol at the outer leaflet. (C) Representative flow cytometry profile of 
asynchronous RPE1 live-cells double stained for DNA (DRAQ5) and cell surface cholesterol (filipin). 
Approximate cell cycle stages are shown (dotted lines) and approximated mean intensities of each 
population are shown (black bar). (D-E) Averages of the means of 8 and 4 experiments of cell surface 
cholesterol levels in HeLa or RPE1 cells, respectively. The values were normalised to those of G1. The 
number of cells analysed for each cell cycle stages are shown. (F) Representative picture of a cell sample 
use in flow cytometry shown in (D-E) taken by spinning-disk confocal (single focal plane shown). Bar, 10 
µm (G) Representative picture of a cell sample use in (H) taken by spinning-disk confocal microscopy (3D 
rendering shown). Bar, 10 µm. (H) Single cells measurements of surface (left, red) and total (right, grey) 
cholesterol acquired by 3D stacks taken by spinning-disk confocal microscopy. The values were 
normalised to that of G1. Mean ± SEM and number of samples analysed are written at the bottom.  
 
Fast 3D image stacks of RPE1 cells were acquired after staining for total or surface cholesterol 
at the plasma membrane, using a spinning-disk confocal fluorescence microscope. Mitotic cells 
were easily identified by their characteristic condensed DNA, whereas the different stages of the 
cell cycle of interphase cells were identified by the intensity of their DNA staining. Total (inner + 
outer leaflets) staining was obtained on cells fixed, permeabilized and stained with filipin, 
whereas outer leaflet staining was achieved by imaging within the first minute after addition of 
filipin to the membrane of cells pre-stained for DNA. This alternative measurement confirmed 
that cells in mitosis have greater total levels of cholesterol in the plasma membrane (figure 
4.2H, right). Importantly, this method indicates that there is a significant increase in cell surface 
cholesterol levels in mitotic cells compared to cells in G2 (figure 4.2G and H, left), suggesting 
that mitosis is the stage of the cell cycle when cell surface (outer leaflet) cholesterol is maximal. 
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4.2.3. Determination of cell surface cholesterol by a membrane-impermeable 
probe 
Since cholesterol (and thus filipin) can flip rapidly across the membrane bilayer (Garg et al., 
2011), even a quick staining with filipin in live cells could not fully exclude inadvertent measuring 
of cholesterol levels at the inner leaflet of the plasma membrane. Therefore, a fluorescent ester 
of polyethylene glycol-cholesterol (fPEG-cholesterol) was used, which partitions in cholesterol-
rich domains but because of the large PEG cannot flip across the plasma membrane (Sato et 
al., 2004; Madenspacher et al., 2010) and therefore allows accurate quantitative determination 
of endogenous cholesterol that is exposed only at the cell surface. 
Therefore, live RPE1 cells were stained with DRAQ5 for 10 min and then with fPEG-cholesterol 
for 20 s, before fixation. First, different concentrations of fPEG-cholesterol were used to stain 
the cells, following single cell examination by fluorescence microscopy. Z-stacks were acquired 
to quantify the total levels of fPEG-cholesterol in the plasma membrane, distinguishing between 
interphase and mitotic cells, as previously. This first analysis allowed the calibration of fPEG-
cholesterol in live RPE1 cells. 1 µg/ml of this probe was chosen for the continuation of these 
studies as it represented the smallest saturating concentration (figure 4.3A). 
To fully characterize fPEG-cholesterol as a probe for cell surface cholesterol levels, RPE1 cells 
were treated with MβCD or with MβCD-cholesterol complexes to deplete or enrich the total 
levels of cholesterol in the cells, respectively. The cells were then stained with fPEG-
cholesterol, fixed and analysed by flow cytometry. As expected, the levels of cholesterol 
associated with the fluorescence of the probe were reduced when cells were depleted of 
cholesterol and increased when cells were enriched with cholesterol complexes, compared to 
the control, non-treated sample (figure 4.3B).  
Next, RPE1 cells were again stained with fPEG-cholesterol and DRAQ5. After fixation, cells 
were immunolabelled against phospho-Histone H3 to identify mitotic cells by flow cytometry 
analysis. Cells in mitosis showed higher levels of fluorescence intensity after staining with 
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fPEG-cholesterol than cells in G2, S or G1 (figure 4.3C). Since fPEG-cholesterol is impermeable, 
the fluorescence measured by flow cytometry analysis is likely to correspond only to surface 
cholesterol. This fully agreed with the results previously obtained with the quick filipin staining. 
Interestingly, the data obtained by flow cytometry analysis showed two peaks of fPEG-
cholesterol fluorescence corresponding to the phospho-Histone H3-positive cells (figure 4.2). 
This is likely because phospho-Histone H3 labels all phases within cell division, including 
cytokinesis (Li et al., 2005). 
Since the flow cytometry profiles corresponding to fPEG-cholesterol fluorescence of dividing 
cells revealed two populations, one with the same fluorescence intensity as the other phases of 
the cell cycle and another with much higher levels of intensity, RPE1 cells were analysed by 
microscopy to solve this apparent discrepancy. Thus, RPE1 cells were stained with fPEG-
cholesterol and DRAQ5 and single cells were analysed by 3D confocal microscopy, as before. 
This analysis showed that the strongest signals corresponded to metaphase cells and therefore 
that cell surface exposed cholesterol was maximal during this stage (figure 4.3D and E).  
To investigate if this increase at the surface during mitosis was specific for cholesterol or due to 
a general change in lipid composition at the plasma membrane, live RPE1 cells were stained 
with Annexin V-FITC, which is impermeable and known to bind specifically to 
phosphotidylserine (PS). Annexin V has been extensively used as a molecular probe for PS, 
mainly to determine early apoptosis, as it is known that apoptotic cells change the structure of 
their membrane, leading to the exposure of PS at the surface (Vermes et al., 1995). Single cell 
measurements by 3D confocal microscopy did not reveal significant differences in the Annexin 
V-FITC fluorescence signals corresponding to metaphase cells compared to those 
corresponding to interphase cells. However, when apoptosis was induced by treating cells with 
staurosporine for 6 h, the levels of Annexin V-FITC fluorescence increased more than 5-fold 
(figure 4.3F). This shows that the levels of PS do not increase at the membrane surface during 
mitosis, which strongly suggests that this process is specific for cholesterol. 
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Figure 4.3. Cell surface cholesterol determination by fPEG-cholesterol. (A) Calibration of fPEG-
cholesterol concentrations in living cells. 1 μg/mL was chosen for subsequent experiments as it 
represented the smallest saturating concentration. (B) Representative flow cytometry profile of RPE1 
cells from control, cholesterol depleted (‘-cholesterol’) or cholesterol loading (‘+cholesterol’) stained with 
fPEG-cholesterol. (C) Representative flow cytometry profile of RPE1 cells stained with fPEG-cholesterol, 
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DRAQ5 and phospho-Histone H3. G1, S and G2 cells were identified by DNA gating and mitotic cells were 
phospho-Histone H3-positive. (D) Representative picture of a cell sample used. fPEG-cholesterol is 
shown in green) and DNA in blue. Bar, 10 μm. (E) Single-cell measurements of cell surface cholesterol. 
The values are integrals of fPEG-cholesterol signals from whole stacks of images. (F) Single-cell 
measurements of cell surface phosphatidylserine (Annexin V-FITC). Apoptosis was induced by 
staurosposine (1 μM, 6h). 
 
4.2.4. Plasma membrane cholesterol asymmetry ceases during mitosis 
It was surprising that, unlike surface cholesterol (Figure 4.2H, left), the total (inner + outer 
leaflets) cholesterol levels at the plasma membrane did not vary between G2 and mitosis (Figure 
4.2H, right). This discrepancy between the filipin fluorescence obtained for the ‘outer leaflet’ and 
the one obtained for the ‘inner + outer leaflets’ suggested that the levels of cholesterol between 
the two leaflets might change from G2 to mitosis.  
To assess if the cholesterol levels vary amid the plasma membrane leaflets during mitosis, an 
assay that takes advantage of the fluorescence of a natural derivative of cholesterol 
(dihydroergosterol, DHE) and of its very fast quenching by 2,4,6-trinitrobenzene sulfonic acid 
(TNBS) was used (Hao et al., 2002). TNBS has been used to determine the transbilayer 
distribution of cholesterol in live cells because, as it is cell impermeable, it only quenches the 
fluorescence of lipid analogues located at the outer leaflet of the plasma membrane (Mondal et 
al., 2009). Many studies including those on neurons, red blood cells or epithelial cells have 
determined that sterols are asymmetrically distributed at the plasma membrane and are mainly 
(70-80%) located at the inner leaflet (Wood et al., 1990; Schroeder et al., 1991; Incerpi et al., 
1992; Igbavboa et al., 1996; Igbavboa et al., 1997; Kirsch et al., 2003; Mondal et al., 2009; 
Wood et al., 2011).  
RPE1 cells were loaded with DHE for 5 min, such that it mainly stained the plasma membrane. 
The fluorescence of DHE was measured by the integral of the signals in whole 3D image stacks 
taken with a spinning-disk confocal fluorescence microscope. TNBS was then applied to quench 
the fluorescence from the DHE. Immediately after this, the remaining DHE fluorescence was 
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measured, following the same method. Example images of DHE fluorescence before and after 
quenching with TNBS are shown in figure 4.4A. In interphase, TNBS only quenched 
approximately 20% of the DHE signal (figure 4.4B and C). Since virtually all DHE signals were 
quenched in permeabilized cells, 20% quenching in non-permeabilized cells is very likely to 
represent a partitioning of 80% of sterols in the inner leaflet of the plasma membrane (figure 
4.4, interphase). This agrees with results from previous studies obtained with other epithelial 
cell lines (Mondal et al., 2009), indicating that in RPE1 cells sterols are asymmetrically 
distributed between the two leaflets of the plasma membrane, as 20% locate at the outer leaflet 
and the remaining 80% at the inner leaflet (figure 4.4D, interphase). However, in mitotic cells, 
TNBS quenched almost 50% of the DHE signal (figure 4.4B and C), indicating a partitioning of 
sterols close to 50-50% in both leaflets (figure 4.4, mitosis). These data suggests that that the 
transient increase of cholesterol at the cell surface of mitotic cells is due to a loss of 
asymmetrical partitioning that takes places during this phase of the cell cycle (figure 4.4E). 
 
4.2.5. Enrichment with cholesterol leads to a volume increase in mitotic cells 
The loss of asymmetrical partitioning of cholesterol during mitosis explains the preferential 
targeting of these cells by Salmonella. In addition, the results described above suggest a 
decrease in the levels of cholesterol at the inner leaflet of the plasma membrane, from 80% 
during G2 to 50% during mitosis. This is consistent with a previous report that shows a decrease 
in the cholesterol-binding protein Caveolin-1 at the plasma membrane during metaphase 
(Boucrot et al., 2011). Pre-loading cells with cholesterol-MβCD complexes is likely to confer 
high levels of cholesterol in the inner leaflet of mitotic cells, despite the reduction from 80% to 
50% that takes place during mitosis, as reported above.  
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Figure 4.4. Cholesterol asymmetry ceases during mitosis. Experiments shown here were carried out 
by Dr. Emmanuel Boucrot. (A) Representative images of DHE fluorescence before and after bleaching 
with TNBS in interphase and mitotic cells (rounded). Bar, 10 μm. (B) DHE fluorescence measurement 
before and after bleaching with TNBS in interphase and mitotic cells. The values were normalised to 
those of G1. Averages ± s.e.m. and number of samples analysed are written at the bottom. (C) Remaining 
DHE fluorescence after bleaching with TNBS, corresponding to the fraction of inaccessible, (cytoplasmic) 
fraction of cholesterol at the plasma membrane. Averages ± s.e.m. and number of samples analysed are 
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written at the bottom. (D) Cholesterol repartitions at the plasma membrane during interphase and mitosis. 
(E) Model proposing the repartition of cholesterol at the plasma membrane of interphase cells (~20:80 
ratio between outer:inner leaflets) and its potential variation during mitosis (~50:50). 
 
An apparent increase in the size of mitotic cells was frequently observed by 
immunofluorescence microscopy when cells were pre-loaded with cholesterol-MβCD 
complexes. These observations suggested that perhaps high levels of cholesterol in the inner 
leaflet of the plasma membrane perturb cell compaction and rounding during mitosis, causing 
metaphase cells to become bigger (figure 4.5A). To test this, non-treated cells and cells 
enriched with cholesterol were fixed, permeabilized and stained for DNA, actin and cholesterol. 
Then, Z-stacks of mitotic cells were acquired by confocal microscopy and subsequently 3D 
projections were generated (figure 4.5B). The volumes of mitotic cells were then determined by 
the quantification of volumetric pixels (voxels) of actin. The results show that treatments of cells 
with cholesterol-MβCD complexes led to a significant increase in volume of mitotic cells, as 
treated cells were on average 23% bigger than control cells (figure 4.5C). 
 
4.2.6. Enrichment with cholesterol does not affect the levels of RhoA, Cdc42 or 
Rac1 in the plasma membrane during mitosis 
Cell rounding during mitosis starts with cellular de-adhesion, a process characterized by 
dissociation of adhesion complexes from the cell edges and subsequent cell membrane 
retraction. During this movement, the cortical actin network reorganizes to reach a spherical and 
rigid shape (Thery and Bornens, 2008). Mitotic cell compaction and subsequent rounding is 
driven partially by RhoA (Maddox and Burridge, 2003), but the downstream mechanism is still 
poorly understood. 
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Figure 4.5. Metaphase cells enriched with cholesterol are bigger. (A) Confocal microscopy images 
showing the total cellular cholesterol levels (filipin, green) in interphase and mitotic cells in control cells or 
upon cholesterol loading using MβCD-cholesterol complexes (ʻ+ cholesterolʼ). Cells were counterstained 
for actin (red) and DNA (blue). Note the difference in size between the two mitotic cells in the centre. Bar, 
20 μm. (B) 3D rendering of a metaphase cell stained for cholesterol (filipin, green), actin (red) and DNA 
(blue) from control or MβCD-cholesterol loading (‘+ cholesterol’) samples. Unit: 13.5 µm. (C) Metaphase 
cell volume in control or ‘+ cholesterol’ samples, determined by 3D fluorescent confocal microscopy. 
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Addition of exogenous cholesterol perturbed cell compaction and rounding during mitosis, 
causing mitotic cells to become bigger (figure 4.5). This was likely due to an increase in the 
cholesterol levels in the inner leaflet of the plasma membrane. Therefore, recruitment to the 
plasma membrane of RhoA and two other Rho GTPases involved in cell cycle progression, 
Cdc42 and Rac1, was assessed with the use of commercial antibodies. Importantly, the 
specificity of each anti-Rho GTPase antibody was tested first. RPE1 cells were transfected with 
EGFP tagged contructs of RhoA, Cdc42 and Rac1, which results in overexpression of the 
tagged protein in the cell. Then, transfected cells were labelled with the corresponding Rho 
GTPase antibody, along with DNA staining. As shown in example images in figure 4.6D, in cells 
transfected with either RhoA-, Cdc42- and Rac1-tagged EGFP contructs, the EGFP 
fluorescence co-localised with that corresponding to the antibody labelling. Furthermore, the 
total levels of fluorescence from the antibody labelling were much higher in transfected cells 
than in non-transfected ones (figure 4.6D). This shows that the antibodies against RhoA, Cdc42 
and Rac1 were specific for the endogenous proteins. 
After assessing the specificity of the commercial antibodies, control cells and cells treated with 
cholesterol-MβCD complexes were fixed, permeabilized and stained for DNA and actin. In 
addition, they were labelled with antibodies against each of the Rho GTPases. Cells were then 
examined by fluorescence microscopy and Z-stacks were acquired to quantify the total levels of 
RhoA, Cdc42 and Rac1 in the plasma membrane, distinguishing between interphase and 
mitotic cells. Representative images of RPE1 cells in metaphase labelled against RhoA, Cdc42 
and Rac1, with or without addition of cholesterol-MβCD complexes, are shown in figure 4.6A. 
In control cells, the quantification of RhoA at the plasma membrane showed that its levels are 
higher in metaphase than in interphase cells (figure 4.6B). This was expected as it agrees with 
previously published results (Maddox and Burridge, 2003). Interestingly, the levels of Cdc42 
also increased in the plasma membrane during mitosis, contrary to the levels of Rac1, which did 
not change significantly from interphase to mitosis (figure 4.6B). However, the levels of RhoA, 
Cdc42 and Rac1 at the plasma membrane were similar between control cells and cells pre-
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loaded with cholesterol-MβCD complexes (figure 4.6C). These results show that the addition of 
cholesterol-MβCD complexes to cells does not affect the levels of RhoA, Cdc42 or Rac1 in the 
plasma membrane during mitosis. Therefore, the effect in cell compaction and rounding caused 
by this treatment is likely to be independent of these three Rho GTPases. 
 
4.2.7. Transient loss in plasma membrane cholesterol asymmetry supports pERM 
recruitment 
Studies over the past decades have implicated ezrin, radixin and moesin, collectively known as 
ERMs, as key organizers of specialized membrane domains. Activated ERM proteins can 
bridge actin filaments to the plasma membrane, through binding to phosphatidylinositol 
4,5‑bisphosphate (Pi(4,5)P2). In interphase cells, inactive ERMs yield randomly oriented 
filamentous actin (F‑actin), which results in low cortical tension. As cells enter mitosis, 
phosphorylation and binding to Pi(4,5)P2 activates the ERM proteins, resulting in their 
recruitment to the plasma membrane. Then, active ERMs attach actin filaments to the cell 
membrane, so that these filaments lie parallel to the cell cortex. This increases cortical tension 
and leads to rounding of the cell membrane during mitosis (Kunda et al., 2008; Fehon et al., 
2010). 
To test if the addition of exogenous cholesterol affected the recruitment of phosphorylated 
ERMs (pERMs) to the plasma membrane during mitosis, the same methodology was used as 
before. In summary, control cells and cells treated with cholesterol-MβCD complexes were 
fixed, permeabilized and stained for DNA and actin, as well as labelled with a specific antibody 
against pERM. Then Z-stacks were acquired using a confocal microscope and the levels of 
pERM proteins in the plasma membrane were quantified, distinguishing between interphase 
and metaphase cells. 
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Figure 4.6. Cholesterol enrichment does not affect the levels of RhoA, Cdc42 or Rac1 in the 
plasma membrane. (A) Immunofluorescence of RhoA, Rac1 and Cdc42 in control or ‘+ cholesterol’ 
samples. Cells were labelled for the respective markers (green) and stained for actin (red) and DNA 
(blue). Z-projections of 3D confocal serial sections are shown. Bars, 10 µm. (B) Recruitment to the 
plasma membrane of endogenous RhoA, Rac1 and Cdc42 in interphase or metaphase cells. 20 cells 
were analysed for each category and for each labelling. (C) Recruitment to the plasma membrane of 
endogenous RhoA, Rac1 and Cdc42 in metaphase cells from control or ‘+ cholesterol’ samples. 20 cells 
were analysed for each category and for each staining. (D) Immunofluorescence of transfected cells 
overexpressing Rac1-, Cdc42- and RhoA-EGFP contructs (green) labelled with the corresponding 
commercial antibody (red). DNA is shown in blue. Bars, 20 µm. Data are mean ± SEM. ns, not significant; 
** P<0.01;  *** P<0.001. 
 
As expected, the levels of pERM proteins in the plasma membrane significantly increased 
during mitosis (figure 4.7A). However, metaphase cells treated with cholesterol-MβCD 
complexes showed a large reduction in the levels of pERM proteins in the membrane compared 
to control metaphase cells (figure 4.7B). Representative images of this reduction in cells treated 
with cholesterol-MβCD complexes are shown in figure 4.7C. This strongly suggests that 
increasing the levels of cholesterol in the inner leaflet of the plasma membrane perturbs the 
recruitment of pERM proteins during mitosis. This could explain the defects in mitotic cell 
rounding caused by cholesterol addition (figure 4.5B and C). Indeed, an increase in volume of 
cells in metaphase is the expected result when pERM recruitment to the membrane is perturbed 
(Stewart et al., 2011).  
Since pERM bind to Pi(4,5)P2 in the plasma membrane during mitosis, the same protocol was 
followed to assess the levels of Pi(4,5)P2 in the membrane of control cells and of cells treated 
with cholesterol-MβCD complexes. But first, the specificity of the anti-Pi(4,5)P2 antibody was 
tested by treating cells with 1-butanol, known to inhibit the Pi5 Kinase and therefore block the 
formation of Pi(4,5)P2 (Boucrot et al., 2006). Cells treated with 1-butanol showed decreased 
fluorescence upon labelling with the anti-Pi(4,5)P2 compared to control cells, confirming the 
specificity of the antibody (figure 4.6F). Then, the levels of Pi(4,5)P2 were measured as before 
and, as expected, shown to be significantly increased in the plasma membrane of control cells 
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during mitosis (figure 4.6D). However, metaphase cells treated with cholesterol-MβCD 
complexes showed a significant reduction in the levels of Pi(4,5)P2 in the cell membrane 
compared to control metaphase cells (figure 4.7D). Example images of this decrease in cells 
treated with cholesterol-MβCD complexes are shown in figure 4.7E. These results indicate that 
increasing the levels of cholesterol in the inner leaflet reduces Pi(4,5)P2 binding to the plasma 
membrane.  
Pre-loading cells with cholesterol-MβCD complexes is thought to confer high levels of 
cholesterol in the inner leaflet of mitotic cells. Therefore, this treatment abolishes the reduction 
from 80% to 50% that happens during mitosis (figure 4.4). Enrichment of inner leaflet 
cholesterol during mitosis caused reduced recruitment of pERMs and decreased the levels of 
their binding partner Pi(4,5)P2 in the plasma membrane (figure 4.7). This led to defects in mitotic 
cell rounding (figure 4.5).  
Taken together, these results indicate that the loss of asymmetrical partitioning of cholesterol 
during mitosis might support cell rounding. The reduction in cholesterol levels in the inner leaflet 
during mitosis, from 80% to 50%, probably allows increased binding of Pi(4,5)P2 to the plasma 
membrane and promotes the subsequent recruitment of the pERM. As the ERM proteins are 
not known to bind directly to cholesterol but to Pi(4,5)P2 (Roch et al., 2010; Roubinet et al., 
2011), a decrease in cholesterol in the inner leaflet could reduce the clustering of Pi(4,5)P2 and 
thus increase its availability (as suggested by (Klopfenstein et al., 2002; Murray and Tamm, 
2009; van den Bogaart et al., 2011)). Another explanation could be that a decrease in 
cholesterol in the inner leaflet of the plasma membrane during mitosis would support higher 
levels of Pi(4,5)P2, as it was recently shown that transient cholesterol enrichment decreases 
Pi(4,5)P2 levels (Chun et al., 2010). 
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Figure 4.7. Loss in cholesterol asymmetry during mitosis supports recruitment of ERM proteins 
and Pi(4,5)P2 to the plasma membrane. (A) Recruitment to the plasma membrane of endogenous 
activated phospho-ERM proteins (pERM) in interphase or metaphase cells. 20 cells were analysed for 
each categories and for each staining. (B) Recruitment to the plasma membrane of endogenous activated 
phospho-ERM proteins (‘pERM’) in metaphase cells from control or ‘+ cholesterol’ samples. 20 cells were 
analysed for each category and for each staining. (C) Immunofluorescence of activated phospho-ERM 
proteins (pERM, green), actin (red) and DNA (blue) in control or ‘+ cholesterol’ samples. Z-projections of 
3D confocal serial sections are shown. Bars, 10 µm. (D) Levels of endogenous phosphatidylinositol 
4,5‑bisphosphate (Pi(4,5)P2) in the plasma membrane of interphase or metaphase cells, in control or ‘+ 
cholesterol’ samples. (E) Immunofluorescence of phosphatidylinositol 4,5‑bisphosphate (Pi(4,5)P2, 
green), actin (red) and DNA (blue) in control or ‘+ cholesterol’ samples. Z-projections of 3D confocal serial 
sections are shown. Bars, 10 µm. (F) Calibration of the anti-Pi(4,5)P2 antibody. Addition of 2% 1-butanol 
for 1 min at 37°C reduced the labelling, as expected for the inhibition of Pi5 Kinase by this treatment. 
Data are mean ± SEM. ns, not significant; ** P<0.01;  *** P<0.001. 
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CHAPTER 5 
INTRACELLULAR SALMONELLA INDUCES CYTOKINESIS FAILURE IN 
HOST CELLS 
 
5.1. Introduction 
In addition to its requirement for growth and development, the cell cycle is important for 
generating immune responses and maintaining epithelial barrier functions. Both these latter 
processes are known to affect colonisation and proliferation of pathogenic bacteria (Ashida et 
al., 2012). For example, the intestinal epithelium is well-known for its fast self-renewal. This fast 
turnover is sustained by the perpetual cell cycle of stem cells located at the intestinal crypts. 
They give rise to cycling progenitor cells that undergo up to six rounds of cell division while 
migrating upwards from the bottom of the intestinal crypts to the villi (Barker et al., 2008). This 
epithelial turnover is thought to constitute a functional barrier against enteric bacteria as infected 
enterocytes can be shed and replaced by newly differentiated ones every day. Nonetheless, 
many pathogens, including S. Typhimurium, persistently colonise the epithelial barriers of the 
intestine (Ashida et al., 2012). Salmonella invades the enterocytes and proliferates 
intracellularly inside the SCV. Most intracellular replication occurs after the SCV reaches the 
vicinity of the Golgi network. Extensive replication depends on the action of the T3SS-2 
effectors and results in the formation of a cluster of SCVs (commonly referred to as the 
microcolony) near the Golgi apparatus (Figueira and Holden, 2012).  Although recent studies 
have indicated that a growing family of bacterial effectors, termed cyclomodulins, interfere with 
the eukaryotic cell cycle to benefit the fate of the pathogen (Nougayrede et al., 2005), the 
influence of Salmonella infections in the progression of the host cell cycle has never been 
assessed directly.  Importantly, the hypothesis that Salmonella interferes with the cell cycle of 
the host, possibly to facilitate colonisation of host tissues, is supported by many studies showing 
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a significant association between Salmonella chronic infections and cancer formation, 
suggesting that long-term Salmonella infections might deregulate the cell cycle of the host 
(Robbins et al., 1988; Caygill et al., 1995; Shukla et al., 2000; Kumar, 2006). Therefore, this 
investigation aimed to assess the impact of intracellular Salmonella on the cell cycle of the host 
and to study its molecular mechanisms, specifically a potential contribution of the T3SS-2.   
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5.2. Results 
5.2.1. Intracellular Salmonella induces an accumulation of cells with 4n DNA 
To investigate if intracellular Salmonella interferes with the progression of the host cell cycle, 
asynchronous populations of HeLa cells and RPE1 cells were infected for 14 h with three wild-
type strains of S. Typhimurium (12023, SL1344 and LT2) expressing EGFP constitutively. 
Following infection, the cells were fixed and permeabilized. The DNA was labelled with 
propidium iodide and the cells were subsequently analysed by flow cytometry. Infected cells 
were identified by gating for EGFP signal.  
The histograms of the DNA content of infected cells showed a highly increased population of 
cells with a DNA content corresponding to 4n, compared to the histograms derived from the 
uninfected populations. The flow cytometry histograms resulting from infections with the three 
wild-type strains and of both cell lines showed that approximately 40-50% more infected than 
uninfected cells carried a DNA content of 4n (figure 5.1). For each infection, the corresponding 
percentages of the increase in 4n cells in the infected population compared to the uninfected 
one are indicated in figure 5.1.  
These DNA histograms acquired by flow cytometry analysis indicate that infection with 
Salmonella leads to the accumulation of host cells harbouring 4n DNA, regardless of the cell 
line or the bacterial strain used.  
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Figure 5.1. Intracellular Salmonella induces an increase of cells with 4n DNA. Asynchronous 
populations of HeLa cells (left) and RPE1 cells (right) were infected for 14 h with EGFP-expressing wild-
type Salmonella strain 12023, SL1344 and LT2. Host cellular DNA was stained with propidium iodide and 
cell cycle distribution was analysed by flow cytometry. The histograms of infected cells are shown in red 
for comparison with uninfected cells, shown in dark grey. The increase in the percentages of infected 
cells with DNA content of 4n compared to the uninfected population is indicated. Infected cells were 
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identified by gating for EGFP-positive cells. At least three independent experiments were made and for 
each experiment at least 30,000 cells were analysed in each sample. 
  
5.2.2. Salmonella induces binucleation in host cells  
The results shown in figure 5.1 suggested an arrest of the host cell cycle in G2 or mitosis. 
Alternatively, this phenotype could also be the result of cytokinesis failure, as this often leads to 
binucleation. Failure during cytokinesis might occur after the nuclear envelope is assembled in 
the emerging daughter cells, resulting in a single cell harbouring two nuclei. To investigate if 
Salmonella caused an arrest in G2 or mitosis or induced binucleation, RPE1 cells infected for 14 
h with the wild-type strains 12023, SL1344 and LT2 were examined by immunofluorescence 
microscopy. A high frequency of binucleated cells infected with Salmonella was found (figure 
5.2A). This observation is in accordance with the results obtained by flow cytometry analysis 
(figure 5.1) as binucleated cells accumulate in the 4n peak of fluorescent intensity. The 
frequency of this phenotype was quantified by counting the number of cells with one or two 
nuclei, calculating this as a percentage of the total cell population and comparing these 
percentages between infected and uninfected cells. Strikingly, for the three different strains of S. 
Typhimurium used, more than 50% of the infected cells contained two nuclei after 14 h of 
infection, compared to approximately 15% of binucleated cells in the uninfected sample (figure 
5.2B). This confirmed that a defect in cytokinesis was induced upon bacterial infection. Since no 
significant differences were observed between the three wild-type strains used, S. Typhimurium 
strain 12023 was selected to be used for the continuation of this study. 
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Figure 5.2. RPE1 Infected cells with S. Typhimurium strains 12023, SL1344 and LT2 for 14 h show 
an increased population of binucleated cells. (A) Immunofluorescence microscopy of RPE1 cells 
infected for 14 h with S. Typhimurium strain 12023. EGFP-expressing S. Typhimurium is shown in green. 
Host cell DNA was stained with DRAQ5 (blue) and cells were immunolabelled against α-tubulin (red). 
Bars represent 20 µm. (B) Cells were scored following fluorescence microscopy as to whether they 
contained one or two nuclei and the percentage in these groups calculated.  Only non-overlapping cells 
were analysed, as determined using the cell membrane marker WGA. DNA was stained with DRAQ5. 
*P<0.05; **P<0.01, ***P<0.001 (compared to uninfected). At least 400 cells were counted for each 
category. 
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5.2.3. Host cell binucleation induced by Salmonella begins at later stages of 
infection  
To determine the timing of onset of host cell binucleation induced by Salmonella, a time-course 
analysis of this phenotype was undertaken. RPE1 cells were infected for 3, 6, 9, 12 and 14 h 
with strain 12023 expressing EGFP constitutively. For each time point, the cells were fixed, 
permeabilized and their DNA was stained with propidium iodide. The fold increase in the size of 
the population of host cells containing 4n DNA in comparison to that in uninfected samples was 
calculated for each time point, following flow cytometry analysis. An accumulation of 4n cells 
infected with Salmonella was not detected at 3, 6 or 9 h. Of all the time points examined, a 
significant increase in the 4n population of infected compared to uninfected cells was only 
obtained at 12 h of infection. As expected, this increase in the 4n population was even higher at 
14 h (figure 5.3). This indicates that longer infection periods allow more infected cells to 
undergo cell division and therefore failure during cytokinesis occurs more frequently, resulting in 
binucleation. 
 
5.2.4. Binucleation of host cells induced by Salmonella is T3SS-2 dependent 
Having established that Salmonella infections led to binucleated host cells, it was determined if 
this phenotype was T3SS-2 dependent. Initially, cells were infected for 14 h with the wild-type 
strain of S. Typhimurium and a strain deficient in a functional T3SS-2. Both strains carried a 
plasmid that allows constitutive expression of EGFP. The latter strain carries a mutation in the 
ssaV gene, which encodes an essential inner membrane component of the secretion system. A 
∆ssaV mutant strain is therefore unable to secrete any of the T3SS-2 effectors. Flow cytometry 
analysis of the DNA content of wild-type and ∆ssaV mutant-infected cells was performed as 
before. The DNA histograms resulting from the flow cytometry analysis showed that fewer cells 
infected with the ∆ssaV mutant contained 4n DNA compared to those infected with the wild-type 
strain. Whilst wild-type-infected cells accumulated 55.5% more 4n cells than the uninfected 
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population, cells infected with the ssaV mutant accumulated only 18.7% more of these cells 
(figure 5.4A, first two panels).  
 
 
Figure 5.3. Time-course of the fold increase in 4n cells infected with EGFP-Salmonella. Flow 
cytometry DNA histograms showing cells infected with Salmonella (red line) and uninfected cells (black 
line) at 3, 6, 9, 12 and 14 h of infection. For each histogram, the time point is indicated. Below left shows 
the fold increase in number of Salmonella 10203 infected cells with 4n DNA relative to uninfected cells 
(indicated by the red line) calculated after flow cytometry analysis of DNA stained with propidium iodide. 
Salmonella constitutively expressed EGFP. Infected cells were identified by gating for EGFP-positive 
cells. For each time-point, experiments were done at least 3 times. At least 30,000 cells were analysed in 
each sample. *P<0.05; **P<0.01. 
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There were at least two possible explanations for this phenotype: it could be due to the lack of 
activity of one or more T3SS-2 effectors or due to an indirect effect of having a much lower 
number of intracellular bacteria than the wild-type strain, since an ∆ssaV mutant has an 
intracellular replication defect. To assess if the phenotype was due to the lack of a functional 
T3SS-2 or to low bacterial numbers, cells were infected with an ∆aroCpurD mutant, which 
possesses a functional T3SS-2 but has a strong replication defect (Beuzon et al., 2002). As a 
positive control for translocation of effectors, cells infected with the ∆aroCpurD mutant were 
labelled for epitope-tagged SseJ (an effector of the T3SS-2). Cells infected with the ∆aroCpurD 
mutant, that were positive for translocated epitope-tagged SseJ, showed an increase in the 
population containing 4n DNA similar to that observed in cells infected with the wild-type strain 
(45.3% more 4n cells, compared to 55.5% more given by the wild-type strain). This suggests 
that the phenotype caused by the ∆ssaV mutant was due to the absence of the activity of one or 
more T3SS-2 effectors and not due to the replication defect of this mutant (figure 5.4A, top row). 
 
5.2.5. Identification of effectors responsible for binucleation of host cells induced 
by Salmonella 
Next, several T3SS-2 effector mutants were tested to determine if any of these recapitulated the 
phenotype associated with the ∆ssaV mutant and thereby identify the effector/s responsible for 
the binucleation of infected cells.  
Due to the large number of effectors, the screen of the T3SS-2 effector mutants was performed 
in three different experiments. For each experiment, flow cytometry analysis following DNA 
staining was done in RPE1 cells infected for 14 h with wild-type, ∆ssaV and a group of mutant 
strains lacking individual T3SS-2 effectors. In total 19 T3SS-2 single effector mutants were 
tested this way. The ratio of the percentage of the 4n population of wild-type-infected to ssaV-
infected cells was determined for each experiment. 
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Figure 5.4. SseF, SseG and SifA contribute to the increase in 4n cells induced by intracellular 
Salmonella. (A) Flow cytometry DNA histograms showing cells infected with wild-type and S. 
Typhimurium mutant strains ∆ssaV and ∆aroCpurD and uninfected cells. The histograms of infected cells 
are shown in red for comparison with uninfected cells, shown in dark grey. (B) % of tetraploid cells shown 
for all the T3SS-2 single effector mutants screened. Percentages were normalised for the SPI-2 effect 
and then for the wild-type strain. The bars corresponding to the mutant strains considered to be positive 
hits are shown in red. (C) Flow cytometry DNA histograms showing cells infected with Salmonella mutant 
strains ∆sseG, ∆sseF, ∆sseFG and ∆sifA and uninfected cells. The histograms of infected cells are 
shown in red for comparison with uninfected cells, shown in dark grey. The increase in the percentages of 
infected cells with DNA content of 4n compared to the uninfected population is indicated. Infected cells 
were identified by gating for EGFP-positive cells. For the DNA histograms, at least three independent 
experiments were made and for each experiment at least 30,000 cells were analysed in each sample. 
 
The SPI-2 effect was determined and used to normalise the percentages of 4n cells caused by 
each T3SS-2 effector mutant tested and therefore to allow comparison between experiments. 
The results of the screen are represented in figure 5.4B. Of the T3SS-2 effector mutants tested, 
only three failed to cause the accumulation of 4n cells: ∆sseG, ∆sseF and ∆sifA (figure 5.4B). 
Representative flow cytometry histograms reporting the distributions of DNA content of cells 
infected with the mutant strains ∆sseF, ∆sseG, ∆sifA and the double mutant strain ∆sseFG are 
shown for comparison with those of the wild-type, ∆ssaV and ∆aroCpurD in figure 5.4C. The 
increase of 4n cells in the infected population compared to the corresponding uninfected one 
was of 20% for ∆sseF, 18.5% for ∆sseG, 22% for ∆sseFG and 14.9% for ∆sifA. These 
percentages were greatly reduced compared to the increase caused by the wild-type strain 
(55.5%) or the ∆aroCpurD strain (45.3%) and were similar to the one caused by the ∆ssaV 
strain (18.7%) (figure 5.4A). Since SseF and SseG are believed to be involved in the same 
function in host cells and interact physically (Deiwick et al., 2006), it was not surprising that 
there was no cumulative effect of 4n cell accumulation induced by the double mutant infection 
compared to those caused by the single mutant strains (figure 5.4C, top row).  
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5.2.6. The T3SS-2 effectors SseF, SseG and SifA are required to induce 
binucleation in host cells 
To study the effects of SseG, SseF and SifA in the binucleation of host cells, 
immunofluorescence microscopy analysis was carried out in cells infected with the wild-type 
strain and with strains lacking each of these effectors. This analysis revealed a decreased 
frequency of binucleated cells when cells were infected with the ∆ssaV, ∆sseF, ∆sseG or ∆sifA 
mutants compared to those infected with the wild-type strain. Less than 15% of cells infected 
with any of the mutant strains were binucleated and there were approximately 40% binucleated 
cells infected with the wild-type strain (figure 5.5A and C).  
The phenotype caused by wild-type Salmonella was restored when a plasmid constitutively 
expressing sseF or sseG was inserted in the corresponding mutant strain, as the transformed 
strains induced binucleation of host cells to a similar extent as the wild-type (figure 5.5B and C), 
which demonstrates that both SseF and SseG are required for binucleation. This 
immunofluorescence microscopy analysis agrees with the previous data obtained by flow 
cytometry (figure 5.4). This strongly suggests that the functions of SseF, SseG and SifA are 
critical in the process leading to binucleation of host cells.  
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Figure 5.5. Immunofluorescence microscopy analysis of RPE1 cells infected for 14 h with wild-
type Salmonella, mutant strains and mutant strains carrying a plasmid expressing sseF or sseG 
constitutively. (A) RPE1 cells were infected for 14 h with wild-type and S. Typhimurium ∆ssaV, ∆sseF, 
∆sseG and ∆sifA mutant strains. EGFP-expressing Salmonella are shown in green. Host cell DNA was 
stained with DRAQ5 (blue) and cells were immunolabelled for α-tubulin (red). Bars represent 10 µm. (B) 
RPE1 cells were infected for 14 h with the ∆sseG or the ∆sseF mutant, each carrying a plasmid 
expressing the corresponding lacking gene. Salmonella was labelled with CSA-1 (green). Host cell DNA 
was stained with DRAQ5 (blue) and actin was stained with phalloidin (red). Bars represent 20 µm. (C) 
Cells were scored following fluorescence microscopy as to whether they contained one or two nuclei and 
the percentage in these groups calculated. DNA was stained with DRAQ5. *P<0.05; **P<0.01, 
***P<0.001. At least 200 cells were counted for each category. 
 
5.2.7. Intracellular Salmonella does not affect centrosomal migration or arrest 
cells in mitosis  
Previous work from our laboratory and others suggests a possible role of SseF and SseG in 
maintaining the SCV associated with the Golgi network, perhaps through a tethering 
mechanism (Salcedo and Holden, 2003; Ramsden et al., 2007a; Ramsden et al., 2007b). The 
Golgi network closely associates with the centrosome during interphase (Yadav and Linstedt, 
2011).  
The centrosome undergoes duplication during S phase. At the onset of mitosis, each 
centrosome migrates to one pole of the cell and the mitotic spindle is formed between them. 
The spindle interacts with the chromosomes and is critical for their correct separation during 
anaphase (Schatten, 2008). It has been shown that laser ablation of centrosomes leads to 
failures in cytokinesis, but the molecular mechanisms behind this are still unclear (Khodjakov 
and Rieder, 2001).    
To assess if the localization of the SCVs near the centrosome interferes with its duplication in S 
phase or with the migration of the two centrosomes during mitosis, RPE1 cells were infected 
with the wild-type strain, the ∆ssaV mutant and the ∆sseFG double mutant strain. For these 
experiments, cells were infected for 9 h to allow immunofluorescence microscopy analysis of 
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centrosomes in infected cells prior to failure during cytokinesis and subsequent binucleation, as 
the time-course analysis showed no significant increase in the population of 4n infected cells at 
9 h compared to uninfected cells (figure 5.3).  
After fixation and permeabilization, the cells were labelled for γ-tubulin, a centrosomal marker, 
and their DNA was stained. Microscopy analysis revealed that there were no significant 
differences in the number of centrosomes during mitosis or their positioning at the poles of the 
cell (figure 5.6A) between infected and uninfected cells, regardless of the Salmonella strain 
used.  
Cytokinesis is a complex process that involves many steps. Many proteins that are important 
during mitosis also play pivotal roles during cytokinesis (Normand and King, 2010). To assess if 
mitosis of infected cells was also affected by Salmonella, possibly leading to defects during 
cytokinesis, RPE1 cells fixed after 9 h of infection with the wild-type strain, the ∆ssaV mutant or 
the ∆sseFG double mutant strain were stained for DNA and labelled with the mitotic cell marker 
MPM-2. flow cytometry analysis revealed similar percentages of cells in mitosis, between 
infected cells and uninfected cells (figure 5.6B), indicating that intracellular Salmonella does not 
arrest cells during mitosis. 
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Figure 5.6. At 9 h of infection intracellular Salmonella does not have an effect on the number or 
migration of centrosomes and does not arrest mitosis. (A) RPE1 cells were infected for 9 h with wild-
type Salmonella and the ∆ssaV and ∆sseFG mutant strains. Infected cells were scored following 
fluorescence microscopy as to whether they contained one centrosome at each pole of mitotic cells, 
comparing with uninfected cells. Cells were immunolabelled for γ-tubulin, a centrosomal marker (red) and 
their DNA was stained with DRAQ5 (blue). Bacteria expressing EGFP are shown in green. Bars represent 
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10 µm. (B) Uninfected RPE1 cells and cells infected for 9 h with wild-type Salmonella or the ∆ssaV and 
∆sseFG mutant strains were stained for DNA and labelled for MPM-2, a mitotic cell marker. Then they 
were subjected to flow cytometry analysis and the percentage of MPM-2 positive cells was measured for 
each population. Infected cells were identified by gating for EGFP-positive cells. Experiments were done 
at least 2 times and at least 30,000 cells were analysed in each sample. 
 
5.2.8. Binucleation of host cells is dependent on the formation of a microcolony 
Salmonella mutant strains lacking either SseF or SseG localize initially to the Golgi network, but 
then scatter throughout the cell, suggesting that these two effectors maintain the juxtanuclear 
positioning of SCVs (Ramsden et al., 2007b). Additionally, a Salmonella mutant strain lacking 
the effector SifA shows centrifugal scattering in infected cells (Boucrot et al., 2005).  
It has been reported that a foreign body, such as latex beads, Chlamydia inclusions or a dead 
cell, can disrupt cytokinesis by physically blocking the cleavage furrow (Krajcovic et al., 2011; 
Sun et al., 2011). These studies suggest that cytokinesis can fail if the foreign body is oriented 
within the cleavage plane, but is successful if the foreign body is positioned away from it 
(Krajcovic et al., 2011).  
Since vacuoles containing the Salmonella mutants that failed to induce binucleation also scatter 
throughout the infected cell, it was hypothesised that the physical presence of a cluster of SCVs 
(microcolony) induces binucleation by blocking the cleavage furrow during cytokinesis. To test 
this hypothesis, RPE1 cells were infected for 14 h with wild-type Salmonella and also with the 
∆ssaV, ∆sseF, ∆sseG and ∆sifA mutant strains, all of which scatter inside the host cell. First, 
the frequency of the binucleation phenotype was quantified by calculating the percentage of 
cells with one or two nuclei, comparing these between cells infected with the wild-type and the 
different mutant strains. As expected, approximately 50% of cells infected with the wild-type 
were binucleated, compared to about 15% of binucleated cells infected with the ∆sseF or the 
∆sseG mutant, 11% infected with the ∆ssaV mutant or 6% infected with the ∆sifA mutant (figure 
5.7A). Then the percentages of infected cells displaying microcolonies or scattered bacteria 
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were calculated for each strain. Approximately 60% of cells infected with any of the mutant 
strains had scattered bacteria, compared to less than 20% of cells infected with the wild-type 
(fig 5.7B). To assess if binucleation of host cells was dependent on microcolony formation, the 
percentage of infected binucleated cells with microcolonies or scattered bacteria was 
determined for each strain. For the wild-type and all the mutant strains, approximately 90% of 
cells that contained a microcolony were binucleated (fig 5.7C). 
Scoring the number of cells harbouring microcolonies instead of scoring the total population of 
infected cells revealed that similar percentages of binucleated cells for all the strains. These 
results show that binucleation of host cells induced by Salmonella is dependent on the presence 
of the microcolony and that this phenotype was not caused by the mutant strains to the same 
extent as the wild-type because these mutants often scatter throughout the cell. A 
representative image taken by immunofluorescence microscopy shows a binucleated cell 
containing a microcolony formed by the ∆sseG mutant strain, although cells with scattered 
bacteria only possess one nucleus (figure 5.7D). 
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Figure 5.7. Binucleation of host cells induced by Salmonella is dependent on the formation of a 
microcolony. RPE1 cells were infected for 14 h with wild-type S. Typhimurium or the ∆ssaV, ∆sseG, 
∆sseF or ∆sifA mutant strains. (A) Percentage of infected cells with one nucleus or binucleated. (B) 
Percentage of infected cells with a microcolony or with dispersed bacteria. (C) Percentage of infected 
binucleated cells with a microcolony or with dispersed bacteria. (D) Immunofluorescence microscopy 
image of cells infected with the ∆sseG mutant strain expressing EGFP (green), following immunolabelling 
for α-tubulin (red) and staining of DNA (blue). Arrow is pointing at a binucleated cells infected with a 
microcolony. Bars represent 20 µm. (A-C) *P<0.05; **P<0.01, ***P<0.001 (compared to uninfected). At 
least 400 cells were counted for each category. 
  
5.2.9. SseG and SseF localize Salmonella to the intercellular bridge during 
cytokinesis   
The last step of cytokinesis is the abscission, which consists of removal of cytoskeletal 
structures from the bridge between the emerging daughter cells, constriction of the cell cortex, 
and fission of the plasma membrane (Fededa and Gerlich, 2012). Since the binucleation of host 
cells was dependent on the formation of the Salmonella microcolony, it was hypothesised that 
the cluster of SCVs might physically block abscission of the intercellular bridge formed at late 
cytokinesis. To test this, RPE1 cells were infected for 12 h with wild-type Salmonella or the 
mutant strain ∆sseFG, both expressing EGFP constitutively. Next, the cells were labelled for α-
tubulin to allow visualization of the intercellular bridge. Infected cells were then scored following 
fluorescence microscopy as to whether they contained bacteria within 10 μm from the middle 
point of the intercellular bridge. Approximately 85% of cells undergoing cytokinesis contained 
wild-type bacteria within this range compared to only 50% of cells infected with the ∆sseFG 
mutant strain (figure 5.8A). This shows that SseF and SseG contribute to the localization of 
Salmonella within the intercellular bridge during cytokinesis, which supports the hypothesis that 
clustered bacteria block cytokinesis during abscission.  
Since SseF and SseG are membrane-bound proteins which localize to the SCV and Sifs after 
translocation (Kuhle and Hensel, 2002), it was hypothesised that they could bind a host protein 
present at the intercellular bridge, pulling the bacteria to this location during cytokinesis. To 
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investigate this, Salmonella strains carrying plasmids expressing constitutively sseF::HA, 
sseG::HA, or sseL::HA gene fusions were used to infect RPE1 cells for 12 h. The cells were 
then labelled for α-tubulin and for the HA epitope, to visualize intercellular bridges and the 
localization of the tagged effectors during cytokinesis, respectively. Immunofluorescence 
analysis of the HA-tagged effectors translocated by Salmonella showed that SseG and SseF, 
but not SseL, localized to the intercellular bridge during late cytokinesis. This was determined 
by calculating the co-localization coefficient between the HA-effectors and α-tubulin at the 
intercellular bridge (figure 5.8C). Representative images of translocated HA-SseF and –SseG, 
but not –SseL, co-localizing to the intercellular bridge during cytokinesis are shown in figure 
5.8B.  
 
5.2.10. Intracellular Salmonella arrests cells in cytokinesis by affecting the NoCut 
pathway  
The process of abscission depends on the Aurora B kinase: active Aurora B present in the 
midbody inhibits abscission until the division plane is cleared. This process, also known as the 
“NoCut pathway”, is thought to function as a “checkpoint” during cytokinesis, to protect 
missegregation of chromosomes and subsequent tetraploidization (Steigemann et al., 2009). 
To assess if intracellular Salmonella induced binucleation of host cells by interfering with the 
NoCut pathway, RPE1 cells infected for 12 h with the wild-type strain or the ∆ssaV, ∆sseFG, or 
∆sifA mutants were labelled for Aurora B and their DNA was stained. Immunofluorescence 
microscopy examination revealed that cells infected with the wild-type strain were arrested 
during abscission, as almost 15% of the total of infected cells had intercellular bridges showing 
Aurora B in the midbody.  
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Figure 5.8. Localization of Salmonella and epitope-tagged effectors to the intercellular bridge 
during cytokinesis. (A) RPE1 infected cells with wild-type S. Typhimurium and the mutant strain 
155 
 
∆sseFG, were scored following fluorescence microscopy as to whether they contained bacteria within 10 
μm from the middle point of the intercellular bridge. (B) Cells were immunolabelled for α-tubulin (red) and 
HA (green). DNA was stained with DRAQ5 (blue). Note that yellow indicates co-localization between α-
tubulin at the intercellular bridge and HA-tagged effector. Bars represent 10 µm. (C) Pearson coefficient 
analysis calculated in Volocity by intensity correlation of α-tubulin fluorescence with HA-effector 
fluorescence. At least 30 cells were measured in each group. The bar indicates the mean. *P<0.05; 
**P<0.01.  
                       
Less than 4% of cells infected with any of the mutant strains showed intercellular bridges 
containing Aurora B. A similar percentage was calculated for the uninfected cells (figure 5.9A). 
This strongly suggests that wild-type Salmonella causes a delay in abscission. In addition, total 
cell lysates of uninfected cells and cells infected for 12 h with the wild-type strain or infected 
with the ∆sseFG mutant strain were subjected to immunoblotting analysis using an antibody 
that specifically recognizes the active form of Aurora B (phosphorylated). In agreement with the 
immunofluorescence microscopy examination, the lysates of cells infected with wild-type 
Salmonella showed much higher levels of phospho-Aurora B than cells infected with the 
∆sseFG mutant strain or uninfected cells (figure 5.9B). Taken together, these results indicate 
that Salmonella arrests cells during abscission by preventing deactivation of Aurora B in a 
process that is dependent on the T3SS-2 effectors SseF, SseG and SifA. 
 
5.2.11. Intracellular Salmonella induces binucleation in vivo 
Oral inoculation of mice with S. Typhimurium induces a systemic disease that resembles 
typhoid fever in humans. Common hallmarks of both diseases include successful colonisation of 
the epithelium of the small intestine, liver, spleen and gallbladder (Valdez et al., 2009). Resident 
stem cells in the intestinal crypts give rise to fast proliferating cells that migrate upwards to 
regenerate the layer of enterocytes in the villi. Since cell division within the small intestine is 
fast, continuous and well known, mice were orally infected with S. Typhimurium to assess if 
binucleation of host cells is induced in vivo.  
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Figure 5.9. Intracellular Salmonella arrests cells in abscission by preventing Aurora B 
degradation. (A) RPE1 infected cells with wild-type and S. Typhimurium mutant strains ∆ssaV, ∆sseFG 
or ∆sifA were scored following fluorescence microscopy as to whether they contained Aurora B positive 
intercellular bridges in comparison to uninfected cells. Cells were immunolabelled for Aurora B (red). DNA 
was stained with DRAQ5 (blue) and EGFP-expressing bacteria are shown in green. Bars represent 10 
µm. (B) SDS-PAGE and immunoblotting of the levels of phosphorylated-Aurora B of RPE1 cell lysates 
infected with wild-type Salmonella or the mutant strain ∆sseFG and uninfected. Control shows 
immunoblotting against actin. This is a representative immunoblot from 2 independent experiments. 
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Initially mice were infected for 72 h, 120 h or 168 h with the wild-type strain 12023, constitutively 
expressing mCherry. This fluorescent protein is more photostable in vivo and has higher tissue 
penetration than EGFP (Shaner et al., 2005). At each time point, the mice were sacrificed and 
their small intestines were removed and sectioned for histochemistry analysis. After staining for 
DNA and actin, to visualize the nuclei and cell margins, respectively, histological slices were 
analysed by fluorescence microscopy. A total of approximately 100 infected and uninfected cells 
were analysed for each time point. Quantification of the number of nuclei in cells from the 
intestinal crypts showed that 48%, 38% and 52% of infected cells were binucleated after 72 h, 
120 h and 168 h, respectively (figure 5.10A and B). 
Next, mice were orally infected for 120 h with the wild-type strain, the ∆sseF mutant and the 
∆sseG mutant strain, all expressing mCherry constitutively. As a negative control, one mouse 
was not infected. Then the mice were sacrificed and their small intestines were removed and 
treated with accutase to allow tissue desegregation. Next, individual cells were stained for DNA 
and analyzed by flow cytometry. DNA histograms of single cells from the small intestine 
belonging to wild-type infected mice showed a peak corresponding to cells with 4n DNA. This 
peak was not present in the histograms from cells belonging to mice infected with the mutant 
strains or the uninfected mouse (figure 5.10C). It is likely that the increase in the 4n peak of 
DNA fluorescence caused by the wild-type infection corresponds to binucleated cells. 
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Figure 5.10. Intracellular Salmonella induces binucleation of host cells in vivo. (A) Histochemistry 
images from slices of the small intestine of mice infected with mCherry-expressing wild-type S. 
Typhimurium 168 h after oral inoculation. Salmonella is shown in red, DNA in blue and actin in green. On 
the left is a wide view of the crypts and the villi (bar represents 50 µm). Arrows point at infected cells. On 
the right are close images showing crypt cells binucleated, as pointed by the arrows (bars represent 10 
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µm (top) and 3 µm (bottom)). (B) Mice orally infected for 72, 120 and 168 h with mCherry-expressing 
wild-type S. Typhimurium and their intestine analysed by histochemistry. Percentages of binucleated cells 
in the crypts were scored by fluorescence microscopy, distinguishing between infected and uninfected. 
This experiment was only made once and approximately 100 cells were analysed for each time point. (C) 
Small intestines of uninfected or orally infected mice for 120 h with mCherry-expressing wild-type S. 
Typhimurium or the ∆sseG and ∆sseF mutants were treated with accutase to obtain single cells and 
analysed by flow cytometry, following DNA staining with DRAQ5. 2 mice per strain of Salmonella were 
infected and analysed. For the DNA histograms, only one experiment was made and at least 100,000 
cells were analysed in each sample. 
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CHAPTER 6 
DISCUSSION 
 
6.1. Salmonella preferential invasion of mitotic cells is mediated by SipB  
The intimate attachment of extracellular Salmonella to the host cell depends on the assembly of 
the translocon complex within the targeted plasma membrane (Misselwitz et al., 2011a). This is 
likely to result from the concerted binding activity of SipB, SipC, and SipD, to their respective 
targets. SipB binds to plasma membrane cholesterol (Garner et al., 2002; Hayward et al., 2005) 
and SipC binds to Exo70, a component of the exocyst complex (Nichols and Casanova, 2010). 
Although the binding partner of SipD remains unknown, its action is essential for the formation 
of the translocon complex, as Salmonella strains lacking sipD do not insert SipB or SipC in the 
plasma membrane of the host cell and therefore are unable to attach to it (Lara-Tejero and 
Galan, 2009). In chapter 3 of this dissertation it is reported that Salmonella invades cells in 
mitosis preferentially. After an infection of 10 min at a multiplicity of infection of 100, 
approximately 60% of G2, but 93% of mitotic cells were infected by SL1344 (figure 3.5B). Less 
than 20% of interphase but 60% of mitotic cells contained over 2 bacteria per cell (figure 3.3D). 
As a consequence, about 30% of all intracellular bacteria in the sample were inside mitotic cells 
(figure 3.3C).  
A report published recently asserts that mitotic cells are targeted by Salmonella preferentially 
due to their prominent topology. In adherent cell cultures, as mitotic cells round up, they 
become significantly higher than interphase cells. Hence, the authors suggest that mitotic cells 
represent obstacles within the cellular landscape and are therefore more likely to be 
encountered by Salmonella (Misselwitz et al., 2012). Nonetheless, during this investigation it 
was found that Salmonella preference for mitotic cells remained when the infection was carried 
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out on rounded cells after detachment, showing that this phenotype cannot be explained only by 
the spherical shape of cells in mitosis (figure 3.6B).  
Furthermore, it was found that the preferential targeting of these cells was dependent on the 
assembly of the T3SS-1 translocon (fig 3.8), and more specifically on the action of the 
translocases SipB and SipD. Since the ∆sipB mutant strain failed to target mitotic cells 
preferentially, it was not surprising that the ∆sipD mutant displayed the same phenotype (figure 
3.11), as in the absence of SipD, the other two translocases, SipB and SipC, are not secreted 
and the translocon pore is not formed (Lara-Tejero and Galan, 2009). These findings suggest 
that the T3SS-1 dependent targeting of mitotic cells by Salmonella was solely dependent on the 
function of SipB. 
 
6.2. Salmonella preference to invade mitotic cells might contribute to their 
tumour-targeting 
Preferential invasion of mitotic cells could help to explain the molecular mechanisms underlying 
the preferential targeting of tumours by S. Typhimurium. More than one century ago, Coley 
observed that some cancer patients were cured of their tumours following post-operative 
bacterial infection (Coley, 1910). Since then many genera of bacteria have been shown to 
preferentially accumulate in tumours and have therefore been used as anti-cancer vectors 
(Malmgren and Flanigan, 1955; Thiele et al., 1964; Kimura et al., 1980). Some bacteria can 
specifically target tumours, actively penetrate their tissue and induce cytotoxicity. Over the past 
decade, bacteria such as Salmonella have been shown to control tumour growth and promote 
survival in animal models (Pawelek et al., 1997; Vendrell et al., 2010). Nowadays, S. 
Typhimurium is the most studied species for use as an anti-cancer vector (Forbes, 2010). To 
date, five interacting mechanisms have been proposed to explain how Salmonella is thought to 
colonise tumours: entrapment of bacterial cells in the vasculature surrounding the tumour 
(Forbes et al., 2003); influx of bacteria into tumours after inflammation (Leschner et al., 2009); 
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chemotaxis towards compounds released by tumour cells (Kasinskas and Forbes, 2006); 
facilitated growth within the tumour microenvironment (Zhao et al., 2005); and protection from 
immune responses (Sznol et al., 2000). Following attenuation, mainly by the introduction of 
auxotrophic mutations, S. Typhimurium has been used extensively in cancer therapy, as it 
replicates in tumours to levels more than 1000-fold greater than in normal tissue (Low et al., 
1999). Importantly, S. Typhimurium was shown not only to colonise established tumours, but 
also exhibits the capacity to invade and clear metastases (Hayashi et al., 2009).  
Since most cells within a tumour are in a proliferative state, and therefore frequently undergoing 
mitosis, perhaps tumour targeting shown by S. Typhimurium might relate to their preference for 
infection of mitotic cells, as demonstrated by this study. But surprisingly, two reports claim that 
tumour targeting by Salmonella is T3SS-1 independent, as both studies report successful 
invasion and colonisation of tumours in mice by S. Typhimurium mutant strains lacking a 
functional T3SS-1 (Pawelek et al., 2002; Crull et al., 2011). It is known that S. Typhimurium can 
invade non-phagocytic cells through the invasin Rck, an outer membrane protein that induces a 
zipper-like mode of entry (Rosselin et al., 2010). Rck induces the activation of the GTPases 
Rac1 and Cdc42 to trigger actin polymerization via the Arp2/3 nucleator complex. This leads to 
membrane rearrangements at the site of bacteria-cell contact, and permits entry of the bacteria 
into the host cell (Mijouin et al., 2012). Thus, it is possible that invasion of tumour cells in vivo is 
solely mediated by Rck. However, it is striking that no differences in invasion of tumours were 
observed between the wild-type and the T3SS-1 null mutant strain (Pawelek et al., 2002; Crull 
et al., 2011), since Rck expression is low and its contribution to the invasion of non-phagocytic 
cells grown in vitro is thought to be negligible (Rosselin et al., 2010). The receptor of Rck on the 
host cell membrane is unknown and it is possible that it is overexpressed in tumours. This could 
be an explanation for how a T3SS-1 null mutant of Salmonella is able to colonise and invade 
tumours in vivo as efficiently as the wild-type strain.  
Importantly, in both studies reporting no influence of the T3SS-1 in tumour invasion and 
colonisation by Salmonella it is not clear if the bacteria recovered from the tissue were extra- or 
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intracellular. In both cases, the authors do not provide any information whether the bacteria are 
localized inside or outside the tumour cells. Although they use the term “invasion”, it is unclear if 
it concerns actual internalization of cells or just generalized infiltration of the bacteria within the 
tumours. Incubating the tumour tissue with gentamicin prior to homogenization and subsequent 
bacterial counting would enable killing of extracellular Salmonella and assess intracellular 
bacterial numbers. If the preferential targeting of mitotic cells contributes to the in vivo targeting 
of tumours, more wild-type Salmonella than the T3SS-1 null mutant strain would be expected to 
be recovered from tumour tissues previously treated with gentamicin. However, since the T3SS-
1 is thought to play a major role in bacterial attachment to host cells (Misselwitz et al., 2011b), it 
is nonetheless puzzling that a T3SS-1 null mutant strain of Salmonella colonises tumours to the 
same degree as the wild-type, even if the bacteria recovered are exclusively extracellular. To 
assess the role of the T3SS-1 in the targeting and colonisation of tumours more thoroughly 
further investigations need to be performed, namely to assess how many intracellular bacteria 
are recovered after tissue homogenization and also if Rck-mediated invasion of cells is 
involved. 
 
6.3. Salmonella preference to invade mitotic cells might facilitate the localization 
of the bacteria to the intestinal crypts  
Besides a possible role in tumour targeting, the preference of Salmonella to infect mitotic cells 
might be important to localize the bacteria to the intestinal crypts, as actively cycling cells are 
abundant there. Indeed, histochemistry analysis of sections from the small intestines of mice 
orally infected with S. Typhimurium for 72 h showed more infected cells in the intestinal crypts 
than in the villi (figure 6.1). This observation supports the hypothesis that preferential infection 
of mitotic cells by Salmonella might target the bacteria to the intestinal crypts, perhaps slowing 
down the fast turnover of the epithelium and therefore facilitating its colonisation. However, the 
targeting of Salmonella to crypt cells in comparison to cells from the villi was not quantified 
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since 72 h is not a suitable time point to assess preferential infection, as Salmonella is thought 
to disseminate throughout the intestinal tissue with time. Therefore, a much shorter time point 
(12 or 24 h) should have been tested to accurately allow determining which sites of the small 
intestine are preferentially infected by Salmonella. Additionally, to help determine if the 
preference of Salmonella to infect mitotic cells is relevant for its pathogenesis, mitotic inhibitors 
could be used to treat mice prior to oral inoculation with the bacteria. Quantification of the 
number of Salmonella colony forming units (CFUs) recovered from the small intestines of mice 
treated or not with the mitotic inhibitor, together with histochemistry analysis, could help to 
determine if preferential infection of cells in mitosis is important for intestinal colonisation and 
progression of the disease. Such mitotic inhibitors, like the highly selective inhibitors of 
CDK4/cyclin D1 and CDK6/cyclin D2 that arrest cycling cells in G1, are available commercially 
for research purposes. Due to time restrictions, these experiments were not performed. 
During the first part of this study it was found that S. Typhimurium invades mitotic cells 
preferentially. This phenotype is at least partially independent of the spherical shape of cells 
during mitosis. Also, it was found that this preferential targeting is dependent on Salmonella’s 
T3SS-1 and specifically on the action of the translocase SipB. Perhaps this attribute of 
Salmonella contributes to the well characterized targeting of tumours, but to accurately assess 
this, more experiments need to be done. In addition, preferential infection of mitotic cells by 
Salmonella might be important for the bacteria to persistently colonise the intestinal epithelium. 
Targeting of cycling cells in the crypts might help to slow down the turnover of the epithelium 
and facilitate its colonisation by Salmonella, but further studies need to be carried out to test this 
hypothesis. 
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Figure 6.1. Salmonella localization to the intestinal crypts. Histochemistry image showing a wide view 
of crypts and villi of the small intestine of a mouse infected with mCherry-expressing wild-type Salmonella 
for 72 h. Salmonella is shown in red, DNA in blue and actin in green. Bar represents 100 µm. 
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6.4. Cell surface cholesterol is maximal during metaphase due to a loss in its 
asymmetry at the plasma membrane during mitosis 
The binding of Salmonella to the host cell and the assembly of the translocon pore depend on 
the presence of cholesterol in the targeted membrane (Garner et al., 2002; Hayward et al., 
2005). In chapter 4 it is reported that, like in interphase cells, the binding of Salmonella to 
mitotic cells was dependent on cholesterol, which suggests the same mode of entry (figure 4.1). 
In addition, the finding that Salmonella invades cells undergoing mitosis more efficiently than 
during other phases of their cell cycle revealed that the levels of cell surface cholesterol when 
cells divide were higher than in cells in interphase (figure 4.2C-H and 4.3). This increase in 
surface cholesterol could be due to a rapid synthesis during mitosis, as the levels of cholesterol 
are known to rise globally along the cell cycle (Fielding et al., 1999). Although the prevailing 
view is that the synthesis of lipids in mitosis is switched-off (Jackowski, 1996; Jackowski et al., 
1997), a report in 2007 showed that phospholipids are actively synthesized in G2/mitosis in 
MCF-7 and CHO cells (Lin and Arthur, 2007).  
Despite this, the increase in the surface cholesterol levels during mitosis reported here is 
unlikely to be due to its rapid synthesis from G2 to mitosis since the total levels of cholesterol in 
the plasma membrane do not change between these two stages, but the surface levels increase 
(figure 4.2H). These measurements suggested a transient loss in cholesterol asymmetry at the 
plasma membrane during mitosis, like phosphatidylserine and phosphatidylethanolamine that 
are transiently exposed at the surface of the cleavage furrow during cytokinesis, although they 
are mainly located at the cytoplasmic leaflet of the plasma membrane during interphase (Emoto 
et al., 2005). Measuring the fluorescence of DHE, a natural derivative of cholesterol, before and 
after quenching with TNBS further supported this hypothesis: the asymmetric distribution of 
DHE between the two leaflets of the plasma membrane observed during interphase (~20:80, 
outer:inner leaflet) ceased during mitosis when it is partitioned more equally (~50:50) (figure 
4.4).  
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Therefore, the large differences in surface cholesterol between G2 and mitosis probably result 
from the activity of a cholesterol transporter within the plasma membrane. 
Taken together, these investigations strongly suggest that the transient interruption in 
cholesterol asymmetry during mitosis increases its levels at the cell surface rendering mitotic 
cells more susceptible to Salmonella. Perhaps other cholesterol-dependent invasive bacteria 
and viruses are also more prone to infect mitotic cells. These cells may constitute a weak point 
in the host cell cycle that pathogens exploit to invade highly replicative organs, such as the 
intestine. To assess this, similar experiments to the ones presented in this dissertation should 
be done using other pathogens that rely on cholesterol to infect host cells. These include 
several species of bacteria, such as Shigella, Listeria or Chlamydia; or many viruses, such as 
Influenza or HIV-1 (Goluszko and Nowicki, 2005).  
 
6.5. A cholesterol transporter within the plasma membrane is probably 
responsible for the loss of its asymmetry during mitosis 
The transbilayer distribution of lipids across biological membranes is believed to be inherently 
asymmetric (Daleke, 2003). It is thought that the most significant contributors to the 
maintenance of the transbilayer lipid asymmetry are proteins that catalyze the movement of 
lipids across the membrane. They are classified according to their substrate specificity, direction 
of transport and energy requirement. Two classes of proteins, “flippases” and “floppases”, are 
responsible for the ATP-dependent transport of lipids across the plasma membrane. Flippases 
use ATP to move the aminophospholipids phosphatidylserine (PS) and 
phosphatidylethanolamine (PE) from the outer leaflet to the inner leaflet of the plasma 
membrane against a concentration gradient. Floppases use ATP to transport substrates against 
concentration gradients in the opposite direction, such as phosphatidylcholine (PC), sphingolipid 
(SL) and cholesterol. On the other hand, ATP-independent and less specific lipid transport 
activities are carried out by “scramblases”. Scramblases facilitate the movement of lipids in both 
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directions along concentration gradients (Daleke, 2003).  The ABC (ATP-binding cassette) 
transporter ABCA1 is thought to act as a floppase for cholesterol as it has been shown to 
transport cholesterol out of cells (Bodzioch et al., 1999; Rust et al., 1999). Perhaps ABCA1 is 
activated during mitosis and moves cholesterol from the inner to the outer leaflet of the plasma 
membrane, leading to the loss of asymmetry reported here. Alternatively, an unidentified 
flippase, or even scramblase, specific for cholesterol partitioning might be inactivated during 
mitosis leading to the changes in its partitioning within the plasma membrane.  
To assess the molecular mechanism by which the cholesterol asymmetry in the plasma 
membrane is lost during mitosis, further studies need to be carried out. For example, if the 
differences in surface cholesterol between G2 and mitosis are due to the activity of a flippase or 
a floppase, this can be assessed by treating cells with sodium azide and 2-deoxyglucose to 
block ATP production by oxidative phosphorylation and glycolysis, respectively. Additionally, to 
test if the loss of cholesterol asymmetry during mitosis is due to the action a scramblase, cells 
could be treated with ionomycin and Ca2+, as this will overactivate the Ca2+-dependent 
scramblase reported to be responsible for lipid reorganization in the plasma membrane (Daleke, 
2003). Determining the cholesterol asymmetry in treated and non-treated cells by measuring the 
fluorescence of DHE before and after quenching with TNBS should provide a strong indication 
to whether this phenotype is due to the activity of a cholesterol flippase, floppase or scramblase. 
Further studies may also include screening cells for this phenotype by knocking down the 
expression of genes annotated as flippases, floppases or scramblases with the use of specific 
siRNAs.              
   
6.6. Cholesterol asymmetry supports mitotic cell rounding 
Conversely, the transient interruption in cholesterol asymmetry during mitosis leads to a 
decrease in the levels of cholesterol at the inner, cytosolic, leaflet of the plasma membrane. The 
decrease in cholesterol levels at the inner leaflet of the plasma membrane reported here is 
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consistent with the recent observation that the levels of the cholesterol-binding protein caveolin-
1 decrease during mitotic rounding, to reach a minimum during metaphase (Boucrot et al., 
2011). To investigate if this had any role during mitosis, cells were enriched with cholesterol 
complexes to mitigate the decrease in its levels at the inner leaflet. Strikingly, the addition of 
cholesterol perturbed cell compaction and rounding causing metaphase cells to become 
significantly bigger (figure 4.5). The formation of the rigid cortical actin network driving mitotic 
compaction is mediated by RhoA (Maddox and Burridge, 2003) and activated ERM (Ezrin, 
Radixin, Moesin) proteins (Kunda et al., 2008) that bridge actin filaments to the plasma 
membrane. Further investigations led to the finding that cholesterol addition did not affect the 
recruitment of Rho GTPases, including RhoA, to the plasma membrane during mitosis (figure 
4.6), but strongly decreased the recruitment of activated ERM proteins (figure 4.7A-C). This 
decrease is likely to explain the defects in mitotic cell rounding caused by cholesterol addition. 
As ERM proteins are not known to bind directly to cholesterol but to phosphatidylinositol-4,5-bis-
phosphate (PI(4,5)P2) (Roch et al., 2010; Roubinet et al., 2011), it was hypothesised that a 
decrease in cholesterol could favour ERM protein recruitment by supporting higher levels of 
Pi(4,5)P2. This hypothesis was tested and verified, as cholesterol enrichment led to a decrease 
in Pi(4,5)P2 levels during metaphase (figure 4.7D and E), in agreement with a previous report 
(Chun et al., 2010). 
These findings indicate that the transient interruption in cholesterol asymmetry during mitosis 
decreases its levels at the cytosolic leaflet of the plasma membrane. This decrease would allow 
higher levels of Pi(4,5)P2 to associate to the plasma membrane and to recruit Ezrin, Radixin 
and Moesin, leading to the formation of the rigid cortical actin network that drives mitotic 
rounding. Importantly, the pause in cholesterol asymmetry during cell division reported here is 
likely to be regulated. Future clarification of its mechanism will help to further understand mitotic 
compaction and cortical rigidity. The loss of cholesterol asymmetry during mitosis might be 
important to ensure efficient bipolar spindle formation, as failure to round up has been recently 
shown to cause defects in spindle morphogenesis (Lancaster et al., 2013).     
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6.7. Intracellular Salmonella microcolonies induce failure during cytokinesis 
leading to binucleated host cells 
After internalization of the host cell, S. Typhimurium proliferates in a vacuole. Most intracellular 
replication occurs after the SCV reaches a perinuclear location that coincides with the Golgi 
network (Salcedo and Holden, 2003; Abrahams et al., 2006). Extensive replication then results 
in the formation of a so-called “microcolony”, a cluster of bacterial cells, each enclosed in its 
own membrane. Salmonella replication inside the host cell depends on the T3SS-2, which 
delivers approximately 30 effectors across the SCV membrane. These effectors are thought to 
enable the replication of intracellular Salmonella by manipulating host cell processes through 
direct interactions with host factors, such as proteins or lipids (Figueira and Holden, 2012). 
Since little was known about the influence of S. Typhimurium infections, and in particular of the 
T3SS-2, in the progression of the host cell cycle, several experiments were made to assess 
this. These results are described in chapter 5 of this thesis. 
Initially, FACS analysis of infected RPE1 cells showed that intracellular Salmonella led to an 
accumulation of cells with 4n DNA (figure 5.1) and subsequent microscopy analysis revealed 
that these cells were 4n because they were binucleated (fig 5.2). After assessing that this 
phenotype was only significant after 12 h of infection (figure 5.3) it was determined that it was 
dependent on a functional T3SS-2 (figure 5.4A). Next, a total of 19 Salmonella mutants lacking 
individual T3SS-2 effectors were tested to determine which were responsible for the 
binucleation of infected cells (fig 5.4B). Of the T3SS-2 effector mutants tested, the ones lacking 
SseF, SseG and SifA failed to cause an accumulation of 4n cells (figure 5.4 and 5.5). Since the 
SCVs containing the Salmonella mutants that failed to induce binucleation also scatter 
throughout the infected cell, it was tested if the Salmonella microcolony induced binucleation by 
blocking the cleavage furrow during cytokinesis. Indeed, more than 90% of infected cells that 
were binucleated contained a microcolony, even when cells were infected with the mutant 
strains that often scatter inside the cell: ∆ssaV, ∆sseF, ∆sseG or ∆sifA (figure 5.7), strongly 
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suggesting a physical obstruction of the cleavage furrow by the cluster of SCVs, similarly to 
what has been reported for Chlamydia inclusions (Sun et al., 2011).  
 
6.8. Possible roles of the effectors SifA, SseF and SseG in cytokinesis failure of 
host cells 
At this point, a direct role of the effector SifA in the localization of the bacteria to the cleavage 
furrow cannot be fully excluded. However, it is well established that SifA is essential for the 
formation of Sifs and to maintain the integrity of the SCV (Barrow et al., 1996; Beuzon et al., 
2000). Indeed, approximately 6 h after infection of cultured epithelial cells, the majority of ∆sifA 
mutant bacteria lose their vacuole, which prevents further translocation of SPI-2 effectors, such 
as SseF and SseG, inside host cells (Beuzon et al., 2000). Since the cytokinesis failure induced 
by Salmonella is only significantly measured after 12 h of infection (figure 5.3), it is likely that the 
∆sifA mutant induces a similar phenotype to the ∆sseF or ∆sseG mutant strains simply because 
at 12 h post-invasion, SseF and SseG fail to be translocated by the ∆sifA mutant. Therefore, a 
potential direct role of the SifA effector in blocking cytokinesis of host cells was disfavoured.   
Moreover, further investigations showed that more wild-type Salmonella than the ∆sseFG 
mutant strain were found within or near the cleavage furrow during cytokinesis of the host cell. 
Additionally, epitope-tagged SseF and SseG, but not SseL, localized to the intercellular bridge 
at late cytokinesis (figure 5.8). This suggests that SseF and SseG are not only essential to 
maintain the bacteria clustered near the Golgi region during interphase but might also help to 
localize bacteria to the cleavage plane during cytokinesis.            
Perhaps SseF and SseG bind to a host protein that participates in cytokinesis, pulling the SCVs 
to the cleavage plane and preventing abscission. Since SseF and SseG are essential to 
maintain the SCVs near the Golgi apparatus and are important to localize them to the cleavage 
furrow during cytokinesis, as shown by this study, perhaps the host target of these effectors is 
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part of the Golgi network during interphase and participates in cytokinesis during cell division: 
for example a protein such as GM130 (Skop et al., 2004). Another possibility is that SseF and 
SseG tether the SCVs to the Golgi apparatus through binding to a host protein and then bind to 
a different one that participates in cytokinesis. Possibly these different host proteins are 
structurally similar and are both targeted by SseF and SseG or alternatively these effectors 
possess different binding sites to different host proteins. However, during these investigations it 
was not possible to identify the host target/s of SseF and SseG. Therefore, future work includes 
the identification of the SseF and SseG host targets. 
Recent work reported that the pulling forces exerted by the emerging daughter cells on the 
intercellular bridge during cytokinesis regulate abscission. The authors found that these forces 
actually prolong the connection, and that abscission occurs only when tension is released. 
Interestingly, membrane tension within the intercellular bridge seems to contribute to the overall 
tension in the bridge that delays abscission, as the authors report low membrane tension in 
cases where cells had short abscission times and high membrane tension when cells showed 
delayed abscission (Lafaurie-Janvore et al., 2013). Release of tension somehow triggers the 
assembly of the ESCRT-III (endosomal sorting complex required for transport-III), which is 
essential for membrane fission and has a central role by recruiting the microtubule-severing 
enzyme spastin (Yang et al., 2008; Lafaurie-Janvore et al., 2013).  
Replication of intracellular Salmonella is accompanied by the formation of Sifs – lysosomal 
membrane glycoprotein-rich tubulovesicular structures that extend away from the SCV along 
with the microtubule network. Sifs are generated by fusion of late endosomes and lysosomes 
with the SCV (Steele-Mortimer, 2008), in a process that ultimately results in extensive 
membrane acquisition by the bacteria and subsequent subversion of the normal membrane 
dynamics inside the host cell. One can speculate that during cytokinesis of infected cells, SCVs 
and Sifs might increase the membrane tension within the intercellular bridge, causing a 
prolonged delay in abscission that could result in cytokinesis failure and thus binucleation. This 
hypothesis actually agrees with the data collected here, as the integrity of the SCV and the 
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formation of Sifs is dependent on SifA and partially dependent on SseF and SseG (Stein et al., 
1996; Beuzon et al., 2000; Ramsden et al., 2007a). However, the impact of SCVs and Sifs on 
membrane tension during cytokinesis of the host cell was not addressed during this study. 
 
6.9. Cytokinesis failure induced by Salmonella probably occurs during abscission 
and seems to depend on the activity of Aurora B  
Studies in yeast and human cells have found an evolutionary conserved pathway that seems to 
work as a checkpoint for cytokinesis (Steigemann and Gerlich, 2009). The kinase Aurora B has 
been shown to regulate the timing of abscission to ensure clearance at the cleavage site at the 
time it occurs. In the human pathway, unsegregated chromosome bridges sustain the activity of 
Aurora B at the midbody, which stabilizes the ingressed cleavage furrow and delays abscission 
up to many hours until chromosome bridges eventually resolve. However, it is still unclear which 
signals lead to inactivation of Aurora B in segregating cells, which occurs about 1 h after furrow 
ingression in cells grown in vitro (Steigemann et al., 2009).  
During this investigation it was found that cells infected for 12 h with wild-type Salmonella have 
higher levels of activated Aurora B compared to cells infected with the ∆sseFG double mutant 
strain or uninfected cells (figure 5.9). Interestingly, this shows that the Aurora B checkpoint is 
activated to a greater extent following infection with Salmonella in an SseF- and SseG -
dependent fashion. Similarly to what occurs when unsegregated chromosomes are located at 
the cleavage plane, perhaps the actions of SseF and SseG localize the SCVs to the cleavage 
furrow and sustain the activity of Aurora B at the midbody, delaying abscission. Possibly the 
signals that sense unsegregated chromosomes preventing Aurora B inactivation are also 
switched on when SCVs are present at the cleavage site. This could explain the cytokinesis 
failure induced by Salmonella reported here, as it has been shown that long-lasting delay in 
abscission often leads to furrow regression and binucleation (Normand and King, 2010) and that 
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overexpression of Aurora B in epithelial cells promotes the generation of tetraploids (Nguyen et 
al., 2009). A scheme representing this hypothesis is shown in figure 6.2. 
 
 
 
Figure 6.2. Intracellular Salmonella microcolonies prevent abscission via Aurora B. (A) When 
Salmonella is scattered inside the host cell, Aurora B is inactivated and abscission occurs normally. (B) 
SseF- and SseG- mediated localization of the Salmonella microcolony to the cleavage plane prevents 
Aurora B inactivation and abscission. Long-lasting delay in abscission leads to furrow regression and the 
formation of a binucleated cell.  
 
Delay in abscission correlates not only with persistent activation of Aurora B, but also of its 
downstream targets, including the midbody protein MKLP1 (mitotic kinesin-like protein 1) and 
A 
B 
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CHMP4C (part of the ESCRT-III complex). MKLP1 phosphorylated by Aurora B is thought to 
stabilize its integration at the midbody, which maintains the intercellular bridge (Steigemann et 
al., 2009). On the other hand, CHMP4C, upon phosphorylation by Aurora B, is thought to 
function as an abscission regulator (Carlton et al., 2012). Clearly, to fully dissect the molecular 
mechanism of cytokinesis failure induced by Salmonella, further work is required, involving the 
assessment of whether MKLP1 and CHMP4C are also over-activated during Salmonella 
infections.     
 
6.10. Implications of cytokinesis failure of host cells during Salmonella infection  
Importantly, it was after assessed that binucleation induced by Salmonella also occurs in vivo, 
as the small intestines of mice infected with wild-type Salmonella carried binucleated infected 
cells in the crypts and higher levels of 4n cells from the small intestine were found in mice 
infected with the wild-type strain compared to mice infected with the ∆sseFG double mutant 
strain or uninfected animals (figure 5.10). Due to time constraints, each of these experiments 
was only carried out once. If confirmed, they strongly suggest that the observations made in 
cultured cells also apply to highly proliferating cells in vivo, namely cells from the epithelium of 
the small intestine. The gut epithelium undergoes continuous self-renewal to maintain overall 
tissue homeostasis and to shed damaged cells. As the damaged cells are eliminated, they are 
replaced by new cells generated from a population of stem cells located at the base of the 
intestinal crypts. Several studies have shown that the epithelial cell turnover increases in 
response to bacterial pathogens (Ashida et al., 2012). This is thought to be an important host 
defence mechanism to eliminate infected cells and therefore to limit persistent bacterial 
colonisation, ultimately ensuring tissue homeostasis. Some bacterial pathogens such as EPEC 
(Enteropathogenic Escherichia coli) or Shigella have been shown to counteract the rapid 
epithelial turnover to maintain enterocytes as a replicative niche. Some EPEC strains deliver the 
protein Cif into host cells, which blocks the host cell cycle by causing both G1/S and G2/M arrest 
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(Samba-Louaka et al., 2008; Yao et al., 2009). Additionally, EPEC also translocates the effector 
NleH, which has been shown to inhibit apoptosis, via procaspase-3 cleavage inhibition. This is 
thought to facilitate EPEC pathogenesis by reducing enterocyte loss, sustaining EPEC’s 
replicative niche (Hemrajani et al., 2010). Interestingly, Shigella seems to be able to manipulate 
epithelial cell turnover by directly accessing the progenitor cells in the crypts, via the 
translocation of the T3SS effector IpaB. In HeLa cells and in the rabbit ileal-loop infection 
model, IpaB was shown to arrest cell cycle progression by direct binding to Mad2L2, an 
anaphase promoting complex inhibitor, to delay the epithelial turnover and promote bacterial 
colonisation (Iwai et al., 2007). Similarly to what has been observed for Shigella, during this 
study it was found that Salmonella also directly accesses the epithelial crypts in the mouse 
model of infection (figure 5.10). Perhaps by blocking cytokinesis in the intestinal crypts, 
Salmonella could delay the epithelial turnover to facilitate its colonisation. To assess this 
directly, further studies are required, involving blocking mitosis in the intestinal crypts of infected 
mice with wild-type or ∆sseFG mutant Salmonella and quantification of the resultant number of 
bacteria in the intestinal epithelium. Also, carrying out histology analysis of small intestines from 
infected and uninfected mice would enable the rate of epithelial turnover to be determined, by 
measuring cell proliferation with BrdU (bromodeoxyuridine) staining. 
Binucleated or tetraploid cells derived from experimentally perturbed cytokinesis induce cancer 
formation in mouse models (Fujiwara et al., 2005). Importantly, multinucleated cells are 
common in all solid tumours and it has been well established that tetraploidy contributes to 
aneuploidy and genomic instability, two hallmarks of cancer formation (Weihua et al., 2011). 
The finding that S. Typhimurium induces cytokinesis failure and consequent binucleation in the 
small intestine of mice suggests that the same process might occur in other organs infected by 
Salmonella, such as the gallbladder. However, assessing binucleation induced by Salmonella in 
the gallbladder of infected mice is extremely challenging, since the gallbladder is not thought to 
enclose many cycling cells and the location of its progenitor cells is not known. Nonetheless, 
this study established the proof of principle that S. Typhimurium induces cytokinesis failure and 
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binucleation in vivo. It is therefore possible that the same occurs in other organs colonised by 
Salmonella, since cytokinesis is an evolutionary conserved fundamental process in cell division. 
Since the molecular mechanisms underlying the association between S. Typhi chronic 
infections and cancer formation are still unclear, it is reasonable to speculate that cytokinesis 
failure in long term Salmonella infections could be an important factor contributing to this. 
Furthermore, during these investigations it was found that wild-type S. Typhimurium somehow 
prevents Aurora B inactivation. Work from others showed that overexpression of Aurora B leads 
to tetraploidy, genomic instability and ultimately tumorigenesis (Smith et al., 2005b; Zeng et al., 
2007; Nguyen et al., 2009; Takeshita et al., 2013). Importantly, the correlation between chronic 
infections with Salmonella and cancer formation concerns the serovar S. Typhi, not S. 
Typhimurium. Since the experiments shown here were carried out using S. Typhimurium 
strains, future work includes assessing if the serovar S. Typhi also induces binucleation of 
infected cells. Interestingly, S. Typhi carries functional SifA, SseF and SseG effectors (Sabbagh 
et al., 2010) and also forms microcolonies inside cells (Spano and Galan, 2012), so it seems 
likely that infections with S. Typhi also lead to binucleation of host cells. If this is the case, it 
further supports the hypothesis that binucleation of host cells induced by Salmonella contributes 
to cancer formation in chronic carriers.    
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